var title_f37_50_38688="Pilocarpine: Patient drug information";
var content_f37_50_38688=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"16\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Pilocarpine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/3/18484?source=see_link\">",
"       Pilocarpine (ophthalmic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/52/28484?source=see_link\">",
"       Pilocarpine (systemic): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10973 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-DB96A30595-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38688=[""].join("\n");
var outline_f37_50_38688=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/3/18484?source=related_link\">",
"      Pilocarpine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?27/52/28484?source=related_link\">",
"      Pilocarpine (systemic): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_50_38689="Contents: Diabetes mellitus";
var content_f37_50_38689=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/56/1934\">",
"       Endocrinology and Diabetes",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Diabetes mellitus",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Diabetes mellitus",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cardiovascular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/15/30970\">",
"           Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/34/11817\">",
"           Glycemic control and vascular complications in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/25/7578\">",
"           Glycemic control and vascular complications in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/33/44567\">",
"           Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/57/28569\">",
"           Heart failure in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/37/27226\">",
"           Prevalence of and risk factors for coronary heart disease in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/20/18761\">",
"           Screening for coronary heart disease in patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/4/5189\">",
"           Smoking and cardiovascular risk in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/20/41289\">",
"           Treatment of acute myocardial infarction in diabetes mellitus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Complications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/26/11687\">",
"           Bone disease in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/11/36023\">",
"           Classification and clinical features of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/7/18551\">",
"           Clinical manifestations and diagnosis of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/33/538\">",
"           Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/46/8938\">",
"           Diabetic autonomic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/25/24985\">",
"           Diabetic autonomic neuropathy of the gastrointestinal tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/38/39527\">",
"           Diabetic neuropathic arthropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/23/10614\">",
"           Dialysis in diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/30/34278\">",
"           Emphysematous urinary tract infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/34/16934\">",
"           Epidemiology and classification of diabetic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/28/38341\">",
"           Erectile dysfunction in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/12/43209\">",
"           Etiology and diagnosis of delayed gastric emptying",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/12/11464\">",
"           Evaluation of the diabetic foot",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/34/11817\">",
"           Glycemic control and vascular complications in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/25/7578\">",
"           Glycemic control and vascular complications in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/15/12534\">",
"           Limited joint mobility in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/28/37321\">",
"           Management of diabetic foot lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/49/42777\">",
"           Microalbuminuria in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/33/39449\">",
"           Microalbuminuria in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/53/22358\">",
"           Musculoskeletal complications in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/63/30714\">",
"           Overview of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/60/41928\">",
"           Pathogenesis and prevention of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/62/14312\">",
"           Pathogenesis of delayed gastric emptying",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/45/30422\">",
"           Pathogenesis of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/38/32362\">",
"           Prevention and treatment of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/18/39207\">",
"           Protein kinase C and the vascular complications of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/39/36472\">",
"           Renal transplantation in diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/32/42501\">",
"           Screening for diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/47/32502\">",
"           Susceptibility to infections in persons with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/50/33576\">",
"           Treatment of delayed gastric emptying",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/48/40714\">",
"           Treatment of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/43/12986\">",
"           Treatment of diabetic neuropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diagnosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/33/14874\">",
"           Classification of diabetes mellitus and genetic diabetic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/54/38758\">",
"           Diagnosis of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/62/37866\">",
"           Medical management and follow-up of gestational diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/63/9210\">",
"           Screening and diagnosis of diabetes mellitus during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/16/2312\">",
"           Screening for diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/9/32920\">",
"           Syndromes of ketosis-prone diabetes mellitus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fluid and electrolytes",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/55/4986\">",
"           Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/16/44295\">",
"           Epidemiology and pathogenesis of diabetic ketoacidosis and hyperosmolar hyperglycemic state",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/48/15114\">",
"           Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hypoglycemia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/57/18330\">",
"           Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/35/22071\">",
"           Diagnostic dilemmas in hypoglycemia: Illustrative cases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/32/18951\">",
"           Factitious hypoglycemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/39/24184\">",
"           Hypoglycemia in adults without diabetes mellitus: Diagnostic approach",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/39/44664\">",
"           Hypoglycemia in adults: Clinical manifestations, definition, and causes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/30/12777\">",
"           Insulinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/63/27641\">",
"           Management of hypoglycemia during treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/36/44614\">",
"           Noninsulinoma pancreatogenous hypoglycemia syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/12/11461\">",
"           Nonislet cell tumor hypoglycemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/60/29638\">",
"           Physiologic response to hypoglycemia in normal subjects and patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/11/3255\">",
"           Postprandial (reactive) hypoglycemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes cases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/1/10259\">",
"           Interactive diabetes case 10: A 45-year old woman with variable glucose values and hypoglycemia unawareness on insulin therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/4/8258\">",
"           Interactive diabetes case 11: A 34-year old pregnant woman with type 2 diabetes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/22/13666\">",
"           Interactive diabetes case 12: Perioperative management of a 67-year-old man with type 2 diabetes who undergoes coronary artery bypass surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/16/32002\">",
"           Interactive diabetes case 13: Deterioration of metabolic control in a 59-year-old man with type 2 diabetes complicated by retinopathy, nephropathy, and neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/12/6339\">",
"           Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/46/37602\">",
"           Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/48/39682\">",
"           Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/54/9058\">",
"           Interactive diabetes case 17: A 57-year-old woman with newly discovered type 2 diabetes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/48/5889\">",
"           Interactive diabetes case 1: Inpatient management in type 1 diabetes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/10/2210\">",
"           Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/20/9538\">",
"           Interactive diabetes case 3: Hypoglycemia in a patient with type 1 diabetes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/21/12626\">",
"           Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/17/13586\">",
"           Interactive diabetes case 5: Insulin management in a 73-year-old diabetic woman admitted to the hospital",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/27/30129\">",
"           Interactive diabetes case 6: Uncontrolled diabetes in a 64-year-old woman treated with insulin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/4/2114\">",
"           Interactive diabetes case 7: Management of diabetes in a 72-year-old man with type 2 diabetes, GI bleeding and multiple other medical problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/13/4306\">",
"           Interactive diabetes case 8: Discordant values for A1C and home blood glucose values",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/60/15299\">",
"           Interactive diabetes case 9: Management of type 1 diabetes in a patient on glucocorticoid therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/35/2617\">",
"           Approach to the patient with weight loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/43/18102\">",
"           Carbohydrate and insulin metabolism in chronic kidney disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/60/28617\">",
"           Clinical manifestations of hereditary hemochromatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/58/25511\">",
"           Insulin action",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/46/41702\">",
"           Insulin secretion and pancreatic beta-cell function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/61/22484\">",
"           Mechanisms of glomerular hyperfiltration in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/42/23210\">",
"           Pathogenesis of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/31/36346\">",
"           Pathogenesis of type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/19/35129\">",
"           Pathophysiology and diagnosis of iron overload syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/63/29688\">",
"           Perioperative management of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/24/9610\">",
"           Risk factors for type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/23/6522\">",
"           Structure and function of the insulin receptor",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obesity and insulin resistance",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/22/18789\">",
"           Determining body composition in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/9/8345\">",
"           Dietary therapy for obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/4/33866\">",
"           Drug therapy of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/21/3418\">",
"           Etiology and natural history of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/23/16758\">",
"           Ghrelin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/35/30266\">",
"           Health hazards associated with obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/57/28567\">",
"           Insulin resistance: Definition and clinical spectrum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/51/23352\">",
"           Lipodystrophic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/45/13016\">",
"           Overview of therapy for obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/38/13929\">",
"           Pathogenesis of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/2/32810\">",
"           Postoperative management of the critically ill obese patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/41/21144\">",
"           Role of physical activity and exercise in obese adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/20/12615\">",
"           Screening for and clinical evaluation of obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/31/33274\">",
"           Surgical management of severe obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/11/29882\">",
"           The impact of obesity on fertility and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/11/32954\">",
"           The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Prediction and prevention",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/30/29162\">",
"           Prediction and prevention of type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/21/32087\">",
"           Prediction of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/5/13401\">",
"           Prevention of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/48/44809\">",
"           Infant of a diabetic mother",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/62/37866\">",
"           Medical management and follow-up of gestational diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/19/20794\">",
"           Medical management of type 1 and type 2 diabetes mellitus in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/62/35818\">",
"           Obstetrical management of pregnancy complicated by pregestational diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/27/36281\">",
"           Pregnancy risks in women with type 1 and type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/31/42487\">",
"           Prepregnancy evaluation and management of women with type 1 or type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/63/9210\">",
"           Screening and diagnosis of diabetes mellitus during pregnancy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/0/3078\">",
"           Alpha-glucosidase inhibitors and lipase inhibitors for treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/23/15734\">",
"           Amylin analogs for the treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/19/41272\">",
"           Benefits and complications associated with kidney-pancreas transplantation in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/60/29641\">",
"           Blood glucose self-monitoring in management of adults with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/4/11332\">",
"           Case illustrating blood glucose monitoring in type 2 diabetes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/8/4232\">",
"           Cases illustrating problems with intensive insulin therapy for diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/7/12402\">",
"           Cases illustrating the effects of exercise in intensive insulin therapy for diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/50/20265\">",
"           Effects of exercise in diabetes mellitus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/45/11993\">",
"           Estimation of blood glucose control in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/55/15225\">",
"           General principles of insulin therapy in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/25/38298\">",
"           Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/33/28178\">",
"           Illustrative cases of intensive insulin therapy in special situations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/63/15353\">",
"           Inhaled insulin therapy in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/35/43577\">",
"           Initial management of blood glucose in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/20/24906\">",
"           Insulin therapy in adults with type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/24/30089\">",
"           Insulin therapy in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/39/26233\">",
"           Management of diabetes mellitus in hospitalized patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/28/37321\">",
"           Management of diabetic foot lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/43/7865\">",
"           Management of hyperglycemia in diabetics with end-stage renal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/63/27641\">",
"           Management of hypoglycemia during treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/19/28986\">",
"           Management of persistent hyperglycemia in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/62/37866\">",
"           Medical management and follow-up of gestational diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/19/20794\">",
"           Medical management of type 1 and type 2 diabetes mellitus in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/26/38312\">",
"           Metformin in the treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/2/25641\">",
"           Nutritional considerations in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/18/14634\">",
"           Nutritional considerations in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/38/36458\">",
"           Overview of medical care in adults with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/63/7162\">",
"           Pancreas and islet transplantation in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/16/7434\">",
"           Patient selection for and immunologic issues relating to kidney-pancreas transplantation in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/63/29688\">",
"           Perioperative management of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/27/36281\">",
"           Pregnancy risks in women with type 1 and type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/31/42487\">",
"           Prepregnancy evaluation and management of women with type 1 or type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/38/32362\">",
"           Prevention and treatment of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/39/36472\">",
"           Renal transplantation in diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/32/42501\">",
"           Screening for diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/46/35559\">",
"           Sulfonylureas and meglitinides in the treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/45/18135\">",
"           The adult patient with brittle diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/50/21290\">",
"           Thiazolidinediones in the treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/48/40714\">",
"           Treatment of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/45/21210\">",
"           Treatment of hypertension in patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/42/682\">",
"           Treatment of type 2 diabetes mellitus in the elderly patient",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-48C0C418C3-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f37_50_38689=[""].join("\n");
var outline_f37_50_38689=null;
var title_f37_50_38690="Patient information: Fecal incontinence (The Basics)";
var content_f37_50_38690=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15852\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/46/4834\">",
"         Colonoscopy",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/56/15236\">",
"          Anal sphincter",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\">",
"           Amount of fiber in different foods",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?20/59/21426\">",
"         Patient information: Constipation in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?34/51/35634\">",
"         Patient information: High-fiber diet (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?5/55/6006\">",
"         Patient information: Fecal incontinence (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?8/39/8817\">",
"         Patient information: High-fiber diet (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Fecal incontinence (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/fecal-incontinence-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H12921751\">",
"      <span class=\"h1\">",
"       What is fecal incontinence?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Fecal incontinence is the medical term for when a person loses control of his or her bowels. If a person has fecal incontinence, he or she might leak:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Solid bowel movements",
"       </li>",
"       <li>",
"        Liquid bowel movements",
"       </li>",
"       <li>",
"        Gas",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Fecal incontinence is most common in women who had 1 or more babies when they were younger. It happens because the muscles that control bowel movements can get damaged in childbirth. Men can also have fecal incontinence for other reasons.",
"     </p>",
"     <p>",
"      Having fecal incontinence can be embarrassing and stressful. People who have it sometimes stay at home instead of going out, because they are afraid of having &ldquo;an accident.&rdquo; If you have trouble controlling your bowels, you should know that the problem is NOT a normal part of aging. It can often be treated and fixed, or at least improved.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12921758\">",
"      <span class=\"h1\">",
"       Is there a test for fecal incontinence?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Doctors can do a few different tests to find out what might be causing fecal incontinence. If you have this problem, your doctor might order 1 or more of these tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Colonoscopy or sigmoidoscopy &ndash;",
"        </strong>",
"        During a colonoscopy, the doctor puts a thin tube into your rectum and advances it up into your colon (",
"        <a class=\"graphic graphic_figure graphicRef52258 \" href=\"mobipreview.htm?4/46/4834\">",
"         figure 1",
"        </a>",
"        ). The tube has a camera attached to it, so the doctor can look inside your colon (also called large intestine). A sigmoidoscopy is very similar, but the tube does not go in as far.",
"       </li>",
"       <li>",
"        <strong>",
"         Anoscopy &ndash;",
"        </strong>",
"        For this test, the doctor inserts a small tube with a handle into your rectum. It allows the doctor to look directly inside. This test and the other 2 mentioned above&mdash;colonoscopy and sigmoidoscopy&mdash;allow the doctor to check for swelling or irritation, and for abnormal growths.",
"       </li>",
"       <li>",
"        <strong>",
"         Manometry &ndash;",
"        </strong>",
"        Manometry allows the doctor to measure the pressure inside the rectum at various points. It can help the doctor find out if the muscles that control bowel movements are working right. The test also shows whether the person&rsquo;s rectum can feel normally.",
"       </li>",
"       <li>",
"        <strong>",
"         Ultrasound &ndash;",
"        </strong>",
"        Ultrasound also helps the doctor check whether the muscles that control bowel movements are working normally.",
"       </li>",
"       <li>",
"        <strong>",
"         Bowel movement tests &ndash;",
"        </strong>",
"        Doctors sometimes check a sample of bowel movement for infections that could cause diarrhea. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12921765\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Some people have fewer problems with fecal incontinence if they:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Avoid foods and drinks that cause loose or frequent bowel movements. Examples include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Dairy foods (for people who have trouble with dairy)",
"       </li>",
"       <li>",
"        Spicy foods",
"       </li>",
"       <li>",
"        Fatty or greasy foods",
"       </li>",
"       <li>",
"        Drinks with caffeine, such as coffee",
"       </li>",
"       <li>",
"        Diet foods or drinks",
"       </li>",
"       <li>",
"        Sugar-free gum or candy",
"       </li>",
"       <li>",
"        Alcohol",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Eat smaller meals, more often. In some people, eating a large meal triggers the urge to have a bowel movement. It can also cause diarrhea. Eating smaller and more frequent meals can reduce the number of bowel movements you have.",
"       </li>",
"       <li>",
"        Eat more fiber. Fiber makes bowel movements bulkier and sturdier. This can make bowel movements easier to control. Foods that have a lot of fiber include fruits, vegetables, and whole grains (",
"        <a class=\"graphic graphic_table graphicRef52349 \" href=\"mobipreview.htm?28/61/29661\">",
"         table 1",
"        </a>",
"        ). You can also get more fiber by taking fiber supplements, such as Metamucil, Citrucel, or Benefiber.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12921772\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you have fecal incontinence, tell your doctor or nurse. People are sometimes too shy to bring it up. But fecal incontinence is a real medical problem that can be treated.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12921779\">",
"      <span class=\"h1\">",
"       How is fecal incontinence treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments your doctor might suggest include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Fiber pills, powders, or wafers",
"        </strong>",
"        &ndash; Fiber supplements make bowel movements bulkier and sturdier. This can make bowel movements easier to control.",
"       </li>",
"       <li>",
"        <strong>",
"         Medicines to reduce the number of bowel movements",
"        </strong>",
"        &ndash; These medicines are often used to treat diarrhea. They can decrease the number of &ldquo;accidents&rdquo; a person has. Examples of these medicines include",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?40/33/41492?source=see_link\">",
"         loperamide",
"        </a>",
"        (sold as Imodium) and",
"        <a class=\"drug drug_patient\" href=\"mobipreview.htm?11/39/11892?source=see_link\">",
"         diphenoxylate",
"        </a>",
"        (sold as Lomotil).",
"       </li>",
"       <li>",
"        <strong>",
"         Medicines to slow the movement of food through the intestines",
"        </strong>",
"        &ndash; These medicines are called &ldquo;anti-cholinergics.&rdquo;",
"       </li>",
"       <li>",
"        <strong>",
"         Treatment to empty the bowels",
"        </strong>",
"        &ndash; Some people with fecal incontinence have bowels that are full and that they cannot empty completely. These people need treatment to flush the bowels. Then, once the bowels are cleaned out, they can take medicines to keep bowel movements regular. &nbsp;",
"       </li>",
"       <li>",
"        <strong>",
"         Scheduled bathroom visits",
"        </strong>",
"        &ndash; Some people have fewer accidents if they visit the bathroom on a schedule. They try to go even when they don&rsquo;t &ldquo;feel&rdquo; like they need to go.",
"       </li>",
"       <li>",
"        <strong>",
"         Biofeedback",
"        </strong>",
"        &ndash; Biofeedback is a way to retrain the muscles that control bowel movements (",
"        <a class=\"graphic graphic_figure graphicRef56581 \" href=\"mobipreview.htm?14/56/15236\">",
"         figure 2",
"        </a>",
"        ). It is done at the doctor&rsquo;s office and involves using devices called sensors that measure muscle activity. These sensors tell you if you are using the muscles the right way.",
"       </li>",
"       <li>",
"        <strong>",
"         Electrical nerve stimulation",
"        </strong>",
"        &ndash; Doctors can implant devices that send a mild electrical current to the nerves that control the muscles in the anus. These devices sometimes help improve bowel control.",
"       </li>",
"       <li>",
"        <strong>",
"         Surgery",
"        </strong>",
"        &ndash; Doctors can sometimes do surgery to repair the muscles that control bowel movements. This is often helpful in women whose muscles were damaged during childbirth. There are also other types of surgery to treat fecal incontinence. &nbsp;",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H12921786\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/59/21426?source=see_link\">",
"       Patient information: Constipation in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/51/35634?source=see_link\">",
"       Patient information: High-fiber diet (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/55/6006?source=see_link\">",
"       Patient information: Fecal incontinence (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=see_link\">",
"       Patient information: High-fiber diet (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/50/38690?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15852 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-41.78.124.10-D68EE5DB58-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38690=[""].join("\n");
var outline_f37_50_38690=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12921751\">",
"      What is fecal incontinence?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12921758\">",
"      Is there a test for fecal incontinence?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12921765\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12921772\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12921779\">",
"      How is fecal incontinence treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12921786\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15852\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/46/4834\">",
"      Colonoscopy",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?14/56/15236\">",
"       Anal sphincter",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\">",
"        Amount of fiber in different foods",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/59/21426?source=related_link\">",
"      Patient information: Constipation in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/55/6006?source=related_link\">",
"      Patient information: Fecal incontinence (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=related_link\">",
"      Patient information: High-fiber diet (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/51/35634?source=related_link\">",
"      Patient information: High-fiber diet (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_50_38691="Tobramycin and dexamethasone: Drug information";
var content_f37_50_38691=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tobramycin and dexamethasone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/44/4805?source=see_link\">",
"    see \"Tobramycin and dexamethasone: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F228654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      TobraDex&reg;;",
"     </li>",
"     <li>",
"      TobraDex&reg; ST",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F228655\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Tobradex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F228671\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic/Corticosteroid, Ophthalmic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F228658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Ocular infection/inflammation:",
"     </b>",
"     Ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ointment: Apply a small amount (~",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     -inch ribbon of ointment) up to 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Suspension: Instill 1-2 drops every 4-6 hours; may be increased to 1-2 drops every 2 hours for the first 24-48 hours, then reduce to less frequent intervals",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F228666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Ocular infection/inflammation:",
"     </b>",
"     Children &ge;2 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F228659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F228641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     TobraDex&reg;: Tobramycin 0.3% and dexamethasone 0.1% (3.5 g) [contains chlorobutanol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, ophthalmic: Tobramycin 0.3% and dexamethasone 0.1% (2.5 mL, 5 mL, 10 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     TobraDex&reg;: Tobramycin 0.3% and dexamethasone 0.1% (2.5 mL, 5 mL, 10 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     TobraDex&reg; ST: Tobramycin 0.3% and dexamethasone 0.05% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F228628\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Suspension (0.3%/0.1%)",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F228643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contact lenses should not be worn during therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment: Do not touch tip of tube to eye. Apply ointment into pocket between eyeball and lower lid; patient should look downward before closing eye.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension: Shake well before using. Tilt head back, instill suspension in conjunctival sac and close eye(s). Do not touch dropper to eye. Apply light finger pressure on lacrimal sac for 1 minute following instillation.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F228642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of external ocular infection caused by susceptible gram-negative bacteria and steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F228676\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       TobraDex&reg; may be confused with Tobrex&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F228669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not always defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Allergic contact dermatitis, delayed wound healing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular:  Conjunctival erythema (&lt;4%), lid itching (&lt;4%), lid swelling (&lt;4%),  cataract formation, glaucoma, intraocular pressure increased, keratitis, lacrimation, optic nerve damage, secondary infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F228646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to tobramycin, dexamethasone, or any component of the formulation; viral disease of the cornea and conjunctiva (including epithelial herpes simplex keratitis, vaccinia, varicella); mycobacterial or fungal infection of the eye",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F228632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bacterial keratitis: Inadvertent contamination of multiple-dose ophthalmic solutions has caused bacterial keratitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infection: Steroids may mask infection or enhance existing ocular infection; prolonged use may result in secondary bacterial or fungal superinfection due to immunosuppression.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: Avoid prolonged use of corticosteroids, which may result in ocular hypertension and/or glaucoma, with damage to the optic nerve, defects in visual acuity and fields of vision, and posterior subcapsular cataract formation. Monitor intraocular pressure routinely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sensitivity reactions: Sensitivity to tobramycin may develop; discontinue if sensitivity reaction occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cataract surgery patients: Use following cataract surgery may delay healing or increase the incidence of bleb formation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Benzalkonium chloride: Suspension contains benzalkonium chloride which may be adsorbed by contact lenses; contact lenses should not be worn during treatment of ophthalmic infections.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For ophthalmic use only. A maximum of 8 g of ointment or 20 mL of suspension should be prescribed initially; patients should be evaluated prior to additional refills.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F228636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F228637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F228648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F228661\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F228649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is unknown if topical use results in sufficient absorption to produce detectable quantities in breast milk.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F228647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ointment",
"     </b>",
"     (TobraDex Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3-0.1% (3.5 g): $191.28",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (TobraDex Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3-0.1% (5 mL): $150.78",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (TobraDex ST Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3-0.05% (5 mL): $133.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Tobramycin-Dexamethasone Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.3-0.1% (5 mL): $130.84",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F228639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intraocular pressure and secondary infection with prolonged use",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F228650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bralifex Plus (ID);",
"     </li>",
"     <li>",
"      Duocom (PH);",
"     </li>",
"     <li>",
"      Mytodex (PH);",
"     </li>",
"     <li>",
"      Ramtrex (PH);",
"     </li>",
"     <li>",
"      Tobesyn Eye Drop (KP);",
"     </li>",
"     <li>",
"      Tobracort (MX, PE);",
"     </li>",
"     <li>",
"      Tobradex (AE, AR, BE, BF, BG, BH, BJ, BR, CH, CI, CL, CN, CO, CR, CY, DK, EE, EG, ES, ET, FR, GB, GH, GM, GN, GR, GT, HK, HN, ID, IL, IN, IQ, IR, IT, JO, KE, KP, KW, LB, LR, LY, MA, ML, MR, MU, MW, MY, NE, NG, NI, NL, NZ, OM, PA, PE, PH, PK, PY, QA, SA, SC, SD, SL, SN, SV, SY, TN, TW, TZ, UG, UY, VE, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Tobragan D (CO);",
"     </li>",
"     <li>",
"      Tobral D (EC);",
"     </li>",
"     <li>",
"      Tobrasone (NO, SE);",
"     </li>",
"     <li>",
"      Tobraxona (PE);",
"     </li>",
"     <li>",
"      Trazidex Ofteno (DO, GT, HN, NI, PA, SV);",
"     </li>",
"     <li>",
"      Vitodex Eye Drop (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F228631\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F228645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10001 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-E8883B2495-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38691=[""].join("\n");
var outline_f37_50_38691=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228654\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228655\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228671\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228658\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228666\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228659\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228641\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228628\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228643\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228642\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228676\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228669\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228646\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228632\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300150\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228636\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228637\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228648\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228661\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228649\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228647\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228639\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228650\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228631\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F228645\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10001\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10001|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/44/4805?source=related_link\">",
"      Tobramycin and dexamethasone: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_50_38692="Clidinium and chlordiazepoxide: Patient drug information";
var content_f37_50_38692=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Clidinium and chlordiazepoxide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/62/22502?source=see_link\">",
"     see \"Clidinium and chlordiazepoxide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F152528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Librax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F152529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Chlorax&reg;;",
"     </li>",
"     <li>",
"      Librax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F11263330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat irritable bowel syndrome.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ulcer disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701768",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to chlordiazepoxide, clidinium, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703527",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Enlarged prostate gland, glaucoma, liver disease, or trouble passing urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697180",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for more than 10 days, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030496\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695830",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 30 minutes before meals.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11344 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-D8D1174216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38692=[""].join("\n");
var outline_f37_50_38692=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152528\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F152529\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11263330\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030491\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030490\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030495\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030496\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030498\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030493\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030494\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030499\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030500\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?21/62/22502?source=related_link\">",
"      Clidinium and chlordiazepoxide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_50_38693="Mixed lymphoepithelial thymoma";
var content_f37_50_38693=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F63167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F63167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mixed lymphoepithelial thymoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Epithelial cells form pseudo-rosettes that can be confused with carcinoid tumor. The presence of a mixture of lymphocytes and epithelial cells favors a thymoma. (Hematoxylin and eosin, magnification 50x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38693=[""].join("\n");
var outline_f37_50_38693=null;
var title_f37_50_38694="Schistocytes on peripheral smear";
var content_f37_50_38694=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F70851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F70851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Peripheral smear in microangiopathic hemolytic anemia showing presence of schistocytes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 249px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood smear from a patient with a microangiopathic hemolytic anemia with marked red cell fragmentation. The smear shows multiple helmet cells (small black arrows), other fragmented red cells (large black arrow); microspherocytes are also seen (blue arrows). The platelet number is reduced; the large platelet in the center (red arrow) suggests that the thrombocytopenia is due to enhanced destruction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEBAYkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDuU8O+KXkMf9lhT03NKAv510nhbwR9lvo7/XJ47q6hb91bRf6uN/Uk/eI/Ku1YjHfHrnvSxH5wBj6Vw3tsdU8VOatscb418WXdnff2bopQT4zNORu2k/wj3ri44r/zDO17dGcnJfzDnNFoTPqV1I5JeSdyT9Ca7vS9NtZrQF9oc+/SjVHV7lCKVjI8OeL7zT7tLbXJWuLKVgomf78JPqe4r0dvl46+9eR+IYI1eRAAQMg16H4VuJLjwtpMs2S7QKCx744BpvVXObE04pKcdLmoXY7dqjGed3YetLnnPam5+b3xRk9ME1Byjs9M4I7Uue/600kY9jRuwTzz6etIQo6kDJFH0I644ppbkZy39KRm5weB1oGP4IPHTig4VSScCkHoKUkFSCAQe3rQA4gHkdOtVtSsLLVLYwajbR3ER5AYcr9D2qxyAQQAB0x6UhPGRTQJtao5M/D7Qd28m9EZ52eccD2re0jSdP0aAxaXarCCeX6sx9z1q5kdM9RnrTvupvkZUA/iJwKdzSVWclaTExkDP86OppI3jmyYpY5QBzsYGklkjt4pZp22xxIXc+wpWZmEm2JTJM6xxj+J2AFRWt5ZXRKWt7bzMD91JAa8j1HULnxFdtdXru0TH9zADhY17cetINI+QPHGUI6MmVI/GqstjtWDsvedmesa2JF0LUwmRL9mfb65wa8d0tlSzgwMqyKoP4V23gXxLOb1NG1Z/OWQEW8zD5iR1Rq5vxLpM3hfU5FCMdKlYtbyjomeqN6Y7UrGmHTpt05bnpljcaXDosbQyRraKm0pxknvkV5fqhjImIwqZYgHsO36VF9uTafnG3r97inaVp9z4mvltLEN9kyBc3OPljXuAe7EdBRYunS9leTZ6P4GLjwbo5kzu8njP93PH6Yqv4y8MHXdl5YukOqQjYpb7sq/3W/xroUSOGKKGEbIYlEaKOwAwBSjA/i56gZ60N6nnqo4z54njM0WqWEzR3um3iSA/wAKblJ9iOtXNO0HXNclCQ20tjb5+e6uBjA77V7mvXvMIHDnjtSbyTlmNCZ0PGytotTN0+203wxoIijdYdPtgXeWQ8s3die5Nc7cfEi0Rithptzcx/8APR8IGH0qh8U7h5dT03TM4tkia5Zf7z5wM/TNc7Bb7toXufz9qd7F0aEZx9pU1udIut+DdYmC6vpQspifvvHhf++hXX6ToukaUqy6TZWyBxlZl+YkeoNebXmi3MduGubd0jI6MOD71Z8Ga1LoOqRWFy7Npdy2xQxz5DnoR7Hpii9x1aV4/u5P0PTycnJPUUAcgdwKZcyR2sU01y4jghUu7noAO9ecan451PUGxoyCxtM/LI67pXHrjoKVjjpUZVfhPSmVghJBwPavNPi4u3XNEc58trd1X0zmqEPibxHayLIb1bll6LMnBHfpW9JcQ/ETQZ7Py1stdsT5sIJyM+oP909DVJHVToyoTU5bD/B0Vu9u5Z1VsDb6k0eK7aBNP3koJt2AB3FefW2o3OnXJhuVktLuM7Wjfgg+3rUmo680yk3M27PQdSTSOn6vJz5k9CzoW4eNNE8rcHNwPu+nevai5W4JGPvV4wv9o+D9DuPGFzpsk10q+VZ2zDiEN1mlxyB2wPUdOtd54D8Y2HjDSRdWZ8q5jwLi2Jy0Tf1U9j/XIrr+oV3hvrajeF7X7Pz7HBjMRTlW9knqkZPjDwRcz6jNqvh5o2eY7prRjgM395T2PtXO2+k+IN2x9GukI4J4r13JB4zThI5P3jkHHWuLcuGLnGPK9Tx7V0uYdZlju4Xhby0ZQ/8AdAx+Wa67SNDhk8NvIrB7x+SQeFHpTviZpVxc21tq1mrPJaArKg6mP1/Cua0HxBNawYhYNE3TJ6U7HTzSq004bkksEloSkqED17Vl6y2LcuOCrBh25BFa1/qzXEbI21c881n6LYv4i16CxiBa1hYTXcnZVB4H1JoS1NYtpc0j1qBy9nas+dzRKTntxS4Hq3506QhpDgfJjCjPQU3I9T+VTqeQ9S8qsxwoYkDdwtG1kYEggjnnivJ7i91e9cvdancluu1H2KPoBU2n+INa0tgVunu4R96C4O7I9j1FaWXc6PqkraMTxlpr6Lr01ysZGn3jeYkgGVR/4lPpzyKZbazti+V+PXNekaTqNlr+lefCivC3yTW8oyUbupFVf+ES8PtJ5h0uDPoM4/Kltoy1iVblqLVHnFra3PiTUBZWeck/vpf4Y07kn1x0FejeIta0/wALabbxlC7hBHa2sZ+ZgBjJ9B71r2Vrb2kawWUEdvET92MY/OvINduX1TxbqV05LLHMbeIHoEXjj8cn8aExxaxM9dIou3HjLxJcuWjnt7Re0cUQb9Tmrmn+O9Rs5ANahivLb+KWJNsij6dDj04qbQdCW/t5HeQRheBisvWdNFo7L/D2NHMaqNGT5LHp8N1b3NpHd20qSWsyhkkB4PoPrUw4HYfhXmnw2vDba6dMmIMUyPLb5P8Aq5ON2PqMV6QoCgY/L0pSVtjhrU/ZS5RScdcAUAhnKAgleo9PrQgJfgDd6+3vXCa/49dLt7Xw9DHMUOHu5RlCe4Ud6SVxU6UqjtE7tCG+dRwO5GDwcU4t279eK8ri8ZeJY33vc28w7o0IAPtXYeF/FcGuS/ZpY/seogZ8k8rKO5U/0p8vY0qYacFd7HSk8ctSHoc8UjNx056Usa73Cjj8ak5zI8Sa9DoNqjFPOvp8+TAO/wDtH0Fed373urS+fqlw8zE5CZwi+wFT6jeHWPEd5escxhzDD6CNTj/69dZo2kwNbrJMgckcKe4qz0IqNCKb3OE+xfZts9u7W8inCOjbTn2rstG1O58T+FNY0u6YHUooSu9RjzFI4P17Gm+KLCC3KtbjarDheuKzPAZaPxpmMkI1q3mY6Yzxn8acX0ZU2qlPn6rU5/QJA6wFlIwArDHQjgj8K9JjFuNLUMV27flx61g+LvDEkU8mq6LGzl23XFsnc92X+ormRrbxKYpi8TDjEgIIpBJe3SlFk2qSC21a0ngOHjuIypHruFeuXgR/MilRZI3yCjDIP1ry3wjpcmv6zFdyxyDTbRxK7sMea4+6g9eeTXp0h3uzEkZ60nsYYpq6XVGMfCXh5pPMbSbctnODnH5ZrYgjjghWG3jSOFeiIMAfhTh796TPHX3pHM5yluxRye/1pf8AOaY5WOIySMscS9WY4ArOXxHoZnMX9rW3mD34/OmlcSi3saoOOKTOBycf1oVlkiWSF1kibo6HI/OkIBIJGdvIOO/rSEcX8ULFmgs9XiUkWuYZ9o+6jd/wOKwdCu47W/triUB0VgzDrn3r1FlR4njmUPEylXQjIIPY155rfgy+sJWm0D/SrM8/ZmP7yP2U9xTO3D1YuPs5Ox1uoazp1zaMd6sGB+XqRXlPiKSPyJZEypU7wfcdKfLc3EBMU9ndRyZwVaM5zWloHhe+167il1GCS00mNg7mXh58HIUD0z1NB0U6caCcm9DpfiTqEi+FNMteQ+osglPT5QASPzxWL4V0+K/n8tyQoHQCun+Ielvq/h9p7dSbqwbzo0H8S9GX8q4nw1q/2WVJ4iSjDkdx7U27kUNaLUNzqdY8Pwx2BeBmMijkEVwjXMuk6vZ6jauUlilAYj+JScEH1rudV8TrJZyRQgfOMFj2HtXCmBtW1ew063JMtxMucc4QHLH8qS0NKHNyv2mx7HrGn6fqo2alZQXcZ+ZfMXJGR2PaqGm+HtF0ufzrDS7aKb/noRuYfTPStaQgSfIPkXCjnsOKIl8yVVPdsZ9qR5qnJKyehn69qenaVpsl1rsyJbSZj2MNzTE/whe/+c180Xd3ceE/FT+IfCcE1rYFz/o8xDgITyjY6qe3ccc5ANdp4o1KbxH4svLmQ/uLeRra2jPREU4JHuazNfTUrXTX/s/SFvomXDtndtHug5b8K93IsZVw+J9jBKUZ6SjJpJr56X7dfyLxWApfV+eo2pLVNdPu/E19Z+Non0O3lsdPFteNcRlgJQ2EUhnHTuPlz6N617NazRXVrBdWsnmwXEayxSDoysMg/lXxHICJGyuw5+76e3NfSn7PmtvqfgubTpW3zaZMEQk9I3BKj8w1fRcS8OUcBgo18MtpO/pLb7tF8zxMHjZVqrjPt+X+e56ip2jjBB6iuV1bwTY3s0ktrK9jcOxbMSjYc+q1u3+pWWnKZL2dExxgnms6w8R2F0s+yYArjaSeua+CUZbpHsQlKGsTnofhy0kh/tHWZHixykEYXd+PWuy02ws9LsltNMtkt7cHO1eSx9SepPvU1sy3EIdGVhjqDT3GRg1LKqVp1NJMb69Np9aOaXJJ56GjI9DSMjm9E8PpfWrSzy+WmSAAOSay9d0p7CVFIyvVW9a1fD2pmEmBziNj19KseK7i2kgiVHV3A6g8Yq3udinNVLPY5fwrftpXiq35P2a8PkTLnjJHyn654/GvUnGCQcZBrxqVTNqmnxpyz3UQXH+9nP5Zr1TxNevp1hPdRjcydBjINNq6ROKjeatuzRQnehPQd68U1C3fTvEep2lwPnW5aQE8ZVjkH8jXWeHPGF5f6nBb3cYKzEjAGCPpWn448MvrYivNPKpqkC7QGOFnTrtJ7EdjRKDg7MdB+wm4z0uZvhu+WOMwudq/Wm+KbiOWQKg4AwCO9cat9Lp0xg1CGWznQ4ZZVI/I9DTn1F76UQ2cct3MxwscKljn+X50tzq9hafMavgmMz+O7HYOIY5JnI7DGK9V4LEfjXN+BvD0mh2c0+obP7UvMGQKciFB0QH+fvXRFuPalLscOJmp1LrZHPfEO/l0/wAKXBt32y3Mi2qsDyobJb9Afzrz7SLIOIoogOcKBXefEa0e88JTvCA0lpKtxgd1HDfoa4jRLxY5IpVIO07hjmjodWG0pO250V34Xmjty6umQOR3/CuTv4ZtOmW4hbZdWreapzyCO35V3v8AaaSI8jPlm469BXFeIbhDHcugBLAhQOpJ4AoWj0LoSk3aR65Z3a32n2l6nC3ESyHHbI5qxER56gjrxnPSqGh2r2Gg6ZZyf6yGBVb2OMkVcIwep60O1zzJWTdjyCxU2k09rLw8MrowPrmuos9ceCAIFzitDxR4T/tO8OoaZMlvfsMSK4+SXHf2NYkXg7XWGJJrGEeoJbNFz0HUpVVeTKurar5m6WaQBVHU+ldB8PtOmt7S61W8jMct7hIUYYIiHQkds1Jo3gyzspo7jU5zqFyhyisMRL/wHv8AjXTuxYZbr2ouYVa0eXkgLyrAgnNMmiguHLXFvBM4HBkjBNScc+nSjFI5bhkbNgARBwFUYx9KQDBz69cUH889vWhhtUGQrGnZmYKM+lIQE4Bx09qIvnYLzzSR7JQTE8cgH9xg38qdEWWRMAA9OaYHl3ivU317WZotx/s+1cxRRg4DsDgsR35zist7SMrhY1I9NtV7RnjluI5BiVJ3Vw3UfMc12+g2dnPZN5qjcRjce1N7nrtqjFJbHM+H9WufDV6JYWd9Pc/v7c9Mf3lHY161CySW0MkUplR0DK56sD3OK81vtPXzSi/d3YJ9a7TwgPL0FIv4YXZAab2OTFKMkprc1mBbAGQfaoLy+srHJvb2C3I/hdwD+VYvjPXptJt0tNPA/tC4UnzDyIk/vY9fSuBtNL+0Ozy7p535aST5mY+pNKxFLD865pOyPUtP8QaXqMmyx1KCWQcBS20n6Zq3JvBPmEk+/NeP6hpSo2HTa45B6EfQ11vgPxBPdSNo2pyebcRrvt5Xzl0HVT6kdqLLoVUw3LHmg7o7JCY/u54HeuV1rwPaahcNdaTMdPuXOWUDdGx9cdq6maWGC3lnuZRFBChaR2/hArzrV/G2oXzMmjAWNn0WQjdK49eegpIihGo5Xpg/w/10uEa9sVi6mXDZH4YrqfDPhez8PCSWN2utQkGJLpxggf3VHYVwMGva/bSebFq9w7DqsuGU/ga7bwd4pGtl7G/jjg1ONdw2fdmX1A7H2p27HRXVbl1enkdGB8vPI9TUkBCzoT2NNHp6dRSNnjH60jhPDtWsZNF8UalZzArmdpoiejoxyCDWrBqKpAECqD9etekeItB0/wAQ2yR6jGwePPlTxnDp+PpXJN8NWDAJrbCM9N0ILCjzPThiqc4pTdmedeItNtdZnSL7GJ72Y7Igg+cn6jt9eKhkjPwp1aUaZqy3kt5aeVPEEwYnPIIIyGwfp1Ne3+GPC+neHhJPbq1zflCGuZzubHcL6CvlrxC0l3r2pTyy/N57A+wyele3gMwxKpTw7m3TatyvVfLt8jOGFw+MrqXLbl1vs3/wDa/4S+5uL0G7gkmP3jI7Z+b6ZqB9WvI2knifCORwT0rHtGjaRM8kDH1pZXJWUbj83ABqlFI9tUYR0SPQ/BPj+4sbqOG4lJicgcnIr36GT7RbxyqMiRQ2RyOa+PUs9tuJTKAxPAHUV9FfDHWZ9Z8CnYxE1rmPcepwK4sXSWkkeXmOGjFKpBHapLE7FY5UY+gYGn4P+TXk+hQ6vdeKBKkbgRN87tkDGa9P+2xf89F/KuOdPldlqebUp8ltTzS11FQu1mKyKMFX4YH3p95qUajLug9MmvUdR0nTNSOb+xhnbHLlcN+Y5qrY+HtEsZBLb6XbiTPDON5H0zSujo+tQ3tqcr4F0W4u9Si1q+jeK2gz9licYaVsYL47Adqu+PPFkOk25tfI84zddwwBXbPvIZ5CAo/iY4H61ia9oem+JbQW87wSMDndG6lv0qoNXTa0MfaxnUUqi0Od8Nvoll4euPEwim220byS7QXKKoyxVR1wMnjmt/wz4q0LxTZi48P6pa30QAJEMmWT/eU/Mp9iBV3TtHtNM0wafbQBYACrK4zuB65r4a8T+CdZ8LfE3XLHQxqEMOlE3wubLJlhtCy4kXDAsVDgHkdD0wcOyqN6mM5c0mz7vnSKddtxFFMo6eYgbH50QRxWylbWCKHPURoFrmPhtMlz4N0+4g8Qz+IoZV3C/mVFZuPu4UDGCOQ2WznJrpx655781k9BXdrC4BbJGaXAPGMfSkP3TjNKOQSOnqakQYHIKBlIKlSOCD1Feba74Mv9MuJJ9BjN3YOd3kA/vIfYeor0nI4OcA0cjlTz0zTua0q0qTujx1BqbtsTStQMh4x5RHNdR4U8I3Rv4tT8QIsQhbfb2YOTu7O/07Cu98x8feY/8Cphz1J5p3sbTxUpKyVhzsWbcevqRQB1xQOpFKBmkcg0AADnPvSHr16U4dBTJpEghlnnbZDEhkc+w5oAivLi3src3F/cR20I/ic4/CsB/G2g7yoku3UjG9YTt+tcRf3s/iHUDfXwJQ/6iHPyxL2GPX3q5b6ZLLGXihYqOuBVaHfHCxS996nouk6pp2rIzabdrMyjmM8MPwNXMdc15BcW8lvcLcWztBcxNlZE4ZT/AF+leleFNbXWtJN1cBUurbK3KjpkDOR7Gi19jGtQ5Pejqir4s8RroiJbWiLNqcy7lRuViX+839BXnd291qMzS6jczTysc/OSF/AelPiuJNU1G61GY7pLmUkZ7KDhR9K7e18MQ/YoZJ5AJXIY5GRt7j69KTutjpioYdK+5wqwyWhElpLJBKOQyMRivQPBXiFtage2vdq6lbKCSOBKv94e/rWZregR2tmbiFyUDYINYPh2RrTxjpTx/wDLSQwsPUMKa10YVFGtBtbo3PG3hq4kvX1fSIjM0mPtNun3iR/Gvr7iuVh1h7PdHJ5kJ7rIpBr2TG1vl4INMkjhuMGeCGUg8M6BiKVznp4nljyzVzyvSm1LXLpYtOt5GXPzzupVEHc5PWvT7C0jsbOO2iJKJwSf4j3NWC2Igq4VR0VQAPypvUYycjvRcyq1vabKyPNfGsp/4TK6iYnAijK554/wrQ8KRB74EkYUZ+pqX4laXIy2+tW0ZdoF8q5Cjny+zfga5vS9WNv+9gfORxjpTep2wXtKK5TrvG8MaQxSLgO3bviuH0yRrfxTpEseTILpUwO4PB/nVzUNTku/mmcs31qX4f6e2qeI11AjNlpxLb+zSkEBR9M5NJFwj7Ok+Y3virdtHb2Gmxk7LuRnmx/Eq9B+ZrnPDWnR6lqaQykiLGWxXSfFGzkn0uy1KNS32NyJQBk7Gxz+BrltB1H7BerOuGVvQ8EUyaH8D3dzs9T8N6fJbPHaxlGUHBz3rzt5n0nWLW6ibElrOMkdxnBH5V3eo+KYBZt9lX984xz0rhLe2l1nXbKwgUtJNKJJSP4UBySfQULQeH5rP2mx6VeeLdHtfGFt4curkw6pdwfabdHQqkq5I2qx4LcE4Fb2Bx/nFcn8UPDWieKPD80Wu3CWCWp8221HeI3s3HR1ckY6DIyM/kR87SfHHV7HxF4a0/Ub23vYNHvnS+v7RyY9QhKhFkx6hWc+hbB4pxhzbHmH1oec0nP4elNVw6q6MGRgCGByCPWuX8YeL4fDZjSSFpJH5yOwqYxcnZFRg5vljudXHjec4OQRmvlDxzpb6b4q1iFkIV5S68cYNfT2gapHq1hHeQgBHHFct4+8EJ4gt5riJgl3/D7/AFrow9T2UmpHXgqyoVfe9D5p08oSJWkO7jaOma1ruzUwecGVmK9V7VJrHhfWtPuXV7CcqGxvVCRWd5Woi3e3isLlucswQ16iknqmfQKcZaplXe3zBvlQDINfQvwJtprbwK8jxkedKSm7jcK8n8I+A9T1e+i/tXGm6bkGSW4O3I9BnvX0LpmqeHoEh0rTtUsx5QCou8Afn0zXHi6iceRHm5jWUo+zjqakYUEkALuHOO9V/sEXvV3yT5igYAPfrke1TeVH/eWvOTaPFuT5xxu5xWL4o1+PQbONlRZr644ghJ/Nm9hWyeSBnk15j4pm+2+NL9m+5bBbeMHtgZOKpGuHpqctdkZ919u1abzdVupbiQ/w7sIvsFHFMbSUQCSMFGB+VkOK6fw1Yrd3qrJ9wDcR6itjxQsIgjEcSIF+X5VobZ1utyy5EjnfDfiu60uaO11mWS6sJGCrNIcyQk8cnuv8q7s6ZZx6rLqKQRm9mhSBpwOXjUsyr9Mux/GvKNVRTE6noQf5V2a69Lpfw207UGw1/JCsNuG7seA34AZp/ErmWIoptOC3OU/sCH4dePDf6HqlvaeH9S3yahoZBZklx8skCjhcnGQcDHrwF6dfiDYeZhtNvVi/v5BP1xXF6VplxfXLN8893KcySvyzE+pre1DwtdWMW8skigZYxnpQ2upaw9KHuyep3Gj6rp+swvLptx5m378bDDr9RV/Gc5xj0NeNWF5Jo+tWl9AdpSRVkHTejHBBr2aUYkbHTr+FJpbo5sRS9lJW2YDryccUHgeh9BSDrnj2pVG0YFSYCAY6CmMvUg4FSfQ+1HY0BcQD160452nBwe2RScZ/zxSmmAgBxg9fWsbxmrv4Q1ZYgd3kHp6Z5/StnoMn8KGVGVkkUOjqVZT3B7UFRlyyTPItP2FUIPBwQa9O0uSI2cQhCiML81eb63pU/hm/MbgtpznNvP2A7IT6iprfVXSPEcpC+gPWmejVh7ZJxZqeKI4hfMYQAD1x61H8Odz6/q9r/DcWgJ+uSP61iahfrtaSaQAeua6/4daVNZ2l1ql4jRXF9gRxsMFIh0J9z1px01FU9yi0zhtLBs3ktpRtmt5GjZT2INdzaeIIzZRJMp8xOAaPF/hR9SuW1HSmSPUCMSxMcLMB0Oexrj2stZt38ubSr3eOPlQsD+IpXHeFdXvqdDrWuNeQrCgCx1S8E2baj4oW5IJttOBd27GQjCr9e/4U3TvC2tamwN0v9nWp+88n+s/4CtegaXp9ppNhHZWMeyFeST1du7E9zRcyqThTi4Q3Lmecjqe9L9Pxpo5wf5d6U4znipOAQ991JjNKOvPWlVSzBQM+1AxobgjGQRggjqK5bV/AGmXTNc2ssumSNy2wjZ/3yeBVTxT4wlhu5dO0HYZY/lmuyMhT/dT1PvXGXMNzdMz3dzdTs3JLyE/pVWtudlCjUXvJ2OvtvhzaSPmfWJ7uMdY4iq5+pHNdha28FjaR2tnAsNtGMLGowP8A9fvXixtZbSQS2k01vIpyrRuQQa9L8EeIH12ylgvsf2laY8wqMCRD0f8AoaT12KxNOoo8zldHQuVaN0kRXjddrKehHpXC6r4CbzjJoN2sMbc/ZpwSqn/ZPYe1d0eefbpSc0jmp1ZU3eJ5vb+BNbmfF1eWdrGD95Mu2PYV2fhzQbLw/bSR2W+SeXma4k+/J7ew9q1PTFFO5U686is9iG4gguoJLe6ijnhddrxyKGUj3B4IryTxt+z94R18yTaUkuhXjchrUboSfeI8fgpWvXLiUwwSSbQSqk4rzHUPGWow6gjSS7oS2AEHCj3rSlGUvhJp0pVHaJ0vhmDU/CHgPT7TXJor67sI/s6zQlsSxrwhII4O3aD15HWsJ5Lbx1qCW15bGF4+sinPFP8AE/i6VvDsc0UGY3O1jjNafw/jhvIY79IPLAXAbpk1oouEXJ7m8IOlDna1Oo0jTrfSdPisrRdsUfT396t8jPf0pw680gJxycmudu5zNtu7EwG+8ikehFYPizXbXw3BEltbQy6ld5MUZUBVA6u3tW+uSwxxk9TXlfjhpZvHl79oGPLjRYv9zH+NEe5th6aqTs9jMu1utUlaW/la4kY7iMYUfQdBVWfSkaPmMY69Oldx4ZtreSFnlABA6eopfEcMCtm3UKMZxjHNGrO9V7S5EhPhXrcsnnaBfM0ssMZlt5XOSV/un6VR8zWv+ep/75rN8JzfY/H+mSAE+YWibHoRXsH9kw/3V/OrUrHJieWnO6W4pwDkdjxXnPja1ax8S/a+fs2oKCrjtIOCM9q9EmjSRNrhtpHVTgis+80e1vrB7O+aWeBuRu+8h9QfWouYUaipyuzjdEv/ALBOHXp/EP51f1rV1vShChAP7tZd94U1rT2P2NRqVsD8pUhZB/vCqyaXr852Jo1wD0zIQoH409zs5acnzpoy9YcrC4UEu3yIo7k8AV03xDsZdP8AC/hqFgGjsysUxHRW2AA/mDWl4Y8JNY3ceo6zJHPeJ/qYY+Y4T/eJ7tXTX9pDf2ctnfx+bbzjbID/ADHoaOaysZzxEVONtUjznwxqK2V0pcAxng+1dhqOs2sdlJtdZC6njvyK4jUPCWuaXKRZxf2lZ5xHJEf3gHYMKht9F8Q3z+XDpk0J7yXJ2ItG5rOnTm+fmIbOxk1nX7OwhGPMkEspHRI1OST/ACr1+cq824joflPoOn8qxfC2gQ+H7SUGQXF9Pgz3BGAfRV/2RUPijxKmhutrbQi51KQbgjH5Yl7Fv8KHroc1aTrTUYdDoINzru8twASPmHocfr1p2CPY15TJrWv3D75NVnQk5CxYVR+Are8M+JNQS5MOryfarXqZSuHi9/cUWXRilhZxVzuVVmYhBkn24FUrnVdLtX2XGo20bjqBJnH5VxPivX5tVn+zadK8elp/y0UlTOfUn+7WCsEaDG0AevWiyW5UMK2rydj1y2nhvIvNs547iMfxRtux9cVJzn39q8lh8/Tp1udOmaCdeQV6N7EdxXpOjajFrejpdBSjPlJowfuOOoosnqjKtQdPXdGjyF6Yo44H4UikYGB9BTj79OlSYjZUjmheGeNJYWHzI4yDXN3XgjRZpS8S3FsT1WGX5fyOa6X8STQRwf50IuFSUPhZhaX4S0bTplmWB7idTlXuG37foOlbzMWYk5JpuQP8aUdyeoouKU5Td5O4dM8cU4O237xAHBwaaMnHfPanCJscLx+WaCRPmJOevrQBj8KcUZeGUgetNGNxwfamA7HPfPamHnj9AaD3OD6c0h3H2buKQgB9ME1m+KL6TTvDGp3kPE0cRCn0JOM/rWhg479fSq+qWCappN7YSEKLmMru64PY/nTWhcbKSvseSaPAirHHnPqfU9zXoNjpluloC0W4sMkntXm8Rm066ksb9DDeQnaytxn0I9Qa6O01yaOER7tyjgD0oZ6leEpaxJPFNrDBODCAAw5FUfh87p43VU+69tIJPoMEfrVHWdVDZkmfBPAHc/QV2Hw20KawgudW1VTBcXSYSN+DFCOct7n+goRNR+zotS6nVXVxb2tq1zezxwW6cM8jbR9B61zzeOvD6uQJrllH8awnH1rhNb1WfxLqTXc2RZIxFrCeip2Yj1PWnx6VcvCZUtpGjHUhaeiMoYSKX7x6nqenX1lqlsZtNuY7lF+8FPK/UdqsHOeeteMQ3F1od7Hf6exjmiILp0Ei91I717DZXcV/Y217b58q5QOo9M9RSa7GNeh7LVapkhG7IPIIII9a4/U/BNpLdSS3dzHb20hyodguPzq3438SvoSRWWnKrapcLv3NyIU/vEevpXm8kE19N519cS3UxPLStk/hVRk463NMPRm1zp2R6pb2OhzaWumQXVlMiDGwSqWNalnZx6fbR28SBI0GFXFeLS6Ui8hMHswGMV1/gHxFOl4uh6nK8iyDNpKxyQRzsP1ApN3HVw0lFyUrnoGcGkPHWk5BPc0E/rUnEGcc1wnxP02b7Rba5bIZIo08q4CjJUdm+ldznpj/ABpykjKsAVIwwI4IoTsaU6jpyUkeR6fqu2IGJwQffNP1DWAYy0j7VAOdxrtdV8EaHfymVIpLKU8lrZtoP4dKNN8D6Fp9wtw0Ut3Kv3ftL7lHvinc7frFF+91MH4baXLc6hJr9zCUt0XZabxy5PVx7e9d9vb1P51If4cKAFGFA4A9hRkUrnHVqOpLmZYzgjpjpikV1LsgOWA3EdwPWuR8TeMRp1y9jpUSXF7Gdss0nMUZ7gDua5p/FHiSXH+niPk/chUE/p0quXuXDC1Jq+x6ptGfl7H16UoYnvn8a4XQfHMn2lLXxBGgU4UXcY24PbePT3Fd2wwccH6H9aTi0Y1KcqbtJCY9DxSDA6HGaXg4x09ar3t1DY2dxeXbbbe3Qu574Hb8elIhK+hY+6hcsEQfxE4H51Wi1GwuJfKi1G2ll/uCYE15Bq2qX3iS5NxfsVg/5Y2w+5GvbI7n3qqbCIqAI14PHFVZI7o4LT3panuqJ+/VWHfPNeLLM95qt/dzktNLcPuJPQA4A/ACug8D+JZ9N1GDTtTmaWxlbZE7nLQt2GfQ1m+LNKn8Pa3cPIrHT7mUyQzfwqW6qfQ5oatsXh6bpTcJbvYfbReY3tWhrNk1j4YknDANOwUkHsTWJb3wAGCCPrWhY3UmtC60aPdJJKFaArkqCBk7j0HPrUpG0000+gujrF/ZpaVcpG4ArotLl0e4tZILyJUk5Kv3+lchveyZtPuFMdxA37xT6+v0qbdnGMc9fpTZE4c3UluFVJZUjOUB+XJre+HDNu1mMH92rRuBnuQf8K5e7u44IWdyFA/X2ru/BGly6bogku1aO8vJPPkTuoxhVP4c/WiJGIaVOz6m+pz60AEZy3f9PSjPOf60ue5oPOF47Hj3pD6nijPTmk4xnBpAIcD24pC2KCfTtSoN8gUdCe9AjC8VeIjo0cdvaqJNSnBZQ3SJf7x/oK4O6kvr1/MvL+5lkPXDlR+AFT+IZ2u/F2qSc/u5BCPYKP8A69bfhrSI9Qd2uHKQxjJA6k1Wq2PThGNGCk9zG07WNV0eQPb3Mk8Q5aCdtysPqeRXpGj6lb6xpyXtoSFb5XQ9Y27g1y/iDRIbOLzbc7ojwVYZ5qv8OJXh8RXdjyYbiHzSPRlI5/Wq+LRmVWMKkOeO6Or1/WbPQ7RZr0l3k4igj+/Ifp6e9cPd+M9buWJtVgsouwVd7fiTWXq13JrHiG+u5zkLI0MQ7IinAA+vX8a2tM8O3N5ZG6UKkPQEnlsUm7aIuFGnTinPcpQ+MPEFs4Lzw3K5zsljxn8R0rs/DPiK18QQv5afZ72HmW3Y5wP7w9RXE6jp7Wxw469Kz9CuW07xZpc8f8cwgYD+JW4IpXvoy6lCE4txVmeo6tpGn6zCE1O1SYqPlfo6/Q1zcvw6sI8OdWu4Ic52uV/LNafjXxEPDtskNuqy6nck+Sp6Io6ua8vuFn1CUzajPLdTk8tI2fyHQUl5mWHhVcbqVkeqaL4W0WwkFxYQx3dynSaWQSFT7DoK0ddSWTQtVWPPnNbSAeudprxhbJraRZrZpIJU5R4mKn/69eheAfFUuoTHS9XYPeKpaGYgDzlHVT74p+gq1CcffvzWOM8OCGT7MHA2YXivV9PuEYYjZFhReV4xivMfEmkT+GdQkZY5G0qRi0MqgsI8n7remPWoF19RBgXKAeoakbVaft0pRZZ8UvF9tumjx5eSc+ldr8PkZPBekLLn5lLD/dJ4rgdJ0q78V3IjtldNP3j7RdsMLt7qvqx6V61GkcEccEChIYlCIg/hA6UzPEyUYKn1PJfFxaTxzrBl+8roq57KF4xW94MsYb25kEiqzou5VPen/EfRJzcrr1jG0g2BLuNRlgB0cD+dctYalsAeGTg4OVNJm8X7SilE9E160sVtDhESXpha86hUt4o0ZbXPmfbEA9cA8n8s1LqGsfL5k8uADnLV0/wx0WaW+Ou6jE0QIMdnG4wxB6uR29BQSl7Cm3Jmn418Wpod39h0+FLjUmG9ix+SFT0J9SfSuSg8b+I4pS87Wlymc+W0e3j69qxXlkv9U1C8ueZpbh9x+hwB+QroU8NXr6eLvYNjLkL3x61TdtBxo0qcUprU7Hw1r9t4htmeBDBdRHE1ux5HuPUe9bGCRycV45aXcmia3aX8ZICuEmXsyE4Oa9lJUkNGdyMAyn2NS0cmIpKm/d2Y3HFKRzQQAMAD2pCRuwPrmpOYXimYHqfzpx4BOCfpT9p/vfqaAPG9HtxtDPlpH5dickk967OHw2z6clyGXcwztrjNOmeCY29wpjuISUkQ9mFdPba1IluYlkwh/KrPVrc9/dMTUrJQrI6gqRg16H4FmmvvCtm1wS8kRaEk/wB1Txn8K5Yz262s9/dDMUX8Pqew/EmsN7/Ub6wkRpZILd23eRCdq/j3NNbWZFSDrRS7HsQjZvu4b/dIOK5X4m+Z/wAITeFBx5sXmf7u7/HFed26TWrCSzurmCQcgpIf69a7Dw34l/tUPoHifbNDeKYo7jGCx/ut7+hoUU9jL6tKi1PdI5XS1jd0D42EjJ6cV6Pq82kTaK6RpCo2ARhRgg15rrOl3vhe9a2v0drMNiC6Ayrr2yR0PsaiOsxiP/XLjr1otodNSl7VqUWN1jCQOw4ZSCpHqDxXtW1brT4kvYlkSWFDJHIMgkqM5rzPwj4dutbvoL6+hkg0iFhIN4w1yw5AA/u+pr1JmLMSR16/0pPRWOTGTV1Fbo5tvBPh0yeZ/Z5UddqykKfwrbsrK1063MGn28VtEeojXr9T3qbBNKoI69vakcsqk5K0ncx9f8P2GubXug0VygwtxEcPj0PqK54+BJgx8vWiFz1aLnFdyfXHOehrmvE3i610WdrS3i+3aj1aMNhIv94+vsKErm1KpV+GBJovhLTtNuFuZWlvrpOVkuPuofVV9a6Ikk5bkmvNT471wPu+y6ft67drc/jXT+GfFtrrUi2c8P2LUT91CcpJj+6f6Gna+w6tKtbmnqdFjFKAM0pznHp3xR1x6dKk5g9aCe/el/zxTTx+PcmmA0jknH40LkfXrUGo31npsHnalcxW8bDjeeW+g6mseLxnoBn2i7lXPG9omC/ypqLKUJS1SOW8aWn9n+LJZcYgv1EqN2LgYYfyq7oOoi1b5ydp64rrr+x0/wASaQ0TSrPak7o5oWBMbeo9DXE3HhLXLJ8WqxX0P8LBtjY9we9HqdtOpGpDkm7NGtrmspcQCKEfL0yar/DmFpvEV7fDiC3i8o+7MQcfkKqWfhHXLxwLxobCA/eYtvfHsBxXd6VYWuk2EVnYoVhQkkscs7HqxPrVJ21JqThTg4Rd2zyrULWTR/EN7Y3O4bpWliY9HRmJGPzxXQ2PiB4LH7KCNnUH0Peuu1zSbHW7cQX8RJX/AFcqnDxn1BrjpfAV6jFbTV4XTsJoyGH5VNylWp1YpT0ZnapqJuBlu38qq+DbGTV/FNvcRx7rOwbzZpOgL/wqD3Pet+08AF3DatqjSx94rdduR7sa6+ztbewtI7SxhS3t4/uog/U+p96kdSvCMeWGp5h48uXu/Hd4smQLaNIYx7EZJ/OtbwlZ2s8xa4AYpyAelTfEbQ5JJhrlihcqgS6jUZOB0cD271zmkakIiHhkHI60bmsffopQOv8AE9tD5G6NFwDngVxNu7W3iHSp4SfMW6jCgd8nB/Qmte/1oNa7XcYxyTVjwNokt/qEevXwEGl2hLwGQ7fNbGN3+6PX1qkhR/d03zno8nEjrgFCSCp5BrPOj6SJzKul2ZkJ6+WKybrxv4fhkdUnnuTnLPDESue/PetfSNX0/WYmfTLlZSn34yNrr9QaHFnn8tSCvZpF0YWMKiqka9FUYA+gphUBmYDDHv60/sQO3pQdoVnkZY41BLsxwAKRAgYqTn8R61z2peD9Av5Wmk0/yZWOS0DbPxrM1Xxy/nGPQraKSJTj7RcA4f8A3R1x7mqtr461GGTOpWNvcQHqYPlYD2B607HTCjWj70dDe0zwdoOmyiWKxM86nKyXDb9vuAa6KOQmVXOMjgD0qpYXlrqljDe2MnmW7nIPdW9CPUVYxyAcY71JhOUpP33qeSX9t/ZvifULWThFmMq+hVuR+HNehWupWc2mBpJUBC/d71R8e6DLqltHqGnpuv7VdpjHWWP0+orz631AEFS5RhwyNwV9sVW53qKxEE76of4idJEunAAU5xXq2gMX0HTJH4ZrdCffivJYrWXXNQh0zT8u8h/euOREnck17LHGkEMUEX+rhQIv0ApMnFtKMY9R27BAPQ0Z7ZoIP4Vj+JvElj4dRBOrXN7KMx20f3iPVv7o96SVzijFydo7mx9en86Xc/v+dec/8LF1AS7hpFp5P93zTu/OrX/CyV/6AMv/AH+FVymrwtX+U6PxH4T0/XJvtTM9pf4wZ4v4/wDeHeucHgXVVbEeqWTL0DGNgfyzXog6enc4piryeOnFStBQxNSKsmcNrvh5NI8HXTz3b3Mkboz7V2qPmA6fjWPpbQyxlMrg8DFem3dvDd2c1rdJvgmjKSD2P9f8K8n1bR9R8M3GydHmsc/urtBkFfRvQ07nTh6ntE4t6mrd6dbrbs5cbh/nFcxqW5IfMT/WI6shH94MMVak1hJodu8v/uAmtnwx4XutXvYLzUoZLXS4nEiq/D3DA5AA7L3JoSs7nTzezjebPTJf3sCLcKrB41Low3Akjng1Qj0jS47kSxaZYrKv3XEK5BrQlJdi2cHuPSm4yecD6UPV3PHUmtmK0hbknNA+bt+dKB6dKUdDj1pCDvzRwfSjOT1GO3vRjkA/5NAirqd5/Z2lX97gF7aB5QP9oDj9a8c0yAyAySsXllJkkc9WY8k17JqlmNR0u9ssgG5heIH0JHH6149pkrw7oJ1Mc8LeXIjdVYcGn0PQwduWVtzopdCuBYpciImL1Fc5qMLRjzIWKTxnejLwVYdK6weIJjYi2JBQDArltYuljgkc/XHcmls9DopObdpHrmj3w1PSLG/GB9ohVyB696t//rrB0+a38KeDNMXVpPLaKEL5Y5d3PO1RXOXPjrVZ5D9gs7e1i7CQb3x71bWp5yoSm3yLQ9Czz1+lVdWvotL0y6v5+Y7dN23+8ew/OuN0/wAe3ULhdZs0khP3pbcYZffbWt8QJI73wFPdWUgmtneOUOvOV3DNCj1D2EozUZrc4KWW41O7a+1F/MuZOcE8IP7qjsBUiafJIh8uF2QdSF4FNsmBYEkV6Jpep2qacYE2o20jBH3qW56FWo6SXKjz3SdQufD18LuyyYSf38GflkXv+Poa9ctbmG7tLe6tWLQToHQn0I/nXlWu+Ws0mBgEZNdx8P8AengrTvNz8xdkH+yXOKe6OfFxUoqp1Oiz78fypjbsjBAGefp7U2TO3KpuORgZp5HBHqCKk4TLOoWM2ppAL2RJYiR5aybUY/7QHWtFsK2euRXml54Q1h9XJhA8tnLGXfjjOa9Kt0KQxxk7nVQCRzmrnGKtys1qQjFKzuIx96QHnjtUjQvj7pxUYXn6etZmYZK9DXO6j4O0W+maYwy20rHJNs+wE+pHSujI4H0pjdAD245oKjOUHeLsc9p3grQ7eUF7eW9cnj7S+4D8Olcv461uXV9Vl0m2YppVkRGyJwJXA5z/ALI6Yr0uAkPwOQpx+VeKaWSxkduXaVyxzzksapOyudmGbqSc5u9i3Bp7uhMULOFHJUdKrK01hcx32nSmK5hOVYDGfVT7V6b4ceKLRo1jVeQd/vXC6+EW5nKY2bifSlexvTrc8nFo9K0jUY9W0m01CNdonTLIv8L9GH51znxLunS1sNNjOBdkvOR1KL0H0zVv4bxOng2zLA/vZZZFH+yW4/lUHj3S5bnVNOuBLEgSJozvbGOc0ddDipxjGvbornIwxDbgDr27VYurRVt1yxDnBypwa0f7Gu4bU3PlrLAvV4zu21nXLg85yD0xSO5S5noaHw6umttevNMB/c3UZmVeyuvUj6ivQMZxXnnw/tzc+KJ71f8AUWcJTce7t2r0PoBkD8KbOLFW9poAOGJDEY7Vnajo+k6jJ51/p9vPL3cr8x/LrWgT8wBP4UKD0JJ5Jyf5UjCLcdUV7GxtdOj8nT7WC2iblhGuCan9iKd3IzzSZ59qQNtu7HwAeYAxOME8968NuLmTVdYv9RuDmSaZsZ7KDgAfhXuUBAkBIyM14rqVidI8R3+nSAqElMkRI+8jHINUtjswNuaXc0LTQ7q6tWmii3IBmq39l3P/ADzaus8Oa2sFmYGAVau/2jB6foKEjV1qik1Yn8F+JJNaV7DUgv8AaEK7g6fKJl9cdj61038Rzn2FeU+HZGt/GekNH/HIY2x3UqcivVgCJJCzlwTlQQBtHoMdfxpy6M48TTVOfu7McBz3oJ+VlP3SMMpGQfwoAx1ye1L6kCoOchgt4LY5t7a2h7/u4lWpXJLElix69aT0znFQ39ytlZ3V3IAwtomlx64HApj1kzL8ReIrHQh5c+Z75wGS1jPzY9WPRRXJyeO9Ydi0FnZQx9gVZj+ea5uz8y8le9vHaS5uD5rsfU9B9K67TfCk11aiZ5lhL/cUrkkepqr2PQ9jSpL39WWtI8dxySrDrlqLbcQBcQnKZ/2h1A967TaOMMCG5DDoR6ivIdSsHgllguUwynawPf8A+tXafDe+ku9CntZ3LyWMvlqSf4COB/OnpJGOIoRjHnhsdSgCoAAAoGABwB9KMHDbjuycjjGB6UDrTu/86g4xpz26+tcz4q8JW+tzfbLWYWeo4w0gXKSD/aHr710pyH2gHpn2xTs5yccUFwnKm+aLPLJPB/iSOTy0itJVPRxOAv1wea6Lwz4HSzvIb3WZku7tG3RQIP3UZ9Tn7x/lXYd/1p8OBKrds800bTxdSStseTeKL99b8T3MrNm2tGMEA7ADq31JrQ0XQrjUg32fYiL1dzgVgLC9nql9azDEsU7gg+5yDXY+HNaSygaKQblznHvT3Z2VLwglTMHVdOlsZnhuFG5e4rT+HF3/AKRqGg3SCSynjaZEbt2YfjUPiLUf7QuTITwOAPak+HVu03iq7ulB8m1tyjN/tMeBn6U46Cm26LcjJ1zRL3w3dOGjebTc5huEBbav91vQiqcWtQopInUfQ17QTxtwCCMEHvVQWFksvmLZWiyE/e8petK5isYmvfWp5bo+j3/ie5CxpJBp5P766kUj5e6rnqTXrUMUcUUUFsgSCNBHGg7KBgCnDc5AyMDj0Arz3xJ4wuLmeSz0FjBbIxR7offkI67fQe/enuQ3PEyslZI9GELn+E/nTCpU4OQR614xtvJDva8u2c87jKx/rWzpHi7U9IZUvne/sQcOr8yKPVT3+hpWT2Y5YOaWjuemgZLfMFGMsSeAO9efeIfGNzdTNa+H28i0QlWusfPKf9n0Hv3re8bamkfgqW50+UPHebIo5FPO1+v6AiuN8P6b9ru7e1jO3cMZPYUbDw9KNnUmVUu9UjYOmp3wf1MpP6V1fhTxZNNdx6drhVpJTthuVGNx/ut/jWhH4W0yUGBZ5fOHR93euD1q3aFZ0Y4kiJww7EdKOZvc2/d17xSPXXUqxBB4puOMiotNuDd6VY3LHJlgVmb1OKsdDUs856OwkfyOG9PWvKPFOlvoGuzsVP8AZ905lhkH3VJ6ofTmvViOeM0y4ihuYHguYo5oG4aNxlTQa0KvsnfoeX2mqvBAUST5SPWqdlZXXifUfsWn5MWf9Iuf4Il789z7V3b+CPDxl3m0kUZz5azMFPtjNb9lBBp1k8VlBHBDGjMI41wM4/U0XOmWKhHWC1ON8VeIG01o/D/hwiJbWJYpbgcmMY4Rf9rHJPvXKiz+0Ltnkkmk67pHLH9aj0vM0RuJG3SzEyOx6liSa6LS4rY2MjScSgnnvjtTu9kbqKpR03Mazn1HQiW0+ZkU/ehb5o3+orVXS7vxHEt1oqR26SHZN5h4ibvgd6qO5kXrkfTmtDwBfSW3iKfTWb9xdRmQr0Cuvcfgad7iqXUXOK1Oy0PS7fRNKjsLY7gpLPIcZkc9TV7OPbnB+tCkMMggg9x6UvoRzz1zUnmNuTuxhyWwenXNKoJOMZ4yPWmzzQ21tNdXb7LeFSzk9sV53qPjDVtRkP8AZ7f2daZ+UKAZGHqT2+lFjSnSlU+E9Gwfujg9aoaprWmaQQupXqQykZ8oAs/5CuItvFWtWFpKXuY7iSQiONpUBZff3xWFDaPdTySys0lzId7u55c07Jbm8MI7++9D1LTNf0jU32WOoRNKeBG/yN+APWqvjDw1H4hgjZZBa6lb58mYjIIPVW9v5V5rd2KuCJF2svQjgg+xrvPAWuyalbTadftuvrQBlkPWVPU+4o06DqUHR/eU3scPc2WtaXKYL3TrnI43wqZEb6EU3zNT/wCgXff9+mr2NXcZwSB9aPNb++3/AH1RcPrj6xOI+H2jS3GoLrl4my2iUi1VxhpGPWTHoBwK78qzA9h1LHpUOo3kVhazXl4VS1t49zY6j0UD3ryfVNW1DxDcNLdyPDbH/V2yMQiL2zjqfrVPUzUZ4mTlsj1xJYZHxHcQSP8A3RIKlZSvUEV4l/ZyKMom09dynkV0nhvxTc6VMlrqkj3GnOQu9zl4c989xSST2HPCNK8Xc9HwPeq2o2wvdNvbUfenhZBnuccfrVsgHaVYFSPlIPBHY0hzweh9qg5E7O54ppMm2LyZhsliPlup6qQeld/pfiS3WBBdKxdAApXoab4r8Irqtyb/AEyVLa/P+tVh8kvufQ+9cufDniRG2f2ajHoWWdcVdz0pOnXV27D9fvxd3s1xjAc+vb3rf+F1s8elajeuD5d7OPLLdWVRgn6c8VS0zwPdXDrJ4gnSK3B5toG3NJ7M3YfSu7iSOGNIoUWOGMBURRhUA7UXsZV6sVD2cdSTgEAnnHWsTxF4p0zQm8m4MlxeEZ+zwcso/wBo9vxqz4i1M6NoN9qKgGSGPEYP98nC8fU5rx20iknkM07mWWVi8zvyzk0aLVkYbDqreUtjtv8AhY7+Z82i/u/+u3zYrpvD3ifTNecw2zPBeAZNtMMMcf3T3/CvN1s/lztwB7Vn3sUsOyeAmK4ibfGyNyrD3oUk9GjplhKclaOjPcjjqetB/Oqeh3/9q6HYX5GDcRBmH+0OD+tW0JIOV2nNJq2h5jVnZnKeM/DEuqSrqWllV1FF2yRtwJ1HTns1cNPJd2Hy3tjd27ZCndGcEk4Az7nAr2Ue30pHYsArDcuQcEAgY5BoudNPFOC5Wro8qsdE1vVjtt7JrSHo090NoX6DqTXomg6Tb6FpiWVoS+CXllf70rnqxrSLE43Enjuc0nXrjNFyKteVTTZCYyMmkZc5yB1zTj35/GgYbPPI6UjAyfFc8lr4X1eeE4kWBgpHbPBNeWaXCqogXoFwB7V6/qNouo6ZeWUh2i4iaPJ7Ejg146nm6deNY36GK7h+VlbjOOhHqD1qulj0cG1ytdTtbHRFuLPzQRnGcCuc1S3WJnXuM81etdZlgtnjV8gnIFZrm61i9Wx0tTLcOcFh92Md2Y9hSsawU025bGnY20l78J7kLHvNndPJF7or5OPzNUdEvvJlhuIn6YwR6V6bpGnw6TpltYW43QwpsJI4kJ+8T9TmuE8ReEbvT7mS50OM3Ni+WMCn54j6D1FNsypVozcovqzUl8QQ/ZZViiZJpEKCRGwyZ7g9j3rxGXxhqlneXVprCpdursjyfcYn144Pr0rv4k1CV1ii029eXpgxEfqa4/4reE9Q0hbTV71Il+1ExSJGd3lsB8uT3JAP/fNcmKcox54PY+n4ap4SeIeExMU1Pa+912e6uv0PVPBvxC8OajptlZrei0uY4liMNz+7yQOzfdPPvmu4DDaCCCD0x6V8m+GbXS4tasx4rjvIdOnUOHj+XIJ4Y8ZK8EHHNfUuiWGn6dpMEGjJGlhtDRCNiwIPcHnOc9aWHrSqJ8xx8T5NhssqR9g5e93ScflLuu1vmXmHHbilIJFNVdvQAZ6+9P7fMa6T5QidAylWUEHqDT4gBIA3CEbT7jGKC3HI/Ok4zkCgDyaS0bStTutOlGGhkPl5/ijJypH4H9KmDhQFzndxiu68S6DBrsEbiTyL+HiKcDII/usO4rhr/R9bsG2z6e8wzxJbneD/AFFM9OnVjUWr1JzpF9JbiYyRQRsfk38bvxq74N0mWPxY89wdy2kLDI6Et/8Aqptpbanq1tDZajp9xHBE2cnj6V2Wk2QsLZlwRI5BYk5PA4qmkloZVa0opxfUtgcYXA9h0FLn35FIy7lK5ZQ3dTz+FLnHPSpOE5H4n3LLpmnWGcLcymST3Ve35muTiTIHQGun+KUDCDSb1cmOKRonPpu6VzFu3QjrTfQ9PDfwlYn1WzePR7G86wiZo2PoSOD+lJFKFSMKvIxhs10NvPZ3mhXOlXhEayjdFJj7jjoa4/z3tWWK8Xy3Bwd3Q+4PpQ0aU25XT6GnqbI90xTnKj8/pS+DWZPHNoseP3kTiT/drGudTt1Y/vVZuwU5JNdl8P8ASX09LzxBrK/ZyYiIo34ZY+7Eds0rahVahTdztVUuPlGR60mE/wCekH/fYry/XvEOp+IJHWzM1rpgHyxRnDSD1Y9fwrn/AOyx/wA8pf8Avo1Vkt2csMHJq8nY9M+KMjLolhbA4We6G/3AGcVzOm2wfaAAK3PFF23iH4f2WsxxkS20oklQc4x8rfrWFp15HEEkYnyyM5xkAe9Nq2jNaKapWW+p0lx4daO280n5gM4rlb+3GGVhg45z6V2UniHzLbYVByuN2a5W+kUknP3jz3zUWsOg5/aOy+HuoPfaE8MxLTWcvlEnk7MfL/Wujx9K474XREWGqXOCIpZ1RCO+0cn9a7IkHJyPSqlucNdJVGkMOOW7e4pO+c49acSTnI74pepxUmJFEm2NFyTtGCWO4n6nvUgBxxSkdOevU0vcjOP60Ac747sZtR8I6jDApaZAs6qOrbTkj8s15jpE6PGjxng8ivbwSrZ4yP8AOK4bxF4DM95LeaBPHbSSHdJbSAhC3qp7Z9KZ3YWvGKcJaGZHfIttsUA5HesDV7hI4JJMHjge57ACtX/hEvFBYr9itwP7xnXFdH4c8EpZ3cV9rU6Xl1Ed0UEY/dRt6n+8RQkdDq06et7m94UsX0zwzplnMCJo4d0g9C3OP1rU5xwOe1DZYk5GSc0uMcdT/Ohu7ueVJ8zuwAIwTjdjnHSjA6elLjGc/p2oIOKQho6jmlUZJ/PJ6AUc46fjXN/ES9ey8MvHA5SW8kWAMD0U/e/SmlcqEXOSiupl6x47C3D2+gwRzhCVa5lPy5/2R3HvWUnjTX423yfZZk6lGi2j8xWfpViJnSGNQM4AA9K2tT8PS2duJGKt6gdqrmtsej7OjD3WjpvDPiK216JkCfZr5FzJbk5yPVT3FXNW0jTtYiCanaRz7ejdHX6Ec15OZJ9Ovor61JSe3fcuO47j6GvZLa4jvLSC7h4iuI1lX2yM0PXVHNXp+xkpQejOYHgPQhJnbeFM8oZjg10On2Nrptt5On28dvEeoQcn6nvUtxNDa20tzdyrDbxDc8jngCuKufiApnP9maW00A4Ekz7N/uF7UKNyF7WtpqztznHp6cfpSjIIxkenNcro3jeyvJ0t9Rtzp8rnakhbdGx9M9vxrq3BBwelJxsZzhKDtJWAuefmwawvF+hR+JfDl3pk7hGmXKOR9xwcqfzH5ZrcAz70lS4pqzKo1p0KkatN2lFpr1Ry3ibwRpWueHLfS5oxEbWIR2s6j5ocAAfUcDI7/XBry/wt4l1T4b60fD/iaNn0wvlJBlvLB/jjPdT3HUc98g+8MAeScrjmsnxF4e0zxHax2+rWyzxxuHU5IKkdQCOcHoawqUbvnhoz28uzmNOEsJjk50Za26xfePn/AF3vowXEdxBHNbypJDKodHQ5UqRwQakYgjINRwwJBEkUMaxxIoRUUYUAdAB2p4z+NbWPCla/u7DSOevvTl4PPXsDQMnrigdcdf6UEjMnpzjNOUtnr9KaR0JBFPA7nrQA/cxHU1GRzk/rThkjofpSHBIB+tMQiKWcqoOQAay77xFollOYbjUo/OU4YIC2D74rL+IGqz2sFrpdnKY5roF5ZFOCsY7D0Jrio7aGGMIAo79OTVWS3Oujh+ePNJ2PTGOl+KNKubGC8injlXB2H5kPY49q8puobzRL5rHVo/KmX7j/AMEq+qmleBoJ1ntJHgnTlZYzhl/xru/DurW3i6yk03X7SCe+txu+YYEq/wB5fQ+op6W0N1F4e7WsfxRxEl/GkRZ3UKPU11vw80154LnUtSgBhm+S3imXPy/3sHpWxa+EtAtJRLFpqtIOR5jFgPwrcJJK9MAYwBxUmdXExlHlgUrbS9MtpfOttPtYpT/GsYyKzPiFJIng+7KEne6I59ATW8cYA+tQX9vFf6dcWVw+1LhSmcd+2PeknZ3OeM/eUpa2Ob8LWdv/AGK0ioC4XPrzVXd/vf8AfNYtvqF/4Vu5NOvuDj5D/DIvqDUn/CSp/wA8Y/8AvurSOx05OTktUztfAdg1p4Pto7yI5ut00kb/AN1+gI+mOK5HW/C2oaNes+jxS3enOC6og+eH2z39q9PlLsTtfbnoAo6elRqjI+RI5QdQ75I9CDSerucsMRKMnLv0PGn1N0fZJDcJJn7jRtkfhitTSdD1XXpQGhlsrHP7y5nXaSPRAeSfrXq5OWyVQN67cmkJLEFuSvP0ouayxmnuxsyCxs7fTrG3tLKMx2sK7VA6+5Puam79T+NIzKiPIzBIlGWdiAFHc5rktQ8e2EU7RabayX23rKDsTPt60WctTmjCdR6K51hzk5+71AHrSqe/4VxcHjzobnSGCdzE+SPwrqNK1Ky1aFp9On8wLw6HhkPuKHFhOlOHxIu9x1pefwpFyBz0FPzgnnn2pGQ3kH2Pagrkd8E08HjNIcg8dO1ADGwckdaULngfTApWPPTv3rm/HOszaXp0FvYtsvL0lRJ/zzQdSPfnAppXLhBzkoos634l0vR5DDcSvPdA4NvbgMw+vYVjnx7Hv+XSJinr5oz+VcvpelmVwsSs7sc5JyWPqTXSP4XlSFmZl3gdBTul0Oz2NGGkndm5ofifTdXnFvGZLW6P3Yp8Df8AQ9623DKCAMnsGPFeP39ptypyjqcqw6qfWvSfCOpyat4ctrmY5uEJhlY92Xv+VNpNXRlXoKC5o7GsAOoJPFcn8TYC/h23uR0tblXf/dPGa6zOOnTpUN7aw3tnPaXK7oJ0KOPr3qUY0p8k1I820KZY7mJ852nr1rrdRuYvsUnO4sO54FcDd2t14evTZaiGCg/uZ8fLKvY59asPqBaLaX6ds0z0Z0udqSKupY2P24P416N4KJbwdo/mDnyjjPpuOP0rzSC3n17Ul06wy0kh/eSD7sKd2Jr2GCGO1toLW2GIII1iT6KMUdDLGSSio9Tz74l6i1zq0GkRFjBbKJZlzgM56Z9cCqOhaWL6UoSQqjJPel8coYvHF7vPySxROpxzjbg1peFdQt7USCc4Vv4sUM1V4UVyFDxDoaW8bL1Qrgg11ngHUX1Dw4qXDl7iyc27Me4/hP5Vz3iPUobnKW/3f7xrU+F8BXQ7266Jd3R2D1CjGaa2aMq15Uby3OvxnGe1Hv2HFBA9ePY/1oyDx2qDgGgYHCge1NwM9OcdakxTW3EHadreuM/pSAjuI/NiKbim7GSvX6U4nOTwAe1LgYwQM0v+7QMTtjvikxwfT6YpTj3J7U2Vo4oDNcypFAgyXdsAUAIfu4HUD60IfmrnrrxlpSsUtluZyON6phTUtl4q0iecQyzPbO3CmZcKT9arldzT2U7XszfB4OOgpT9KCpU56jqpHeg+h79KRkcF8Romj1+xuOqTW5jGfVTkiszTfJa+ha7XMS8lfX2rvfE2kjW9Ha2VlS5jPmW7n+Fx2Psa86sIbo3b281tJHdRnDoeMH/CnuehQmpU7dUb3iWys22TWSBFI+YDp+Vc7oUklr4u0h4eGklER91bgiurn0mddKSUvGS3/LMcEVjeGdKnvvFlvKY2S3sW853Pdh0Ao2KhNcjTdz0dgA7qMjBoUAEcdaU8sT1ye1Gdoyeg5wKlnnDMHuMe1RscduDUud0YZWBB5BB4x7UxlwDz1pDKd9ZWepQmDULWK4iByBIPu/Q9RWR/whnhz/oGn/v+/wDjXQquDnvSZ/zii5aqSjpFiprWkSSiNNVtC+eAJBzWhj5QykMh53L0IrxVrNMYKLkDGBWt4U16bQr+OCWRn0yU7ZI258sn+JfT6Vsop6I3ng7K8Hc9TA2nGc496Cchv5U+RdpPTBqIg5yexrI4jz74j6lLPqUWiwuVtooxLcAH77H7qn2GM1jafpz3DLFEmXPQAVc8dQNbeM5JW5juYVKk+oyCPyrU8KXUFtcF5cD5cA96rdHqp+zpJxMi906eywLiMpu6AmqtreyaLqcGoQHGxgsgH8aE8g/0roPFeqR3syLHxHGMA965uztZNa1e302AE73DSkDiOMEFmPpxwPrTjdMqL5oXmexPgkFeVPPPvSjtn17VXiu0mvJbZYZV8pAd7r8pHbHvVkDr+nFJ7nkPQRRgDB4xxinEHvnNGMHpS47dc0hDSB+NcJ8SonTUNIuT/qtrw+wbOf5V3pGODWdr2kwa1pUtlOSgJDJIBko46EU1obUJqE02cj4WnhguR5pIB711Mt9ZxI7NcAsvGByQfSvPL6x1TRJNl9bM8WcLcQjcrD146VU/tMSNhFlkOeioST+lP0OyVD2j5ky7qsyyTyOOASWOOwrsPh3btD4XSRxxczPMoP8Ad6D+Vc1o3hjUNbmD6hFJZad1bdxJKP7oH8I9zXpMUMcMUcUMaxxRqERFGAoHansjPE1Eo+zQhHHU59aQDPHH4U9umQMEd65/xvq8mj6Hm1YLe3T+TE393+834CkldnJCLm1FEniDVtBtUaz1qaGbd1g272Hvx0rl7K18BahOix+ZA78hJXdFPtk8frXO2lgvLHLO3JY8lj6k+tTzachGGTIx0p3iuh6UaCgrKTPU7DTbPTLbyNPtoraE84jH3vqepqZ/72TgAkqO4/z/ADrgPBmuTaXfw6XeymSwnbZEznJic9AD6GvRGBVjkjA4HalJdUcFaEoStLU5TxzoDazYx3Voyrf2inZnpIndT/SvNftbW5C3MckMnoymvctjc+WMjrj0qLyY0lc7I9rHOCBgUrm9HFezjytXPINJ02/8R3K29nFJHbZ/fXLqQqL3x6t6CvXLK2hsrKC0tIylvAgSNfYd/wAasbvlALKAOw6YrP1/VYdD0t72VfMcnZFFn/WOeg+lNa6Izq1pV2opF1gI4g0hSGNe7EKKZDJDOSIJ4ZfZHBryi+mu9Wm+0apO0zk5CZwieyiofsiROHh/dyDlWQ7SD9RR7pqsG7ay1PYGBBOc0hznHvXKeCfEU9/O+l6mwe5RN8Ex4MgHVT7iusGCcAjNS1Y5pwdOXLIac7fxxSE4xx+FUb7WdIsXMd7qNvG46qDuI+uKlsb6x1DJsb2C4I/hVvmx9KOV72FZ2vYtLjBaTCoo3MT2A5ry/XdXl8RXzSMSNOjbbbw54I/vn1Ndz4ume18JatJGxDiHbx1AJAP9a8807bHFGFHCqBTWiOvCwWs2SQwFiFAyeuBRdWeUZZI/lPUEV3Ph6C1TS45vKXzWyX3nJFZPiaS3kkDRbQcc4FKxrGvedrB8PNTlMtxo125cRr5tszHJC91/Cu05615p4Q58cWgTosErPjsMf416SCO5P5VT1OXFRSnp1HjaAzudqKNzMTgAetefa/4pGqThNIQwqvy/a2X5nHsPT3ra+I928PhuO2iYhr2dYif9jqw/KuJghAQBVGOBgelGkUaYaimueQ0tqMLGT+0p9w7ls5/DpXZeEPE0F7Kml3UK296QWR14SfH8j7Vyzw7TtYHjtis2/EkEkE9ru+0RSK6bRzkGi99GdM6UaiseyYA4yeeKcODgUrBm2yFG+dQxwO9Jnkc/jipPLGkYYlBgdce9NOFx608cZI5x+tIw4x6+gpWAiY8kYox/tindCQV47UZP92SkO5k+I9I0+10ORxGkDxcrL3PrmvNNSCm2Zt3ylchh3FbmoaxPdBVmlLYHGTxVHSNNk8Q6ullGMQD57iQdET6+p6CtlHU9OipU4tzZ6vppeTSNOaVm3tbxlvc7atYzjnpSnbuAUAAcADsO1ARuPkPPpUvV3R5Lepm67o9rrmnm1vFPBzHKv3o27EVwr+D/ABBbybbeS2uoxwsm/YfxBr00qeAQeKMDIOAB2pLQ2p4idNWWx5vb+CtZupB9vvLe0hz8wQ+Y5Ht2rs9D0Sy0S1aCxQ5fHmSu2XkPuf6VemkitonmuJEigjXc0jngVyreO7MTN5Gn3MluOkmQCw9QtUk2W51a6slodb1IBJxQq8c7hg561V0jU7PV7czWEhOw4dHGGQ+4q6Oec5HbFJqz1OZpp2YAAHgnHbJp2OOM/nQuTnIxzxnvQTjJPA96QgOBSY5zj3FOIz0HtxWBr/iW30ydrW2j+1X4HK5wseem4/0qkrlRi5u0Texnt9RimiNVO5I41PchQDXnsviPXZX3faoYv9lI+B+ZrT0fxfKtwsGtxxhWOEuY1IVSf7w7D3pqKexrLD1Iq515QE5bBPqTSFVHYY6VKVA9CD0NUdaupLTSLye2QSzRISiep7UktTBJt2RZAAxg/jXFfFGI/ZdIuMfJFOyMfTcOK2vB2pXGq6Ubi7iMbhtuMcHir2u6bHrWj3FjK20SDKP3Vh0NNx5XZm1N+yqLm6Hn2lJGZU3rxkZz9a7bWLOzk0p3WONSi5Ur3rzqGWWwu3s9QUw3kRwwPAb3X1FaU2pO8YUyNtAwFzxj/GlY7alOUpJpmLrYEcDup2lcMCOxHevUNc1uLSNHgvrlPMnmRVjgHV3Iz+AHevOtLsm8Q63DYwqTbxsJLmTsiA5xn1PTFbPxEmM/ie2gP+qgtgyr6Ficn8gKpKy1CrFVJxgzMu/EGu37l3vWt1z8scA2gfj3qfTfFGs6cVF04v7YfeSQfPj2ap9D0z7fcCIsAMZLH0q7rOgLaQF4X3xgd+1LmY26V+RpHW6XfW2qWUd5ZPuibgg9UPcEdjXF/EuUtrGlWx5iSFpsdtxOM034eztb+JbmyDHy7m3MmPRlI5+uDWl8SNLkuLO11O2QySWeVlVRyYz1OPanZGEIKlXSexz+k2y3d1FC7bQTya6LW/D9ra2vmRZXb1J71yFjdj5HifnqGFaN3q9xcQbZZCyAdzxUWOicZuSs9DMgf7N4h0qeFf3gukAA7gnBH5V13xG1uXT1i0rT3MdzdAvLKOqRZxx7k8fTNYngrTm1bXk1B1P2CxbcrkcSS9gPYdc0zx4jHxvIXBw1tGV+nIP65prQJKM6qT6Iw7ewQR8Lg7sk9SfrSSWZjkEsDNFMpyjocMDXVeGrSG5uVSc4Qjuat+KNLgsyDDnaRyvWo13Lddc3Ix3hjWD4n0q+0TVio1DySokHAlXs31BxmuHtxNY3UljfKUuoG2Mp7+jD1Bq5pszWPijSriMEMZhG3urcEV6P4h8PafreFvkZZY+I54+HUeme49qbZk5RoSt9l/gcNBfvHEAshC+xqlf6gsUReaQKB09/wrdf4fzbsRaywjzj5oecU+70nQ/B0cV5f+bqmpyH/R4pMYJHfHQAepprXYpVKV/d1Zf+Hei3FpZz6peRFLu9A8uNuscQ5Gfc/wCFdcY32/dP868qvde13V5S8l5JbIfuxW/yhfqepqBLvWLVg0Gp3ilTkbn3D9aqy7mNTDzqS5pNI6r4npnRNPuRytvdANjsG4zXKW0mGQjkqc/Wt/RPEU+v3Z0PxClklvcRMnmgMHmfsB2Ujryee1ZWpeFdZ0aTEETahag4SSL7+P8AaX1+lKSsa0fcXs56M1v3GphQMRug+cj0HeuevNUMknlaXEsUG7HmkZd/f2q7pun6zdWt8ItPniDQkBpBsP05qroFpEzRm5kVDjAX0PvSXcuKUb3ew2a/1hZw0OqXiMvA+fIGPau08G+In1mOW01AKup243MV4Eyf3gPX1rn9U0W6sCXdA8LdHXoazNJnaz8WaRMhI3TeU2O4bqKd76MidOFSGiPVsdT6c0jDt2NSuNjsOeD0/Gm7SGJySD0GOlQebcj2569R3pu1vf8AOpipyMfoKPyoA4+1+HsQkJvNVnmjB5SJAh+hNddpenWulWn2XT7ZYIc9urn1J6k/Wr2MZwPfiopXEMEkrDCxoX/IZrQudadXSTOU8XeK20yY2Olokl6BmWVuVhz2x3b+Vce+o6vc5kl1O8Zuo2SlQPwFVNPDXebmUl5ZiZHY9yTmuq0bQ5b5WYYULxnsabdtjvUKdGOqKujeLtQ06RV1NmvLP+IsMyJ7g9/pXo0TxTwRT27h4ZFDK4PUHpXm+q6c1rI0bDkdMCt74bXDNp99Yu2RbTZjHorDOPzzT+NGGIpxcfaQM74j3TT3lnpSkiJV+0TAHhj0UH+dYkFsSoIXHvWn4tw3jW6B4xDEOe9b2hWCTQEn6c0maqapU0cnazXOjXyX1ocunEiE8SL6H+hr0+xuUvLG3u4sbZlDjBzj2zXF+ILFIJNqcjGfpWn8OZS2jXNselvOQvsDzj+dNe8vQxxCU4e0R046n0HvRIQiMx6DnAGacBliBycZx6U/bnpjNTZnEY3ifUzpGjT3MY/ftiKHI/jbgfl1rzq2VYoyxJdidzknJZj1JrsfiSrDSbFsMVW7XdgdMqwGfxNctZSC1u4bgqJPLYMUPQj0p26HoYdWp3IvtUWdpyG9CMUy4CTIy7cqeCa7xdT0C+Hm3EUSydxInNZd++lTzCO0QLuIAPQUcjRUa2uzNLwZemXwlBPeyqn2cMjyM3ACnqSfasu98dQ+Zs0uxa5izzNKdit9B1qjr2BaJpsfFsCJHA6O3v7VTsdN8x1VW6/KBVNrciNKDvORoDxrqMcgA021MPXarEH866Tw/wCIbHW9yW+6G7Ubngk4P1HrXL6noc9ihLEEDAIz2rCmeTT7qG+tn2zQMGVh3HcH2pKSk7Mp0KdSPubnp+r6NYavGE1G2SXb91+jL9D1rCXwHpAlJZ7x4uuwzHBHp611g/eIHUnDgNg9sgU7bjNTaxxRrTgrJlWwsrTT7Vbewt47eAfwoMZ9z/jXJfEfT3D2mrRqSkS+TcYHRc5Vvzz+ddttDKeDz+dOdBKjI6BkYbWUjIIoQ6dVwnzHlmiag1ncpcQkEjtngitvWteF5beXGgQY+YDv7Uan4EdZ5JNGuxCrHcYJhlVPse30qvaeB9QuHH9p38UUP8S2wJZvbJ6U/I7HKjJ87ZV+H0DXfiW5v0z9ntITCW7M7YOB64A/WvRcfxcdMH/Cs2STS/C2jxq222s4xhEHLO38ya5e48e3LSYstNRYs/KZn+Y/gKrlbMZqeIlzQWho6l4K0y9naa386xkbk+QcIx9StQ2ngLTUkDX1xdXajokjbVP1Ap+k+OLa5mEOq2/2N3O1ZFO5Cfc9q65h0PY/kahxsKVStT92TIIIIreBILeJIoFGFRAAAK5jx9os19bQajYp5l3Zgh0HWSLuB7jrXR6jeWunWrXF/OkMA7seT9PWuYk8f6ekmLeyvJkH8eAv5A0KLJoqpzc8Vc5PTb9AqvBIMexwR+FW7vUJJwfMYk4wMnNX2t/C/ii7ZreWXSdUkOChG3e306E/Sp4vh4TIVu9XmeIdVjTaT+NDi1udrqU07y0ZgeF7R9W8XWgVQ0Fk3nzSdhxwp9816s4JLe5zUGk6VZ6PZC206EQxdWPUufUnvVwL61LOKvWVSWmyI1QEgHua8n8RynU/FGoyyMGMD/Z1XP3Avb+teuYxgjH0rzrxxpUmnau+pRqTYXZBkYf8s5Pf2NNIvCSSm77kXhrTVu5sMOF569a6e/0KB7NiqBGFcjpN+9lOJYiPw71q6h4lnurcxbUGSDuHb1p8prVjUc7x2OT1u2CJIR8skZ3Iw42kdDXq+hXjX+iadeOT5k0CM3ucYNeUzxzatex6dYr5lzcHaxHIRe7H2r2CztUs7S3tYseXBGsY464GM0PYWLa5Yp7kquRJy2exH+NeQarZyaPr93ZzZAZzNAx6OhOePcdK9fA6nHSs/WtGstatPs9/GWCnMcinDxn1BpIww9ZU5a7M84fUJ5IBGZCVwB68D/JpvhKzbV/FduyKWtbD97K/bf2X610S/DmJn2tq140OeUCgH6ZrrNG0W10WyFpp8IjhzkknLO3qT3o3OqeIpxi+Tdk/3iT3PNB/XvUmwqMEdPWmyZCkKCT0ApWPOuRsMk+vvTtsnof++ahvrmLStMuby4YtFbxliW5JxXmH/CzdZ/58IfzNVGm5am1OjOr8CuevD/WH6n+dRXv/AB5Xf/XJv5GiikzKHxI8b0X/AI9k/wCuf9a9N8Jf8eR+h/nRRVyPQxfwmV4y/wBc3+6KZ8N/+PvV/rF/I0UUU9mS/wCAyh4s/wCR1l/64R10nh3/AFLfj/I0UUuhNb+GvRGd4o/1yUfDb/mN/wDXZP8A0E0UVcOoP+Azrb7/AI8H/GuY0H/kJv8AWiitY/CcXQvfET/kVLr/AHk/9CFcQn+q/CiisJHoYf8Ah/Mi/iH1p0X+sj/3v6UUU0avZmj4j/5CDf8AXOP+VS6T/rk/3x/SiikzN/Abvi37p+lcHrf/AB7H/eH8xRRUvdBhfhR7An/HvF/uj+VNf/ln/vCiiqluea9yRfv1Ff8A3RRRVw3BbD7P/UCnn+tFFE9xs89+Kn/H/o//AG0/pXLL1f60UUn09D1cN/CX9dSpqH/Hm/8AuCvZdF/5Aenf9cU/lRRUv4TLG/DH+uxw3xf/AOPnSPq1csOr/wCe9FFOWyN8N/Cj8/zKuo/8sf8Arsv8694P3V+g/lRRQ/h+f+Rz437PzEP3Kd/AaKKzPPFPb61neJv+Rd1H/ri1FFDKpfGjx3Sf9Qn4f0q1P/qB/un+VFFansvc3Pg//wAf2qf7gr0f+99f6Ciiol1POxn8T5Dz9wfSiTp+NFFSjlRIn+r/AA/pWKv+ub6iiitqewmbUvQfSo06j6Giis3uN7nOfEH/AJEfUf8AdH868xoopv4Uergfgfqf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38694=[""].join("\n");
var outline_f37_50_38694=null;
var title_f37_50_38695="Paradigm-based treatment approaches for burn pain control";
var content_f37_50_38695=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Paradigm-based treatment approaches for burn pain control",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38695/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38695/contributors\">",
"     Shelley Wiechman, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38695/contributors\">",
"     Sam R Sharar, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38695/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38695/contributors\">",
"     Marc G Jeschke, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38695/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38695/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/50/38695/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H13089398\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain management is a central component of the treatment of patients with burns. Despite advances in burn care, control of burn pain is often inadequate during the acute and chronic rehabilitation phases of burn care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/1\">",
"     1",
"    </a>",
"    ]. Pain is among the most common causes of distress during the first year after recovery and, hence, should be aggressively managed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Burn pain management is typically based upon clinical experience and physician",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    institutional preference, since available evidence is insufficient to clearly support one approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The approach to the management of patients with acute, background, procedural, and chronic pain secondary to burns will be discussed here. An overview of the pharmacologic and nonpharmacologic treatment options for managing burn pain is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13089859\">",
"    <span class=\"h1\">",
"     SELECTION OF ANALGESIC REGIMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selection of an analgesic regimen is based upon the clinical setting, the effectiveness of the approach in alleviating pain, and clinician and institutional preferences. No regimen is appropriate in all settings and there is no high-quality evidence that any regimen is better than another. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H11800898#H11800898\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Pharmacologic treatment options'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H11800906#H11800906\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Nonpharmacologic treatment options'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We, and many other burn centers, advocate a structured approach to analgesia that incorporates both pharmacologic and nonpharmacologic therapies, targets the specific clinical pain settings unique to the burn patient, and is individualized to meet specific patient needs and institutional capabilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    In addition, the regular use of a weight-based pediatric medication worksheet (placed at the bedside and in the patient record) containing all analgesic and resuscitation drugs provides a supplemental safeguard against accidental overdose in pediatric patients. This is particularly important in the young pediatric age group where risks from analgesia and clinical unfamiliarity are both elevated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13090170\">",
"    <span class=\"h2\">",
"     Challenges and limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute and chronic burn pain is challenging to treat because of multiple components that must be addressed and the changing patterns of pain with time:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Variability of pain",
"      </strong>",
"      &mdash; Burn pain is variable among patients and within each individual. Adequate pain management must be directed towards the current situation. As an example, burn pain can be excruciating with dressing changes and physical therapy but less painful when the burn sites are undisturbed (background pain).",
"     </li>",
"     <li>",
"      <strong>",
"       Dosing of analgesics",
"      </strong>",
"      &mdash; Opioid analgesic dosing is based on patient weight, which is variable in the burn patient due to physiologic fluid shifts. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/51/22330?source=see_link&amp;anchor=H2#H2\">",
"       \"Hypermetabolic response to severe burn injury: Recognition and treatment\", section on 'Hypermetabolic changes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Pharmacokinetics",
"      </strong>",
"      &mdash; Burn injuries reduce the volume of distribution and clearance of anesthetics, and increase the terminal elimination half-life of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Route of drug administration",
"      </strong>",
"      &mdash; Options include intravenous, inhalation, oral, transmucosal, enteral tube, or rectal. The intravenous route provides rapid onset and short duration of pain relief, is used for patients with moderate to severe burns, and monitoring of vital signs is mandatory. Oral administration is ideal for the outpatient setting.",
"     </li>",
"     <li>",
"      <strong>",
"       Opioid tolerance",
"      </strong>",
"      &mdash; Tolerance to analgesic effects generally occurs after more than two weeks of opioid use. The frequency of opioid tolerance has not been objectively documented in burn patients, but clinical experience is that the majority of burn patients receiving opioids on a daily basis develop analgesic tolerance during the initial weeks of treatment [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/9\">",
"       9",
"      </a>",
"      ], possibly due to pharmacodynamic changes at the opioid receptor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/8\">",
"       8",
"      </a>",
"      ]. Over time, a higher dose of medication is needed to achieve the same level of pain relief.",
"     </li>",
"     <li>",
"      <strong>",
"       Hyperalgesia",
"      </strong>",
"      &mdash; Hyperalgesia is an increased sensitivity to pain and is induced by the acute inflammatory response of a burn injury. Primary hyperalgesia occurs in the tissues directly damaged by the burn. Secondary hyperalgesia occurs in the normal tissues adjacent to the burn. Continued or repeated painful stimuli associated with background pain or repeated procedural pain can cause central nervous system adaptations that amplify the pain experience (ie, windup). Such pain may be opioid-resistant and become irreversible and thus contribute to ineffective opioid analgesia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13090177\">",
"    <span class=\"h2\">",
"     Optimizing pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principles for optimizing opioid pharmacotherapy in burn patients are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treat burn pain based upon the five components of the burn pain paradigm: background, procedural, breakthrough, postoperative, and chronic. (See",
"      <a class=\"local\" href=\"#H13088200\">",
"       'Burn pain paradigm'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Individualize dosage, set a flexible dosing schedule, and use frequent dose adjustments as needed to account for variability in analgesic requirements.",
"     </li>",
"     <li>",
"      Assess and document pain management efficacy at regular intervals to adjust dosages and dosing intervals.",
"     </li>",
"     <li>",
"      Monitor side effects and prevent or treat them; do not under medicate.",
"     </li>",
"     <li>",
"      Consider using nonopioids in conjunction with potent opioids to enhance analgesia and reduce risks of opioid side effects. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H11800898#H11800898\">",
"       \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Pharmacologic treatment options'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Monitor anxiety and changes in mood.",
"     </li>",
"     <li>",
"      Apply nonpharmacologic interventions to complement, not replace, analgesia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H11800906#H11800906\">",
"       \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Nonpharmacologic treatment options'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13088200\">",
"    <span class=\"h1\">",
"     BURN PAIN PARADIGM",
"    </span>",
"    &nbsp;&mdash;&nbsp;A burn pain paradigm guides the use of analgesics for management of the different phases and variability of burn pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/9\">",
"     9",
"    </a>",
"    ]. This paradigm is based upon five phases of burn pain occurrence and includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Background",
"      </strong>",
"      ��� Pain that is present while the patient is at rest, results from the thermal tissue injury itself, and is typically of low to moderate intensity and long duration.",
"     </li>",
"     <li>",
"      <strong>",
"       Procedural",
"      </strong>",
"      ��� Brief but intense pain that is generated by wound debridement and dressing changes",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      rehabilitation activities (eg, physical therapy and occupational therapy).",
"     </li>",
"     <li>",
"      <strong>",
"       Breakthrough",
"      </strong>",
"      ��� Unexpected spiking of pain levels that occurs when current analgesic effects are exceeded, either at rest, during procedures, or with anxiety.",
"     </li>",
"     <li>",
"      <strong>",
"       Postoperative",
"      </strong>",
"      ��� A predictable and temporary increase in pain occurs after burn excision, donor skin harvesting, and grafting, due to the creation of new and painful wounds in the process. The duration of pain is typically two to five days.",
"     </li>",
"     <li>",
"      <strong>",
"       Chronic",
"      </strong>",
"      ��� Pain that lasts longer than six months or remains after all burn wounds and skin graft donor sites have healed. The most common form of chronic pain is neuropathic pain, which is the result of damage sustained by the nerve endings in the skin.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13089845\">",
"    <span class=\"h1\">",
"     PARADIGM-BASED TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following sections outline the approach to treatment of burn pain based upon the five phases of the paradigm. The regimens used at our institution are illustrated in the table (",
"    <a class=\"graphic graphic_table graphicRef59472 \" href=\"mobipreview.htm?17/54/18285\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99875883\">",
"    <span class=\"h2\">",
"     Drugs and dosing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug options and dosing for opioids, nonopioids, benzodiazepines, and adjuvant analgesics are compiled in the following tables:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Opioid analgesics for adults (",
"      <a class=\"graphic graphic_table graphicRef58864 \" href=\"mobipreview.htm?11/31/11760\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Opioid analgesics for children (",
"      <a class=\"graphic graphic_table graphicRef76614 \" href=\"mobipreview.htm?29/50/30508\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Patient controlled anesthesia (",
"      <a class=\"graphic graphic_table graphicRef51791 \" href=\"mobipreview.htm?9/50/10029\">",
"       table 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Nonopioid analgesics for adults (",
"      <a class=\"graphic graphic_table graphicRef70067 \" href=\"mobipreview.htm?23/54/24431\">",
"       table 5",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Benzodiazepines for adults (",
"      <a class=\"graphic graphic_table graphicRef65653 \" href=\"mobipreview.htm?39/16/40205\">",
"       table 6",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Adjuvant analgesics for adults (",
"      <a class=\"graphic graphic_table graphicRef82318 \" href=\"mobipreview.htm?1/28/1485\">",
"       table 7",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These tables are an adjunct to the treatment recommendations described in the following discussion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13088214\">",
"    <span class=\"h2\">",
"     Background pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacologic and nonpharmacologic management strategies relieve background pain. Background pain decreases with time as the burn wound and associated donor skin graft sites heal, and analgesics can be slowly tapered as the pain lessens in severity and frequency. The optimal treatment of background pain is mild to moderately potent analgesics administered so that plasma drug concentrations remain relatively constant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pharmacologic approaches:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Continuous intravenous (IV) opioid infusions, such as patient-controlled analgesia (PCA) &nbsp;",
"     </li>",
"     <li>",
"      Oral administration of long-acting opioids with prolonged elimination (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      ) or prolonged enteral absorption (sustained-release",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Oral administration on a regular schedule of short-acting oral opioid analgesics or non-steroidal anti-inflammatory agents (NSAIDs)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H11800898#H11800898\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Pharmacologic treatment options'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonpharmacologic approaches:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Relaxation techniques including meditation, progressive muscle relaxation, and guided imagery",
"     </li>",
"     <li>",
"      Information provision",
"     </li>",
"     <li>",
"      Enhanced coping skills",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H11800906#H11800906\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Nonpharmacologic treatment options'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13088221\">",
"    <span class=\"h2\">",
"     Procedural pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticipatory anxiety is an important issue that can develop with the repeated performance of wound care. When adequate analgesia is not provided for an initial, painful procedure, the effectiveness of analgesia for subsequent procedures is reduced, in large part due to anticipatory anxiety and heightened arousal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Thus, efforts to provide effective procedural burn pain management should begin with the first wound care procedure.",
"   </p>",
"   <p>",
"    Procedural pain (eg, daily dressing changes) is more intense and shorter in duration than background pain and is optimally managed using potent sedation, analgesia, anxiolytics,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    general anesthesia. However, it is impractical to use general anesthesia on a daily basis. Nonetheless, the provision of deep sedation with carefully titrated inhaled or IV anesthetic agents, brief general anesthetics, and regional analgesic techniques can have a role in procedural burn pain settings. Nonpharmacologic techniques (eg, information provision, distraction, relaxation) serve as an adjunct to pharmacologic management.",
"   </p>",
"   <p>",
"    Administration of moderate or deep sedation should follow institutional guidelines developed for safety and efficacy. Such guidelines have been established by the American Society of Anesthesiologists (ASA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/13\">",
"     13",
"    </a>",
"    ] and adopted by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/14\">",
"     14",
"    </a>",
"    ]. These guidelines dictate the safety monitoring requirements and specific agents that can be used for procedural analgesia, as some of the more potent opioids (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/50/5927?source=see_link\">",
"     remifentanil",
"    </a>",
"    ) or anesthetics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    ) may result in excessive sedation.",
"   </p>",
"   <p>",
"    The optimal pharmacologic analgesic regimens include moderate- to highly-potent opioids with a short duration of action, often in combination with anxiolytics (eg, benzodiazepines). The use of potent opioid analgesics and anxiolytics should only occur in settings with established intravenous access, and adequate monitoring, personnel, and resuscitation equipment. For most burn wound debridement procedures, opioid analgesia with or without the concurrent use of anxiolytic sedatives (eg, benzodiazepines) will typically produce moderate sedation.",
"   </p>",
"   <p>",
"    The following illustrate the pharmacologic approaches to procedural pain, based on anticipated severity of pain:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99876219\">",
"    <span class=\"h3\">",
"     Severe procedural pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;General anesthesia, deep sedation, or regional anesthesia is useful for severely painful dressing changes or ones that require extreme cooperation in a noncompliant patient (eg, face debridement in a young child) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99876226\">",
"    <span class=\"h3\">",
"     Mild to moderate procedural pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous and inhalation medications have a rapid onset of action and a short duration of activity, while oral agents have a prolonged onset of action and duration. Inhalation anesthetics can be used if IV access is not possible. The following intravenous, oral, and inhaled analgesics are used to control mild to moderate procedural pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      IV opioid analgesics (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/50/5927?source=see_link\">",
"       remifentanil",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      IV anesthetic agents (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/53/33622?source=see_link\">",
"       dexmedetomidine",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Orally administered opioid analgesics (eg,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/34/10792?source=see_link\">",
"       oxycodone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/48/25353?source=see_link\">",
"       hydromorphone",
"      </a>",
"      ) &nbsp;",
"     </li>",
"     <li>",
"      Oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"     </li>",
"     <li>",
"      Oral transmucosal",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"     </li>",
"     <li>",
"      Inhaled",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/29/11732?source=see_link\">",
"       nitrous oxide",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99876233\">",
"    <span class=\"h3\">",
"     Minor procedure pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minor procedures may also require analgesia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sedation, particularly for children. These procedures include removal of numerous staples from grafted sites, meticulous wound care of recently grafted sites",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    donor sites, and wound care involving the face",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neck.",
"   </p>",
"   <p>",
"    Either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    can be used for minor procedures, depending on the surgeon&rsquo;s preference. Historically, IV or intramuscular ketamine has been used in children and adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/45/10967?source=see_link\">",
"       ketamine",
"      </a>",
"      is an option for pediatric burn patients without IV access [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/17\">",
"       17",
"      </a>",
"      ]. However, ketamine use is limited by the potential risk of associated emergence delirium reactions (5 to 30 percent incidence), particularly in the elderly.",
"     </li>",
"     <li>",
"      When administered by appropriately trained and experienced personnel (eg, anesthesia providers),",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      is a safe and effective alternative in the burn pain management setting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/23\">",
"       23",
"      </a>",
"      ] and is being evaluated as a potential drug for PCA delivery for less aggressive wound care procedures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/24\">",
"       24",
"      </a>",
"      ]. Propofol is particularly advantageous as it can be titrated to effect both in terms of level of consciousness and duration of action using continuous IV infusion techniques and has the additional benefit of a rapid awakening with a minimal risk of nausea. However, propofol is more rapidly cleared and has a higher volume of distribution in burn patients, necessitating careful increases in dose [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/25,26\">",
"       25,26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13088228\">",
"    <span class=\"h2\">",
"     Breakthrough pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breakthrough pain occurs when the comfort provided by background pain management is exceeded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/27\">",
"     27",
"    </a>",
"    ]. The cause of breakthrough pain includes inadequate background analgesic management, development of opioid tolerance,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    changes in the burn wound that increase pain (eg, proliferation of epidermal skin buds during the spontaneous burn healing process, burn wound infection). A change in the pharmacologic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nonpharmacologic pain management is based upon the correct diagnosis for the breakthrough pain. As an example, an adult patient hospitalized with a partial thickness burn covering 10 percent total body surface area is receiving 10 mg oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    every 12 hours for background pain. After one week, as painful new skin buds start to appear, the patient consistently requests (and receives) 1 to 2 doses of 10 mg oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/34/10792?source=see_link\">",
"     oxycodone",
"    </a>",
"    between methadone administration times. After confirming that the burn wound is not infected, the oral methadone should be increased to 15 mg every 12 hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13088235\">",
"    <span class=\"h2\">",
"     Postoperative pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacologic management of postoperative pain includes a temporary (approximately one to four days) increase in background opioid analgesic support. The optimal management includes the use of continuous regional block techniques and additional opioid dosing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=see_link\">",
"     \"Management of postoperative pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One of the most useful nonpharmacologic analgesic techniques in this setting is information provision, so that patients anticipate both the increase and temporary nature of the postoperative pain. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H810810#H810810\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Information provision'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13088242\">",
"    <span class=\"h2\">",
"     Chronic pain management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The study of chronic pain and hyperalgesia in the burn patient population is in the early stages of investigation, as most of the research has focused on acute pain. Retrospective reviews found that 33 to 50 percent of burn patients have chronic pain that persists for years after the burns are healed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/29-31\">",
"     29-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common form of chronic pain is neuropathic pain. Neuropathic pain is the result of damage sustained by the nerve endings in the skin. Other causes of chronic pain are likely from musculoskeletal pain associated with deconditioning. Patients report that chronic pain is exacerbated by temperature change, dependent position, or weight bearing activities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42778?source=see_link&amp;anchor=H185828303#H185828303\">",
"     \"Overview of the treatment of chronic pain\", section on 'Neuropathic pain'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No data from randomized trials have identified the optimal management of chronic pain in burn patients. Chronic pain, like acute pain, is best managed with opioid and nonopioid analgesics, with adjustments of the doses and dosing schedule based upon response. We use the nonopioid medication",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    in our practice, based on two preliminary reports suggesting that a three week course of the drug can reduce",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"     morphine",
"    </a>",
"    requirements in the acute pain setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/32\">",
"     32",
"    </a>",
"    ] as well as reduce neuropathic post-burn pain that is unresponsive to opioids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/33\">",
"     33",
"    </a>",
"    ]. Nonsteroidal antiinflammatory drugs (NSAIDs) can also be used as a nonopioid option. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/36/5703?source=see_link\">",
"     \"NSAIDs: Therapeutic use and variability of response in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who do not have relief of chronic pain or hyperalgesia with opioids and nonsteroidal anti-inflammatory agents, clinical experience and case studies have shown efficacy with antidepressants (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/62/37864?source=see_link\">",
"     duloxetine",
"    </a>",
"    ),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anticonvulsant analgesics (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/31/16887?source=see_link\">",
"     pregabalin",
"    </a>",
"    ) following burn injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38695/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42778?source=see_link&amp;anchor=H18#H18\">",
"     \"Overview of the treatment of chronic pain\", section on 'Anticonvulsants'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42778?source=see_link&amp;anchor=H9187567#H9187567\">",
"     \"Overview of the treatment of chronic pain\", section on 'Antidepressants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonpharmacologic approaches should focus on the impact of chronic pain. These approaches include diversion techniques and relaxation techniques and can target healthy lifestyle choices and more adaptive thinking styles. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=see_link&amp;anchor=H11800906#H11800906\">",
"     \"Burn pain: Principles of pharmacologic and nonpharmacologic management\", section on 'Nonpharmacologic treatment options'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13088249\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain management is a central component of the treatment of patients with burns. Despite advances in various aspects of burn care, control of burn pain is often inadequate during the acute and chronic rehabilitation phases of burn care. Pain is among the most common causes of distress during the first year after recovery and, hence, should be aggressively managed.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Optimum management of burn pain requires a structured approach that incorporates both pharmacologic and nonpharmacologic therapies, targets the specific clinical pain settings unique to the burn patient, and is individualized to meet specific patient needs and institutional capabilities. (See",
"      <a class=\"local\" href=\"#H13089859\">",
"       'Selection of analgesic regimen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A burn pain paradigm can be used to guide management of the different phases and variability of burn pain. This paradigm is based upon five phases of burn pain occurrence: background, procedural, breakthrough, postoperative, and chronic. (See",
"      <a class=\"local\" href=\"#H13088200\">",
"       'Burn pain paradigm'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For background pain management, the combination of pharmacologic and nonpharmacologic techniques can be used. We suggest using continuous or scheduled intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      for pain management in the critical care setting (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For patients who are tolerating oral intake, the regimen can be adjusted to include scheduled",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/57/36761?source=see_link\">",
"       methadone",
"      </a>",
"      , extended release morphine, and eventually",
"      <span class=\"nowrap\">",
"       NSAIDS/",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"        acetaminophen",
"       </a>",
"       .",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H13088214\">",
"       'Background pain management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For procedural pain management (eg, dressing changes), the combination of pharmacologic and non-pharmacologic techniques can be used. The approach depends on the anticipated pain caused by the procedure. For procedures that are severely painful, we suggest general or regional anesthesia (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For mild to moderately painful procedures, a drug with rapid onset and short duration in combination with a nonpharmacologic technique (eg, information provision) may be sufficient. Appropriate regimens are shown in the table (",
"      <a class=\"graphic graphic_table graphicRef59472 \" href=\"mobipreview.htm?17/54/18285\">",
"       table 1",
"      </a>",
"      ). For procedures that cause minor pain, mild pharmacologic sedation with nonpharmacologic approaches will usually suffice. (See",
"      <a class=\"local\" href=\"#H13088221\">",
"       'Procedural pain management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For postoperative pain management, a transient increase in dosing of opioids and the use of regional anesthetics can be added as needed. We suggest using intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/31/19962?source=see_link\">",
"       morphine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"       fentanyl",
"      </a>",
"      for the critical care setting (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For non-critical care settings, when IV access is not available, postoperative pain can be managed with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/34/10792?source=see_link\">",
"       oxycodone",
"      </a>",
"      . Nonpharmacologic techniques that were effective prior to the operation and that matched a person&rsquo;s coping style should continue to be used in the postoperative period. A particularly helpful technique is information provision. (See",
"      <a class=\"local\" href=\"#H13088235\">",
"       'Postoperative pain management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For chronic and neuropathic pain management, the combination of pharmacologic and nonpharmacologic techniques may be useful in managing pain. We suggest opioids",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      nonopioid regimens, with adjustments of the doses and dosing schedule based upon response (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We use nonopioids, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      and nonsteroidal antiinflammatory drugs, as optimal pharmacologic choices. Nonpharmacologic options, such as cognitive distraction and relaxation techniques, should focus on the impact of chronic pain. (See",
"      <a class=\"local\" href=\"#H13088242\">",
"       'Chronic pain management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/1\">",
"      Ptacek JT, Patterson DR, Montgomery BK, Heimbach DM. Pain, coping, and adjustment in patients with burns: preliminary findings from a prospective study. J Pain Symptom Manage 1995; 10:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/2\">",
"      Askay SW, Stricklin M, Carrougher GJ, et al. Using QMethodology to identify reasons for distress in burn survivors postdischarge. J Burn Care Res 2009; 30:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/3\">",
"      Wiechman Askay S, Patterson DR, Sharar SR, et al. Pain management in patients with burn injuries. Int Rev Psychiatry 2009; 21:522.",
"     </a>",
"    </li>",
"    <li>",
"     Burn Pain: A Unique Challenge. Pain Clinical Updates. International Association for the Study of Pain. Vol IX, Issue 1. March 2001. www.iasp-pain.org.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/5\">",
"      Faucher L, Furukawa K. Practice guidelines for the management of pain. J Burn Care Res 2006; 27:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/6\">",
"      Sheridan RL, Hinson M, Nackel A, et al. Development of a pediatric burn pain and anxiety management program. J Burn Care Rehabil 1997; 18:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/7\">",
"      Gibbons J, Honari SR, Sharar SR, et al. Opiate-induced respiratory depression in young pediatric burn patients. J Burn Care Rehabil 1998; 19:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/8\">",
"      Furman WR, Munster AM, Cone EJ. Morphine pharmacokinetics during anesthesia and surgery in patients with burns. J Burn Care Rehabil 1990; 11:391.",
"     </a>",
"    </li>",
"    <li>",
"     Patterson DR, Sharar SR. Burn pain. In: Bonica's Management of Pain, 4th edition, Fishman SM, Ballantyne JC, Rathmell JP (Eds), Lippincott Williams and Wilkins, Philadelphia 2010. p.754.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/10\">",
"      Richardson P, Mustard L. The management of pain in the burns unit. Burns 2009; 35:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/11\">",
"      Weisman SJ, Bernstein B, Schechter NL. Consequences of inadequate analgesia during painful procedures in children. Arch Pediatr Adolesc Med 1998; 152:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/12\">",
"      Thurber CA, Martin-Herz SP, Patterson DR. Psychological principles of burn wound pain in children. I: theoretical framework. J Burn Care Rehabil 2000; 21:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/13\">",
"      American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002; 96:1004.",
"     </a>",
"    </li>",
"    <li>",
"     Joint Commission Resources. Approaches to Pain Management, Second Edition. PDF book. www.jcrinc.com/e-books/EBAPM10/2213/ (Accessed on February 28, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/15\">",
"      Dimick P, Helvig E, Heimbach D, et al. Anesthesia-assisted procedures in a burn intensive care unit procedure room: benefits and complications. J Burn Care Rehabil 1993; 14:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/16\">",
"      Powers PS, Cruse CW, Daniels S, Stevens BA. Safety and efficacy of debridement under anesthesia in patients with burns. J Burn Care Rehabil 1993; 14:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/17\">",
"      Humphries Y, Melson M, Gore D. Superiority of oral ketamine as an analgesic and sedative for wound care procedures in the pediatric patient with burns. J Burn Care Rehabil 1997; 18:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/18\">",
"      Sharar SR, Bratton SL, Carrougher GJ, et al. A comparison of oral transmucosal fentanyl citrate and oral hydromorphone for inpatient pediatric burn wound care analgesia. J Burn Care Rehabil 1998; 19:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/19\">",
"      Sharar SR, Carrougher GJ, Selzer K, et al. A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care. J Burn Care Rehabil 2002; 23:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/20\">",
"      Filkins SA, Cosgrav P, Marvin JA. Self-administered anesthesia:  A method of pain control. J Burn Care Rehabil 1981; 2:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/21\">",
"      Demling RH, Ellerbe S, Jarrett F. Ketamine anesthesia for tangenital excision of burn eschar: a burn unit procedure. J Trauma 1978; 18:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/22\">",
"      Ward CM, Diamond AW. An appraisal of ketamine in the dressing of burns. Postgrad Med J 1976; 52:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/23\">",
"      Mills DC, Lord WD. Propofol for repeated burns dressings in a child: a case report. Burns 1992; 18:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/24\">",
"      Coimbra C, Choini&egrave;re M, Hemmerling TM. Patient-controlled sedation using propofol for dressing changes in burn patients: a dose-finding study. Anesth Analg 2003; 97:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/25\">",
"      Yamashita S, Kaneda K, Han TH. Population pharmacokinetics of a propofol bolus administered in patients with major burns. Burns 2010; 36:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/26\">",
"      Han TH, Greenblatt DJ, Martyn JA. Propofol clearance and volume of distribution are increased in patients with major burns. J Clin Pharmacol 2009; 49:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/27\">",
"      Carrougher GJ, Ptacek JT, Sharar SR, et al. Comparison of patient satisfaction and self-reports of pain in adult burn-injured patients. J Burn Care Rehabil 2003; 24:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/28\">",
"      Cuignet O, Mbuyamba J, Pirson J. The long-term analgesic efficacy of a single-shot fascia iliaca compartment block in burn patients undergoing skin-grafting procedures. J Burn Care Rehabil 2005; 26:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/29\">",
"      Choini&egrave;re M, Melzack R, Papillon J. Pain and paresthesia in patients with healed burns: an exploratory study. J Pain Symptom Manage 1991; 6:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/30\">",
"      Malenfant A, Forget R, Amsel R, et al. Tactile, thermal and pain sensibility in burned patients with and without chronic pain and paresthesia problems. Pain 1998; 77:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/31\">",
"      Dauber A, Osgood PF, Breslau AJ, et al. Chronic persistent pain after severe burns: a survey of 358 burn survivors. Pain Med 2002; 3:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/32\">",
"      Cuignet O, Pirson J, Soudon O, Zizi M. Effects of gabapentin on morphine consumption and pain in severely burned patients. Burns 2007; 33:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/33\">",
"      Gray P, Williams B, Cramond T. Successful use of gabapentin in acute pain management following burn injury: a case series. Pain Med 2008; 9:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/34\">",
"      Ahuja RB, Gupta R, Gupta G, Shrivastava P. A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. Burns 2011; 37:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38695/abstract/35\">",
"      Naraynsingh V, Hariharan S, Dan D, et al. Conservative management for idiopathic granulomatous mastitis mimicking carcinoma: case reports and literature review. Breast Dis 2010; 31:57.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16505 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.81.197.98-4F96C3A324-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38695=[""].join("\n");
var outline_f37_50_38695=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13088249\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13089398\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13089859\">",
"      SELECTION OF ANALGESIC REGIMEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13090170\">",
"      Challenges and limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13090177\">",
"      Optimizing pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13088200\">",
"      BURN PAIN PARADIGM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13089845\">",
"      PARADIGM-BASED TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H99875883\">",
"      Drugs and dosing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13088214\">",
"      Background pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13088221\">",
"      Procedural pain management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H99876219\">",
"      - Severe procedural pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H99876226\">",
"      - Mild to moderate procedural pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H99876233\">",
"      - Minor procedure pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13088228\">",
"      Breakthrough pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13088235\">",
"      Postoperative pain management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13088242\">",
"      Chronic pain management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13088249\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/16505\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/16505|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/54/18285\" title=\"table 1\">",
"      University of Washington Burn Center Pain Medication Guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/31/11760\" title=\"table 2\">",
"      Select opioids chronic pain and equianalgesic doses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/50/30508\" title=\"table 3\">",
"      Opioids children with burns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/50/10029\" title=\"table 4\">",
"      PCA dosing guideline",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/54/24431\" title=\"table 5\">",
"      Nonopioid analgesic and NSAID table",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/16/40205\" title=\"table 6\">",
"      Pharmacology benzodiazepines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/28/1485\" title=\"table 7\">",
"      Dose ranges adj analgesics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/23/34169?source=related_link\">",
"      Burn pain: Principles of pharmacologic and nonpharmacologic management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/51/22330?source=related_link\">",
"      Hypermetabolic response to severe burn injury: Recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27546?source=related_link\">",
"      Management of postoperative pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/36/5703?source=related_link\">",
"      NSAIDs: Therapeutic use and variability of response in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/49/42778?source=related_link\">",
"      Overview of the treatment of chronic pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_50_38696="Nonaneurysmal subarachnoid hemorrhage";
var content_f37_50_38696=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nonaneurysmal subarachnoid hemorrhage",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38696/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38696/contributors\">",
"     Farhan Siddiq, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38696/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38696/contributors\">",
"     Jose Biller, MD, FACP, FAAN, FAHA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38696/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38696/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/50/38696/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subarachnoid hemorrhage (SAH) refers to bleeding within the subarachnoid space, which lies between the arachnoid and pia mater and is normally filled with cerebrospinal fluid. Most cases of subarachnoid hemorrhage are caused by rupture of an intracranial aneurysm. Approximately 15 to 20 percent of patients presenting with SAH do not have a vascular lesion on initial four-vessel cerebral angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The causes of these nonaneurysmal SAH (NASAH) are potentially diverse, and the mechanism of bleeding in these cases is often not identified.",
"   </p>",
"   <p>",
"    This topic discusses nonaneurysmal subarachnoid hemorrhage. Aneurysmal SAH and perimesencephalic SAH are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=see_link\">",
"     \"Treatment of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=see_link\">",
"     \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Perimesencephalic nonaneurysmal subarachnoid hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subtype of NASAH, so-called perimesencephalic nonaneurysmal SAH is characterized by a specific pattern of localized blood on computed tomography (CT), normal cerebral angiography, and a benign course that distinguishes these patients not only from aneurysmal SAH, but also from other patients with nonaneurysmal SAH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2-5\">",
"     2-5",
"    </a>",
"    ]. In some case series, this makes up the majority, up to two-thirds, of patients with NASAH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The CT findings that define perimesencephalic NASAH (PM-NASAH) include blood isolated to the perimesencephalic cisterns anterior to the brainstem; there may be extension into the ambient cisterns or basal parts of the sylvian fissures, but not into the lateral sylvian fissure, anterior interhemispheric fissure, or lateral ventricles (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76973 \" href=\"mobipreview.htm?40/12/41158\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1,5\">",
"     1,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Perimesencephalic nonaneurysmal subarachnoid hemorrhage is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=see_link\">",
"     \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Occult aneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to 24 percent of all SAH patients with initial negative angiography have an aneurysm found on repeat angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6-10\">",
"     6-10",
"    </a>",
"    ]. This may increase to as much as 49 percent if patients with perimesencephalic SAH and patients with normal CT scans are excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/7\">",
"     7",
"    </a>",
"    ]. Reasons for an initial false-negative angiogram include technical or reading errors, small aneurysm size, and obscuration of the aneurysm because of vasospasm, hematoma, or thrombosis within the aneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1,2,6,7\">",
"     1,2,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even two negative angiograms do not exclude an aneurysmal source of bleeding. In some cases, another angiogram or surgical exploration have revealed an aneurysmal bleeding source, even after two negative angiograms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2,6,11,12\">",
"     2,6,11,12",
"    </a>",
"    ]. Other case series suggest that the similarities in rebleeding and other complication rates among patients with aneurysmal SAH and patients with SAH and no identified bleeding source suggest that an occult aneurysm is likely in these patients as well [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2,4,7,13,14\">",
"     2,4,7,13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Vascular malformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less than 10 percent of SAH are caused by vascular malformations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6,13\">",
"     6,13",
"    </a>",
"    ]. These can be intracranial or spinal in location.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Intracranial",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial vascular malformations include both acquired and congenital lesions; the latter are more common. These typically exist within the brain parenchyma and produce intracerebral hemorrhage. However, depending on the location of the vascular lesion, bleeding can be primarily or exclusively in the subarachnoid space [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6,8,15-17\">",
"     6,8,15-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rebleeding occurs in more than half of patients. Rebleeding from arteriovenous malformations is less likely to be acute than with aneurysmal SAH; however, dural arteriovenous fistulae, particularly those with cortical venous drainage, appear to be at higher risk for early rebleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/16,18\">",
"     16,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most brain vascular malformations that produce SAH are either arteriovenous malformations or dural arteriovenous fistulae. These are usually visualized on cerebral angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/10,15,19\">",
"     10,15,19",
"    </a>",
"    ]. Catheterization of the external carotid artery may be required to image intracranial dural arteriovenous malformations. Angiographically occult vascular malformations such as some cavernous malformations, venous angiomas, and capillary telangiectasias are visualized on brain MRI, but are less likely to be a source of SAH.",
"   </p>",
"   <p>",
"    Vascular malformations associated with bleeding are usually managed surgically",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    with endovascular interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/6/32872?source=see_link\">",
"     \"Brain arteriovenous malformations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/9/18584?source=see_link\">",
"     \"Vascular malformations of the central nervous system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Spinal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal vascular malformations can also be a source of NASAH. Up to 10 percent of spinal vascular malformations present with SAH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/8,21,22\">",
"     8,21,22",
"    </a>",
"    ]. Dural arteriovenous fistulae are the most common type of spinal vascular malformation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/23\">",
"     23",
"    </a>",
"    ]. Those that cause SAH are usually, but not always, located in the cervical cord or craniocervical junction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/24\">",
"     24",
"    </a>",
"    ]. Prominent back or neck pain or myelopathic signs at presentation can indicate this source, but these are often absent and the clinical appearance can mimic that of intracranial aneurysm rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/24-27\">",
"     24-27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vascular malformations in the spine can be difficult to visualize on neuroimaging modalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/8,24,25\">",
"     8,24,25",
"    </a>",
"    ]. Proximal vertebral artery angiography may reveal more rostral lesions. Often the diagnosis is delayed until the patient presents with recurrent SAH. These lesions are generally managed by neurosurgical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    endovascular interventions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32426?source=see_link&amp;anchor=H17#H17\">",
"     \"Disorders affecting the spinal cord\", section on 'Vascular malformations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Intracranial arterial dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dissection of an intracranial artery can produce SAH; in one case series, this accounted for 4.5 percent of SAH cases, but this high proportion likely reflects referral or case-ascertainment bias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dissection of an intracranial artery is usually initiated by a tear in the media producing an intramural hemorrhage that dissects longitudinally between the adventitia and media [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/29\">",
"     29",
"    </a>",
"    ]. When the tear extends through (or is initiated in) the intima, a second, so-called false, lumen is created. Usually, this leads to narrowing of the lumen, thrombus formation, and thromboembolic stroke. However, if the dissection tears through the adventitia, a SAH occurs. The latter scenario is more common with vertebrobasilar dissections.",
"   </p>",
"   <p>",
"    If SAH occurs, bleeding is massive and often devastating [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/28,30,31\">",
"     28,30,31",
"    </a>",
"    ]. If patients survive the initial event, rebleeding occurs in 40 to 60 percent, often within the first 24 hours.",
"   </p>",
"   <p>",
"    Many intracranial dissections are believed to occur in the setting of sudden or unusual stretching of arteries, but such a history is often lacking. While connective tissue diseases such as Ehler-Danlos syndrome and fibromuscular dysplasia are associated with intracranial arterial dissection, most patients with dissection do not have these conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/8,28,29\">",
"     8,28,29",
"    </a>",
"    ]. Migraine and hypertension may be risk factors.",
"   </p>",
"   <p>",
"    Most cases of intracranial arterial dissection in the setting of SAH are diagnosed by conventional cerebral angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2,29,30\">",
"     2,29,30",
"    </a>",
"    ]. Magnetic resonance imaging (MRI) with fat saturation is also a sensitive test, demonstrating intramural blood on cross-sectional images [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vertebrobasilar dissections are generally treated surgically or with endovascular intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Management is individualized according to location and other anatomic features, and can include ligation of the vertebral artery, trapping or wrapping of the pseudoaneurysm, bypass, and stenting. These are complicated procedures that can incur additional morbidity in these very sick patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebral venous thrombosis can rarely present with subarachnoid hemorrhage as its primary manifestation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6,32-36\">",
"       6,32-36",
"      </a>",
"      ]. Usually the presentation is somewhat less abrupt than with aneurysmal rupture and the bleeding is localized and superficial. The thrombosis may be visualized on venous phase of digital subtraction angiography",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      on MRI. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7594?source=see_link\">",
"       \"Etiology, clinical features, and diagnosis of cerebral venous thrombosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sickle cell disease can be complicated by subarachnoid as well as intracerebral hemorrhage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1,8,37\">",
"       1,8,37",
"      </a>",
"      ]. Most reported cases occur in children with an established diagnosis. These children are often found to have one or more aneurysms; in some cases SAH is believed to result from fragile collateral blood vessels. Recent transfusion and treatment with corticosteroid therapy may be risk factors. Case fatality rate was as high as 34 percent in one report [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/37\">",
"       37",
"      </a>",
"      ]. Survivors appear to have a low rate of recurrence. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/11/31930?source=see_link&amp;anchor=H18#H18\">",
"       \"Cerebrovascular complications of sickle cell disease\", section on 'Subarachnoid hemorrhage'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bleeding disorders and anticoagulant therapy can be complicated by SAH, but this is a somewhat rare complication; intracerebral and subdural hemorrhages are more common [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/4,8,38-40\">",
"       4,8,38-40",
"      </a>",
"      ]. Systemic bleeding usually accompanies the SAH if this is the primary cause; if it does not, the patient should be assumed to have an underlying aneurysm or other vascular lesion until proven otherwise. Similarly, analysis of one case series suggested that perimesencephalic nonaneurysmal SAH can appear atypical, with more extensive hemorrhage, in the setting of reduced platelet activity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/41\">",
"       41",
"      </a>",
"      ]. However, this would be a diagnosis of exclusion as well. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=see_link\">",
"       \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pituitary apoplexy often presents with sudden onset of headache and vomiting, and there can be prominent subarachnoid blood on CT scan, which may distract from or obscure the pituitary adenoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/42-45\">",
"       42-45",
"      </a>",
"      ]. Pituitary apoplexy is usually heralded by vision change and is accompanied by extraocular nerve palsy. If not visualized on the initial CT scan, MRI will demonstrate the tumor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/46,47\">",
"       46,47",
"      </a>",
"      ]. Neurosurgical decompression is indicated for visual loss. Patients also require endocrine evaluation for potentially life-threatening, acute hypopituitarism. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/38/9833?source=see_link&amp;anchor=H11#H11\">",
"       \"Causes of hypopituitarism\", section on 'Pituitary apoplexy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Traumatic SAH is usually identified by the clinical setting. However, if a clinical history is unavailable, radiologic clues of a traumatic origin include localized bleeding in superficial sulci, adjacent skull fracture, and cerebral contusion as well as external evidence of traumatic injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/8,40\">",
"       8,40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cocaine abuse has been associated with both aneurysmal and nonaneurysmal SAH [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6,8,48,49\">",
"       6,8,48,49",
"      </a>",
"      ]. The mechanism of bleeding in the latter is not known, but may be related to acute blood pressure surges",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an underlying hypertensive or toxic vasculopathy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/8,50\">",
"       8,50",
"      </a>",
"      ]. Patients with SAH and cocaine abuse should be assumed to have an underlying aneurysm or other vascular lesion until proven otherwise.",
"     </li>",
"     <li>",
"      Cerebral amyloid angiopathy can cause SAH in older adults. Bleeding is usually quite restricted, often to a single sulcus; microbleeds",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      superficial siderosis are often present on MRI [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/51-54\">",
"       51-54",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37001?source=see_link\">",
"       \"Cerebral amyloid angiopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rare causes of SAH include spinal aneurysms that can produce subarachnoid hemorrhage, usually with prominent neck or back pain and myeloradicular symptoms [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/55,56\">",
"       55,56",
"      </a>",
"      ]. Brain or cervical tumors have been reported to produce SAH as the presenting manifestation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6,57,58\">",
"       6,57,58",
"      </a>",
"      ]. Moyamoya disease is associated with cerebral aneurysms which can rupture and produce SAH; rarely SAH occurs due to rupture of the fragile transdural anastomotic vessels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/59\">",
"       59",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/44/3786?source=see_link\">",
"       \"Moyamoya disease: Etiology, clinical features, and diagnosis\"",
"      </a>",
"      .) SAH has also been reported with cerebral vasculitis, reversible vasoconstriction syndrome, cerebral hyperperfusion syndrome after carotid endarterectomy, and also with reversible posterior leukoencephalopathy syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/51,54,60,61\">",
"       51,54,60,61",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12601?source=see_link&amp;anchor=H13#H13\">",
"       \"Thunderclap headache\", section on 'Reversible cerebral vasoconstriction syndromes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/16/43273?source=see_link\">",
"       \"Reversible posterior leukoencephalopathy syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/27/40378?source=see_link&amp;anchor=H93838598#H93838598\">",
"       \"Carotid endarterectomy\", section on 'Hyperperfusion syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H109870614\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of nonaneurysmal subarachnoid hemorrhage often mimics that of aneurysmal subarachnoid hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the manifestations may differ, often depending on the underlying etiology (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Etiologies'",
"    </a>",
"    above.). In particular, restricted subarachnoid hemorrhage over the convexity may manifest with transient motor or sensory symptoms that suggest epileptic phenomena",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    frank seizures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subarachnoid hemorrhage (SAH) should be considered in any patient complaining of a severe headache of sudden onset. Emergent computed tomography (CT) of the head should immediately follow consideration of the diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/40\">",
"     40",
"    </a>",
"    ]. If the suspicion is high and the CT scan fails to show blood in subarachnoid space, a lumbar puncture must be obtained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link&amp;anchor=H26#H26\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A perimesencephalic pattern of blood on CT scan has a high probability of being nonaneurysmal in origin. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=see_link\">",
"     \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with SAH should undergo basic laboratory testing including complete blood count, serum chemistries, coagulation studies, and toxicology screen. A baseline electrocardiogram should also be obtained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cerebral angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most vascular lesions responsible for SAH are identified using conventional digital subtraction cerebral angiography (DSA) that includes injections of the external carotid circulation and deep cervical branches, which may supply a cryptic dural arteriovenous fistula. Angiographic demonstration of key branch points, including the proximal posterior circulation, is essential to definitively rule out aneurysm. Proximal vertebral artery angiography may reveal a vascular malformation in the cervical spine or cranio-cervical junction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The utility of CT angiography (CTA) is continuously improving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/62\">",
"     62",
"    </a>",
"    ]. A major advantage of CTA over conventional angiography is the speed and ease by which it can be obtained, often immediately after the diagnosis of SAH is made by head CT when the patient is still in the scanner. CTA is increasingly used as a first test in many patients with SAH, avoiding the need for conventional angiography in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. In this setting, CTA is a more practical approach to acute diagnosis than magnetic resonance angiography (MRA), given the constraints of acute patient management. CTA has imperfect sensitivity for the detection of cerebral aneurysms, particularly small aneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/65\">",
"     65",
"    </a>",
"    ]. Even when an aneurysm is identified by other technologies, DSA is often advocated to exclude multiple aneurysms and to better plan surgical intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Repeat angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to 24 percent of all SAH patients with initial negative angiography have an aneurysm found on repeat angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1,6-8,10,12,67\">",
"     1,6-8,10,12,67",
"    </a>",
"    ]. This may increase to as much as 49 percent if patients with perimesencephalic SAH and patients with normal CT scans are excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1,7,9\">",
"     1,7,9",
"    </a>",
"    ]. Repeat studies may also reveal an arterial dissection or a vascular malformation not identified on the initial study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/24,25,68\">",
"     24,25,68",
"    </a>",
"    ]. Therefore, it is critical to repeat DSA if the initial angiogram is negative. The appropriate timing of this study is unclear and probably should be individualized according to the patient's condition and presence of other complications. In reported case series, the repeat DSA has been performed between four days and four weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1,6-10,69-71\">",
"     1,6-10,69-71",
"    </a>",
"    ]. Repeat DSA may not be necessary in patients who have an identified nonaneurysmal etiology of SAH and possibly in those with perimesencephalic SAH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/3,7\">",
"     3,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=see_link&amp;anchor=H9#H9\">",
"     \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\", section on 'Repeated testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A third angiogram at a period of two to three months is advocated by some, but is probably not necessary in most patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2,6,8,67,68\">",
"     2,6,8,67,68",
"    </a>",
"    ]. If the prior studies are technically inadequate, or if rebleeding occurs, repeat angiography, if not surgical exploration, is warranted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Further diagnostic study'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI may demonstrate angiographically occult vascular lesions that can cause SAH. Such lesions include some vascular malformations in the brain or spinal cord, tumors, including pituitary adenoma, and arterial wall hematoma suggesting arterial dissection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/27,72\">",
"     27,72",
"    </a>",
"    ]. All patients with SAH and negative angiography should have gadolinium-enhanced MRI of the brain and spinal cord [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6,23\">",
"     6,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Further diagnostic study",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical exploration is not a routine aspect of the diagnostic evaluation, but is reported to lead to a diagnosis of ruptured aneurysm, even after two or more negative angiograms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2,6,11\">",
"     2,6,11",
"    </a>",
"    ]. While in some cases this intervention was prompted by an episode of rebleeding or a suspicious but not diagnostic finding on angiography, it is not always certain in other cases why surgical exploration was performed.",
"   </p>",
"   <p>",
"    Spinal angiography is also undertaken for diagnosis in some cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/24-27\">",
"     24-27",
"    </a>",
"    ]. Usually this is prompted by a specific clinical suspicion for a spinal vascular anomaly such as prominent back or neck pain, radicular or myelopathic features on examination, or an abnormal, but not diagnostic finding on other neuroimaging studies, such as MRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common complications of SAH are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rebleeding",
"     </li>",
"     <li>",
"      Vasospasm and cerebral ischemia",
"     </li>",
"     <li>",
"      Hydrocephalus",
"     </li>",
"     <li>",
"      Increased intracranial pressure",
"     </li>",
"     <li>",
"      Seizures",
"     </li>",
"     <li>",
"      Hyponatremia",
"     </li>",
"     <li>",
"      Cardiac abnormalities",
"     </li>",
"     <li>",
"      Hypothalamic dysfunction and pituitary insufficiency [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38696/abstract/68\">",
"       68",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is little specific information about the incidence or severity of these complications in NASAH in comparison to aneurysmal SAH. Rebleeding risk is likely specific to the origin of SAH; this is discussed above under the individual etiologies. Other complications, however, may be expected to be somewhat similar across etiology.",
"   </p>",
"   <p>",
"    The pathogenesis and clinical features of these complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link&amp;anchor=H13#H13\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general care of patients with NASAH should be the same as aneurysmal SAH patients. Patients are admitted to an intensive care setting for constant hemodynamic and cardiac monitoring, given stool softeners, kept at bedrest, and given analgesia to diminish hemodynamic fluctuations and lower the risk of rebleeding. Pneumatic compression stockings to limit risk of deep vein thrombosis should be utilized while patients are immobile. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of aneurysmal subarachnoid hemorrhage\", section on 'General management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should receive other interventions to monitor, prevent, and treat complications of SAH. These are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of aneurysmal subarachnoid hemorrhage\", section on 'General management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of aneurysmal subarachnoid hemorrhage\", section on 'Prevention of vasospasm'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=see_link&amp;anchor=H24#H24\">",
"     \"Treatment of aneurysmal subarachnoid hemorrhage\", section on 'Management of complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with perimesencephalic SAH may be managed somewhat differently once aneurysmal SAH has been excluded. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=see_link\">",
"     \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Interventions to prevent rebleeding and other etiologic-specific complications are individualized to the underlying etiology. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Etiologies'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    Basics topic (see",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/19/30002?source=see_link\">",
"     \"Patient information: Subarachnoid hemorrhage (The Basics)\"",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An estimated 15 to 20 percent of patients with subarachnoid hemorrhage (SAH) are nonaneurysmal. The causes of nonaneurysmal SAH (NASAH) are potentially diverse, and the mechanism of bleeding in these cases is often not identified.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perimesencephalic NASAH make up the majority of NASAH in some case series. These have a distinctive appearance on computed tomography and a benign course. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=see_link\">",
"       \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other causes of NASAH include occult aneurysm, intracranial or spinal vascular malformations, and intracranial arterial dissection. Less common etiologies include sickle cell disease, pituitary apoplexy, cocaine abuse, cerebral venous thrombosis, and bleeding disorders. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of SAH is usually made by computed tomography (CT) of the brain, which should always be performed emergently in a patient with an abrupt onset of headache. A lumbar puncture should follow a negative CT scan if the clinical suspicion is high. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with SAH should be evaluated with basic laboratory testing including complete blood count, serum chemistries, and coagulation studies and toxicology screen. A baseline electrocardiogram should also be obtained. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that conventional digital subtraction cerebral angiography (DSA) be performed in all patients with SAH, unless CT",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      CT angiography adequately defines the pathogenesis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Cerebral angiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend repeating DSA within 4 to 14 days after an initial negative study, because of the risk of a false negative. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Repeat angiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with negative angiography should undergo gadolinium-enhanced magnetic resonance imaging (MRI) of brain and spinal cord. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some patients will not have an etiologic diagnosis after DSA and MRI. If rebleeding occurs in such patients, further diagnostic interventions may include further angiographic study of the brain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      spinal cord,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      surgical exploration. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Further diagnostic study'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of aneurysmal SAH, hydrocephalus, vasospasm and cerebral ischemia, seizures, hyponatremia, and cardiac abnormalities also occur in NASAH. In this regard, patients with NASAH should be managed similarly to aneurysmal SAH. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=see_link\">",
"       \"Treatment of aneurysmal subarachnoid hemorrhage\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients may also require interventions that are etiology-specific. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiologies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31670724\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. David Brock, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/1\">",
"      Schwartz TH, Solomon RA. Perimesencephalic nonaneurysmal subarachnoid hemorrhage: review of the literature. Neurosurgery 1996; 39:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/2\">",
"      Rinkel GJ, Wijdicks EF, Hasan D, et al. Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991; 338:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/3\">",
"      van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A. Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 1985; 35:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/4\">",
"      Canh&atilde;o P, Ferro JM, Pinto AN, et al. Perimesencephalic and nonperimesencephalic subarachnoid haemorrhages with negative angiograms. Acta Neurochir (Wien) 1995; 132:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/5\">",
"      Rinkel GJ, Wijdicks EF, Vermeulen M, et al. Nonaneurysmal perimesencephalic subarachnoid hemorrhage: CT and MR patterns that differ from aneurysmal rupture. AJNR Am J Neuroradiol 1991; 12:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/6\">",
"      Tatter SB, Crowell RM, Ogilvy CS. Aneurysmal and microaneurysmal \"angiogram-negative\" subarachnoid hemorrhage. Neurosurgery 1995; 37:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/7\">",
"      Jung JY, Kim YB, Lee JW, et al. Spontaneous subarachnoid haemorrhage with negative initial angiography: a review of 143 cases. J Clin Neurosci 2006; 13:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/8\">",
"      Rinkel GJ, van Gijn J, Wijdicks EF. Subarachnoid hemorrhage without detectable aneurysm. A review of the causes. Stroke 1993; 24:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/9\">",
"      Urbach H, Zentner J, Solymosi L. The need for repeat angiography in subarachnoid haemorrhage. Neuroradiology 1998; 40:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/10\">",
"      du Mesnil de Rochemont R, Heindel W, Wesselmann C, et al. Nontraumatic subarachnoid hemorrhage: value of repeat angiography. Radiology 1997; 202:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/11\">",
"      Di Lorenzo N, Guidetti G. Anterior communicating aneurysm missed at angiography: report of two cases treated surgically. Neurosurgery 1988; 23:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/12\">",
"      Suzuki S, Kayama T, Sakurai Y, et al. Subarachnoid hemorrhage of unknown cause. Neurosurgery 1987; 21:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/13\">",
"      Ildan F, Tuna M, Erman T, et al. Prognosis and prognostic factors in nonaneurysmal perimesencephalic hemorrhage: a follow-up study in 29 patients. Surg Neurol 2002; 57:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/14\">",
"      Ruigrok YM, Rinkel GJ, Van Gijn J. CT patterns and long-term outcome in patients with an aneurysmal type of subarachnoid hemorrhage and repeatedly negative angiograms. Cerebrovasc Dis 2002; 14:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/15\">",
"      Cordonnier C, Al-Shahi Salman R, Bhattacharya JJ, et al. Differences between intracranial vascular malformation types in the characteristics of their presenting haemorrhages: prospective, population-based study. J Neurol Neurosurg Psychiatry 2008; 79:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/16\">",
"      Halbach VV, Higashida RT, Hieshima GB, et al. Dural fistulas involving the transverse and sigmoid sinuses: results of treatment in 28 patients. Radiology 1987; 163:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/17\">",
"      Bikmaz K, Erdem E, Krisht A. Arteriovenous fistula originating from proximal part of the anterior cerebral artery. Clin Neurol Neurosurg 2007; 109:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/18\">",
"      Duffau H, Lopes M, Janosevic V, et al. Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature. J Neurosurg 1999; 90:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/19\">",
"      Brown RD Jr, Wiebers DO, Torner JC, O'Fallon WM. Frequency of intracranial hemorrhage as a presenting symptom and subtype analysis: a population-based study of intracranial vascular malformations in Olmsted Country, Minnesota. J Neurosurg 1996; 85:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/20\">",
"      van Rooij WJ, Sluzewski M, Beute GN. Dural arteriovenous fistulas with cortical venous drainage: incidence, clinical presentation, and treatment. AJNR Am J Neuroradiol 2007; 28:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/21\">",
"      Caroscio JT, Brannan T, Budabin M, et al. Subarachnoid hemorrhage secondary to spinal arteriovenous malformation and aneurysm. Report of a case and review of the literature. Arch Neurol 1980; 37:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/22\">",
"      Kandel EI. Complete excision of arteriovenous malformations of the cervical cord. Surg Neurol 1980; 13:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/23\">",
"      Koch C. Spinal dural arteriovenous fistula. Curr Opin Neurol 2006; 19:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/24\">",
"      van Beijnum J, Straver DC, Rinkel GJ, Klijn CJ. Spinal arteriovenous shunts presenting as intracranial subarachnoid haemorrhage. J Neurol 2007; 254:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/25\">",
"      Aviv RI, Shad A, Tomlinson G, et al. Cervical dural arteriovenous fistulae manifesting as subarachnoid hemorrhage: report of two cases and literature review. AJNR Am J Neuroradiol 2004; 25:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/26\">",
"      Kinouchi H, Mizoi K, Takahashi A, et al. Dural arteriovenous shunts at the craniocervical junction. J Neurosurg 1998; 89:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/27\">",
"      Rogg JM, Smeaton S, Doberstein C, et al. Assessment of the value of MR imaging for examining patients with angiographically negative subarachnoid hemorrhage. AJR Am J Roentgenol 1999; 172:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/28\">",
"      Sasaki O, Ogawa H, Koike T, et al. A clinicopathological study of dissecting aneurysms of the intracranial vertebral artery. J Neurosurg 1991; 75:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/29\">",
"      Caplan LR. Dissections of brain-supplying arteries. Nat Clin Pract Neurol 2008; 4:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/30\">",
"      Santos-Franco JA, Zenteno M, Lee A. Dissecting aneurysms of the vertebrobasilar system. A comprehensive review on natural history and treatment options. Neurosurg Rev 2008; 31:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/31\">",
"      Zhao WY, Krings T, Alvarez H, et al. Management of spontaneous haemorrhagic intracranial vertebrobasilar dissection: review of 21 consecutive cases. Acta Neurochir (Wien) 2007; 149:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/32\">",
"      Adaletli I, Sirikci A, Kara B, et al. Cerebral venous sinus thrombosis presenting with excessive subarachnoid hemorrhage in a 14-year-old boy. Emerg Radiol 2005; 12:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/33\">",
"      Oppenheim C, Domigo V, Gauvrit JY, et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol 2005; 26:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/34\">",
"      Chang R, Friedman DP. Isolated cortical venous thrombosis presenting as subarachnoid hemorrhage: a report of three cases. AJNR Am J Neuroradiol 2004; 25:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/35\">",
"      Sztajzel R, Coeytaux A, Dehdashti AR, et al. Subarachnoid hemorrhage: a rare presentation of cerebral venous thrombosis. Headache 2001; 41:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/36\">",
"      Kurosu A, Suzukawa K, Amo M, et al. Perimesencephalic non-aneurysmal subarachnoid hemorrhage caused by cavernous sinus thrombosis: case report. Neurol Med Chir (Tokyo) 2007; 47:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/37\">",
"      Strouse JJ, Hulbert ML, DeBaun MR, et al. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 2006; 118:1916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/38\">",
"      Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003; 21:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/39\">",
"      Schwartzman RJ, Hill JB. Neurologic complications of disseminated intravascular coagulation. Neurology 1982; 32:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/40\">",
"      van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001; 124:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/41\">",
"      Naidech AM, Rosenberg NF, Maas MB, et al. Predictors of hemorrhage volume and disability after perimesencephalic subarachnoid hemorrhage. Neurology 2012; 78:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/42\">",
"      Bjerre P, Videbaek H, Lindholm J. Subarachnoid hemorrhage with normal cerebral angiography: a prospective study on sellar abnormalities and pituitary function. Neurosurgery 1986; 19:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/43\">",
"      Wohaibi MA, Russell NA, Ferayan AA, et al. Pituitary apoplexy presenting as massive subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry 2000; 69:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/44\">",
"      Sergides IG, Minhas PS, Anotun N, Pickard JD. Pituitary apoplexy can mimic subarachnoid haemorrhage clinically and radiologically. Emerg Med J 2007; 24:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/45\">",
"      Satyarthee GD, Mahapatra AK. Pituitary apoplexy in a child presenting with massive subarachnoid and intraventricular hemorrhage. J Clin Neurosci 2005; 12:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/46\">",
"      Inamasu J, Hori S, Sekine K, Aikawa N. Pituitary apoplexy without ocular/visual symptoms. Am J Emerg Med 2001; 19:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/47\">",
"      Hernandez A, Aguirre M, Vaamonde J, et al. Pituitary apoplexy: a transient benign presentation mimicking mild subarachnoid hemorrhage with negative angiography. Eur J Neurol 1998; 5:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/48\">",
"      Levine SR, Brust JC, Futrell N, et al. A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride--a review. Neurology 1991; 41:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/49\">",
"      Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 1996; 46:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/50\">",
"      Storen EC, Wijdicks EF, Crum BA, Schultz G. Moyamoya-like vasculopathy from cocaine dependency. AJNR Am J Neuroradiol 2000; 21:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/51\">",
"      Kumar S, Goddeau RP Jr, Selim MH, et al. Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 2010; 74:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/52\">",
"      Katoh M, Yoshino M, Asaoka K, et al. A restricted subarachnoid hemorrhage in the cortical sulcus in cerebral amyloid angiopathy: could it be a warning sign? Surg Neurol 2007; 68:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/53\">",
"      Karabatsou K, Lecky BR, Rainov NG, et al. Cerebral amyloid angiopathy with symptomatic or occult subarachnoid haemorrhage. Eur Neurol 2007; 57:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/54\">",
"      Beitzke M, Gattringer T, Enzinger C, et al. Clinical presentation, etiology, and long-term prognosis in patients with nontraumatic convexal subarachnoid hemorrhage. Stroke 2011; 42:3055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/55\">",
"      Gonzalez LF, Zabramski JM, Tabrizi P, et al. Spontaneous spinal subarachnoid hemorrhage secondary to spinal aneurysms: diagnosis and treatment paradigm. Neurosurgery 2005; 57:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/56\">",
"      Massand MG, Wallace RC, Gonzalez LF, et al. Subarachnoid hemorrhage due to isolated spinal artery aneurysm in four patients. AJNR Am J Neuroradiol 2005; 26:2415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/57\">",
"      Scotti G, Filizzolo F, Scialfa G, et al. Repeated subarachnoid hemorrhages from a cervical meningioma. Case report. J Neurosurg 1987; 66:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/58\">",
"      Navi BB, Reichman JS, Berlin D, et al. Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology 2010; 74:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/59\">",
"      Marushima A, Yanaka K, Matsuki T, et al. Subarachnoid hemorrhage not due to ruptured aneurysm in moyamoya disease. J Clin Neurosci 2006; 13:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/60\">",
"      Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007; 130:3091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/61\">",
"      Spitzer C, Mull M, Rohde V, Kosinski CM. Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background. Neuroradiology 2005; 47:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/62\">",
"      Brilstra EH, Hop JW, Rinkel GJ. Quality of life after perimesencephalic haemorrhage. J Neurol Neurosurg Psychiatry 1997; 63:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/63\">",
"      Madureira S, Canh&atilde;o P, Guerreiro M, Ferro JM. Cognitive and emotional consequences of perimesencephalic subarachnoid hemorrhage. J Neurol 2000; 247:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/64\">",
"      Marquardt G, Niebauer T, Schick U, Lorenz R. Long term follow up after perimesencephalic subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2000; 69:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/65\">",
"      Colen TW, Wang LC, Ghodke BV, et al. Effectiveness of MDCT angiography for the detection of intracranial aneurysms in patients with nontraumatic subarchnoid hemorrhage. AJR Am J Roentgenol 2007; 189:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/66\">",
"      Hashimoto Y, Kin S, Haraguchi K, Niwa J. Pitfalls in the preoperative evaluation of subarachnoid hemorrhage without digital subtraction angiography: report on 2 cases. Surg Neurol 2007; 68:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/67\">",
"      Topcuoglu MA, Ogilvy CS, Carter BS, et al. Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests. J Neurosurg 2003; 98:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/68\">",
"      Hashimoto H, Iida J, Hironaka Y, et al. Use of spiral computerized tomography angiography in patients with subarachnoid hemorrhage in whom subtraction angiography did not reveal cerebral aneurysms. J Neurosurg 2000; 92:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/69\">",
"      Bradac GB, Bergui M, Ferrio MF, et al. False-negative angiograms in subarachnoid haemorrhage due to intracranial aneurysms. Neuroradiology 1997; 39:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/70\">",
"      Duong H, Melan&ccedil;on D, Tampieri D, Ethier R. The negative angiogram in subarachnoid haemorrhage. Neuroradiology 1996; 38:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/71\">",
"      Inamasu J, Nakamura Y, Saito R, et al. \"Occult\" ruptured cerebral aneurysms revealed by repeat angiography: result from a large retrospective study. Clin Neurol Neurosurg 2003; 106:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38696/abstract/72\">",
"      Wijdicks EF, Schievink WI, Miller GM. MR imaging in pretruncal nonaneurysmal subarachnoid hemorrhage: is it worthwhile? Stroke 1998; 29:2514.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1111 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.170.48.130-B1CD8C1B47-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38696=[""].join("\n");
var outline_f37_50_38696=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Perimesencephalic nonaneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Occult aneurysm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Vascular malformations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Intracranial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Spinal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Intracranial arterial dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H109870614\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cerebral angiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Repeat angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Further diagnostic study",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31670724\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1111\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1111|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?40/12/41158\" title=\"diagnostic image 1\">",
"      CT perimesencephalic nonaneursymal SAH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/6/32872?source=related_link\">",
"      Brain arteriovenous malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/27/40378?source=related_link\">",
"      Carotid endarterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/38/9833?source=related_link\">",
"      Causes of hypopituitarism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37001?source=related_link\">",
"      Cerebral amyloid angiopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/11/31930?source=related_link\">",
"      Cerebrovascular complications of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7594?source=related_link\">",
"      Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/44/3786?source=related_link\">",
"      Moyamoya disease: Etiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/19/30002?source=related_link\">",
"      Patient information: Subarachnoid hemorrhage (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/18/6441?source=related_link\">",
"      Perimesencephalic nonaneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/16/43273?source=related_link\">",
"      Reversible posterior leukoencephalopathy syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12601?source=related_link\">",
"      Thunderclap headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=related_link\">",
"      Treatment of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/9/18584?source=related_link\">",
"      Vascular malformations of the central nervous system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_50_38697="Lung transplantation: Procedure and postoperative management";
var content_f37_50_38697=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lung transplantation: Procedure and postoperative management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Marcelo Cypel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Tom Waddell, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Shaf Keshavjee, MD, MSc, FRCSC, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Elbert P Trulock, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/50/38697/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/50/38697/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over the past decade, lung transplantation has become an increasingly important mode of therapy for patients with a variety of end-stage lung diseases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/1\">",
"     1",
"    </a>",
"    ]. Four types of transplant procedures are generally available [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Single lung transplantation (SLT)",
"     </li>",
"     <li>",
"      Bilateral lung transplantation (BLT)",
"     </li>",
"     <li>",
"      Transplantation of lobes from living related donors",
"     </li>",
"     <li>",
"      Heart-lung transplantation (HLT)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The procedures of single, bilateral, and living donor lobar lung transplantation and issues related to the early postoperative management will be reviewed here. The indications for each type of transplant, technique of heart-lung transplantation, donor lung preparation, and immunosuppression are discussed separately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26953?source=see_link\">",
"     \"Lung transplantation: General guidelines for recipient selection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12425?source=see_link\">",
"     \"Lung transplantation: Deceased donor evaluation and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/32/5640?source=see_link\">",
"     \"Lung transplantation: Donor lung preservation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/6/99?source=see_link\">",
"     \"Heart-lung transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/38/3688?source=see_link\">",
"     \"Induction immunosuppression following lung transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recipient is prepared for surgery once a donor lung has been identified, but induction of anesthesia is postponed until the donor lung has been inspected and approved by the retrieval team. If the donor lung is satisfactory, the recipient operation begins while the donor lung is in transit. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/32/5640?source=see_link\">",
"     \"Lung transplantation: Donor lung preservation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SINGLE LUNG TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single lung transplantation extends the limited supply of donor organs to more patients, but it provides less lung function as a buffer for late complications. The indications for single versus bilateral transplantation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/29/31192?source=see_link\">",
"     \"Lung transplantation: Disease-based choice of procedure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A standard posterolateral or anterolateral thoracotomy incision is made for SLT. While ventilation is being given to the contralateral lung, the lung to be excised is deflated and mobilized. If irreversible hypoxemia develops, the pulmonary artery is clamped to eliminate the shunt through the deflated, unventilated lung. Either refractory hypoxemia or hemodynamic instability at this stage would be an indication for cardiopulmonary bypass, which is always on standby.",
"   </p>",
"   <p>",
"    As the dissection is completed, the phrenic and vagus nerves must be safeguarded, and on the left side, the recurrent laryngeal nerve must be avoided. The native lung is extracted, and the donor lung is implanted. The three anastomoses are performed in their posterior-to-anterior anatomic sequence: bronchus, pulmonary artery, and pulmonary veins-left atrium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cardiopulmonary bypass",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for bypass has been difficult to predict before surgery and varies with recipient lung disease. Bypass has rarely been needed in recipients with obstructive lung disease, but it has been required in 17 to 41 percent of patients with restrictive lung disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Preoperative pulmonary function tests and resting oxygenation have not been discriminatory; however, preoperative hemodynamic parameters may be helpful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/4\">",
"     4",
"    </a>",
"    ]. Patients with more severe pulmonary hypertension are more likely to need bypass. Pulmonary artery pressure always increases when the pulmonary artery is clamped, more in patients with restrictive disease than in those with obstructive disease, but the change in cardiac index ultimately determines the need for bypass. In patients with restrictive disease, bypass has usually been necessary if the decrease in cardiac index is greater than 1.0 to 1.5",
"    <span class=\"nowrap\">",
"     L/min/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Bronchial anastomosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bronchial anastomosis has been the most vulnerable site for complications. The bronchial blood supply to the donor lung is disrupted during transplantation, so the donor bronchus is dependent upon retrograde bronchial blood flow through the pulmonary circulation, unless direct bronchial revascularization is performed.",
"   </p>",
"   <p>",
"    Originally, an end-to-end bronchial anastomosis combined with an omentopexy was the standard approach, and direct revascularization was rarely attempted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/6\">",
"     6",
"    </a>",
"    ]. However, the technique has evolved considerably [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Bronchial healing has been good without an omentopexy or other tissue wrap [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/9-12\">",
"     9-12",
"    </a>",
"    ], and use of a telescoping anastomosis, with the cartilaginous portions of the donor and recipient bronchi intussuscepted, is now favored by most surgeons.",
"   </p>",
"   <p>",
"    Bronchial artery revascularization is anatomically and technically feasible, but the donor bronchial arteries must be salvaged when the lungs are harvested. Revascularization is accomplished by anastomosis of the donor bronchial artery to the recipient internal thoracic (mammary) artery. This technique has been successfully employed in single and double lung transplantation, but it adds some time and complexity to the operation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. While revascularization has theoretical appeal, its benefits are uncertain, and it has not been widely employed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26121?source=see_link&amp;anchor=H7#H7\">",
"     \"Airway complications after lung transplantation\", section on 'Specific complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One series of 67 consecutive bronchial anastomoses for lung transplantation suggested that anastomotic complications have become uncommon with current operative techniques that do not utilize direct bronchial revascularization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/19\">",
"     19",
"    </a>",
"    ]. Over the course of 236 serial bronchoscopic examinations, only one of 67 anastomoses (1.4 percent) showed limited focal necrosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     BILATERAL LUNG TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;BLT is performed in 97 percent of pediatric lung transplant cases and slightly more than 50 percent of adult cases. The main indication for BLT is generalized bronchiectasis or other chronic pulmonary infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/29/31192?source=see_link\">",
"     \"Lung transplantation: Disease-based choice of procedure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to bilateral transplantation (BLT) has changed significantly since its inception. The original double-lung technique was performed through a median sternotomy with the recipient on cardiopulmonary bypass, and the donor lungs were implanted en bloc with a single tracheal anastomosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/20\">",
"     20",
"    </a>",
"    ]. While this operation was successful, its limitations became apparent as it was extended to more difficult cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 1989, the bilateral sequential operation was introduced [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/22\">",
"     22",
"    </a>",
"    ]. This operation, which has become the standard approach, is performed through a transverse thoracosternotomy, and the lungs are implanted separately and sequentially [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/23\">",
"     23",
"    </a>",
"    ]. The incision provides excellent exposure of the pleural space, and the bronchial anastomoses are less prone to complications than the tracheal anastomosis. In the majority of cases, cardiopulmonary bypass can be avoided by supporting the recipient with the contralateral lung. An alternative approach is via bilateral anterolateral incisions.",
"   </p>",
"   <p>",
"    After the chest is opened, both native lungs are mobilized. The native lung with the worst function is removed first, while one-lung anesthesia is used on the contralateral lung. Problems with hypoxemia or hemodynamic instability are managed in the same manner described for SLT, and implantation of the first graft proceeds. When the vascular anastomoses have been completed, air is purged from the pulmonary circulation and the left atrium, and ventilation and perfusion are restored to the graft. One-lung anesthesia is then switched to the allograft, and the contralateral recipient pneumonectomy and donor lung implantation are performed.",
"   </p>",
"   <p>",
"    After completion of the reanastomosis, two chest tubes are placed in each pleural space and the chest is closed. The upper and lower portions of the chest wall are approximated with pericostal sutures and the sternum is secured with wires. Instability and displacement of the sternum are rare. The airway is inspected endoscopically, anesthesia is reversed, and the recipient is transferred to an intensive care unit.",
"   </p>",
"   <p>",
"    Early experience with a less invasive surgical approach, involving limited bilateral thoracotomy guided by thoracoscopic illumination and visualization, has been positive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/24\">",
"     24",
"    </a>",
"    ]. The use of this technique, particularly in patients with impaired wound healing due to chronic glucocorticoid therapy, allows for an improved cosmetic outcome, and does not preclude the use of cardiopulmonary bypass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cardiopulmonary bypass",
"    </span>",
"    &nbsp;&mdash;&nbsp;In pediatric recipients and in recipients with pulmonary vascular disease, cardiopulmonary bypass is obligatory, but in adult patients with other diagnoses, the need for cardiopulmonary bypass during BLT has not been predictable from the preoperative hemodynamic profile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Unstable hemodynamics or refractory hypoxemia most often arise at one of three points in the operation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      After clamping the pulmonary artery during the first transplant",
"     </li>",
"     <li>",
"      After perfusing the first allograft but before starting the second lung",
"     </li>",
"     <li>",
"      After clamping the pulmonary artery during the second transplant",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In three series of recipients without pulmonary vascular disease, cardiopulmonary bypass was instituted in 23 to 32 percent of recipients for one of these reasons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/4,5,23\">",
"     4,5,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Elective use of cardiopulmonary bypass for bilateral lung transplantation in patients with COPD does not appear to have a deleterious effect on early lung function or clinical outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/25\">",
"     25",
"    </a>",
"    ], but these conclusions should not be extrapolated to single lung transplantation, to diseases other than COPD or to different operative scenarios, such as emergency use of cardiopulmonary bypass.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LOBAR TRANSPLANTATION FROM LIVING DONORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lobar transplantation from blood group compatible living donors has been performed for selected recipients. The ethical issues surrounding transplantation from living donors have been reviewed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/26-28\">",
"     26-28",
"    </a>",
"    ], but the debate continues. Nonetheless, recipient outcomes have been satisfactory and donor morbidity has been minimal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/29-32\">",
"     29-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a 2004 update, 123 recipients of lobar transplants from living donors were reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/31,33\">",
"     31,33",
"    </a>",
"    ]. Eighty-four percent of the patients had cystic fibrosis. In another report, among 76 living lobar donors, the majority were parents of the recipient, but other relatives and three nonrelatives were also donors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/31\">",
"     31",
"    </a>",
"    ]. Actuarial survival at one year among the recipients was 70 percent, and lung function was good [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/33\">",
"     33",
"    </a>",
"    ]. Rejection occurred at a rate of 0.8 episodes per recipient and was usually unilateral; obliterative bronchiolitis or bronchiolitis obliterans syndrome developed in approximately 16 percent of the recipients by five years after transplantation. There were no deaths among the donors, and the mean decrement in vital capacity for the donors was about 18 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, living lobar transplantation should be reserved for suitable candidates who, because of their clinical status, urgently need transplantation and, because of their place on the waiting list, seem unlikely to survive until a cadaveric donor becomes available. However, intubated patients and those undergoing retransplantation are at high risk for mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early postoperative care focuses on ventilatory support and weaning, fluid and hemodynamic management, immunosuppression, detection of early rejection, and prevention or treatment of infection. As the patient recuperates, the emphasis shifts toward regulating the medical regimen, establishing the routine for postoperative monitoring, and continuing the postoperative rehabilitation and education. This section provides an overview of post-transplantation care, while details about rejection and immunosuppressive drugs, prophylaxis and treatment of infections, and other complications are covered separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/38/3688?source=see_link\">",
"     \"Induction immunosuppression following lung transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/47/29433?source=see_link\">",
"     \"Infection in the solid organ transplant recipient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Ventilatory support and weaning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard ventilation and weaning techniques have been satisfactory after single or bilateral lung transplantation except in special circumstances. After SLT for COPD or emphysema, positive end-expiratory pressure (PEEP) is not used, or is limited to low pressures (eg, 5 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O), because PEEP may overinflate the more compliant native lung [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/34\">",
"     34",
"    </a>",
"    ]. After SLT or BLT for other indications, low-level PEEP is a standard part of postoperative ventilatory support. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/1/13336?source=see_link\">",
"     \"Overview of mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risk factors for postoperative respiratory failure (primary graft dysfunction) include: intraoperative hemorrhage or cardiovascular complications, ischemia-reperfusion lung injury, and the use of cardiopulmonary bypass in patients with severe right ventricular dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. A discussion of the management of primary graft dysfunction is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/13/36057?source=see_link\">",
"     \"Primary lung graft dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the majority of patients without ventilatory difficulty after transplant, weaning can usually proceed quickly during the first few hours to days. Recipients with pulmonary hypertension are managed differently, because hemodynamics and oxygenation are labile during the first few days, especially after SLT. Episodes of pulmonary hypertension and oxyhemoglobin desaturation sometimes occur with minimal provocation. Therefore, neuromuscular paralysis, sedation, and ventilatory support are generally continued for 24 to 48 hours after surgery. Thereafter, the paralysis and sedation are gradually reversed, as tolerated, and weaning follows.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hemodynamics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some degree of pulmonary edema of the newly transplanted lung is almost universal because vascular permeability is increased and lymphatic drainage has been severed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Pulmonary capillary wedge pressure should be kept as low as possible, consistent with adequate urine output, oxygen delivery, and systemic blood pressure. Vasopressor, inotropic, and diuretic drugs are often used concomitantly to achieve this balance.",
"   </p>",
"   <p>",
"    The optimal fluid for volume replacement post transplant is unknown. We prefer to use blood products to a goal hemoglobin of 10",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    It is our preference to use colloid instead of crystalloid solutions for further volume replacement.",
"   </p>",
"   <p>",
"    Fluid management may influence the degree of lung dysfunction. In a retrospective study involving 118 transplant patients, after controlling for cardiac disease and vasopressor requirements, central venous pressure (CVP) correlated positively with duration of mechanical ventilation and a CVP greater than 7 mmHg was associated with higher ICU and hospital mortality rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/39\">",
"     39",
"    </a>",
"    ]. It is unclear, however, whether a strategy aimed at keeping CVP less than 7 mmHg would alter outcome or whether a high CVP was merely a marker of severity of illness. Maintenance of adequate filling pressures and cardiac output is often in direct conflict with the desire to minimize lung water in these patients and requires individualized management to achieve the right balance.",
"   </p>",
"   <p>",
"    Persistent postoperative hypotension may be caused by typical postoperative sequelae (eg, intravascular volume depletion, blood loss, acute myocardial injury, and auto-PEEP). In addition, tension pneumothorax may develop from an airway anastomotic leak and, as the pericardium is entered for the pulmonary venous anastomosis, pneumopericardium and pericardial effusion with tamponade can occur [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Ischemia-reperfusion injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia-reperfusion injury is a form of acute lung injury with alveolar damage and increased vascular permeability. It occurs in 10 to 15 percent of recipients in the early post-transplantation period [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/41\">",
"     41",
"    </a>",
"    ]. Although mild forms occur, moderate to severe ischemia-reperfusion injury is typically associated with impaired oxygenation, decreased lung compliance, elevated pulmonary arterial pressures, and pulmonary infiltrates on chest radiograph. Ischemia-reperfusion injury is the main cause of primary graft dysfunction (PGD). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/13/36057?source=see_link\">",
"     \"Primary lung graft dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The International Society for Heart and Lung Transplantation has proposed a grading system for primary graft dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Grade 0 &ndash;",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      &gt;300 and normal chest x-ray",
"     </li>",
"     <li>",
"      Grade 1 &ndash;",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      &gt;300 and diffuse allograft infiltrates on chest x-ray",
"     </li>",
"     <li>",
"      Grade 2 &ndash;",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      200 to 300",
"     </li>",
"     <li>",
"      Grade 3 &ndash;",
"      <span class=\"nowrap\">",
"       PaO",
"       <sub>",
"        2",
"       </sub>",
"       /FiO",
"       <sub>",
"        2",
"       </sub>",
"      </span>",
"      &lt;200",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one of the first studies to utilize this grading system, 402 consecutive lung transplant recipients were evaluated retrospectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/43\">",
"     43",
"    </a>",
"    ]. Grade 3 primary graft dysfunction was associated with increased 90-day mortality (17 versus 9 percent), compared to patients with lower grade primary graft dysfunction. Factors associated with grade 3 primary graft dysfunction included advanced donor age, greater than 10 pack-year donor smoking history, elevated recipient pulmonary arterial pressure, and recipient diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Inhaled nitric oxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some case series of patients with severe ischemia-reperfusion injury have found improved hemodynamics and ventilation perfusion matching with inhaled nitric oxide (iNO), a potent pulmonary vasodilator with potential anti-inflammatory effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. However, other reports have not found a clinical benefit to iNO in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/46\">",
"     46",
"    </a>",
"    ]. Nebulized",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/22/359?source=see_link\">",
"     epoprostenol",
"    </a>",
"    (prostacyclin) has been proposed as an alternative to iNO [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Routine administration of iNO after lung transplantation does not appear to prevent or reduce ischemia-reperfusion injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/44,49,50\">",
"     44,49,50",
"    </a>",
"    ]. In a prospective randomized trial, the administration of iNO (20 ppm) for six hours after lung reperfusion did not reduce the incidence of ischemia-reperfusion injury and did not significantly affect relevant physiologic variables or other outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/13/36057?source=see_link&amp;anchor=H22#H22\">",
"     \"Primary lung graft dysfunction\", section on 'Nitric oxide'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H764950\">",
"    <span class=\"h3\">",
"     Extracorporeal membrane oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients not responding to inhaled nitric oxide and failing to maintain adequate oxygenation and clearance of carbon dioxide, extracorporeal membrane oxygenation (ECMO) can be used to bridge patients to recovery. The use of ECMO in treating primary lung graft dysfunction is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/13/36057?source=see_link&amp;anchor=H25#H25\">",
"     \"Primary lung graft dysfunction\", section on 'Extracorporeal membrane oxygenation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immunosuppressive regimen is begun just before or after surgery. Loading doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    may be given preoperatively, and a bolus of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    (usually 500 to 1000 mg) is given intraoperatively before perfusion of the graft. Postoperatively, the three-drug maintenance regimen is begun; all the drugs can be given intravenously until oral administration is feasible. A discussion of whether to use a cytolytic agent as part of induction and a description of ongoing immunosuppression posttransplant are presented separately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/38/3688?source=see_link\">",
"     \"Induction immunosuppression following lung transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection has been one of the leading causes of early morbidity and mortality. In the perioperative period, bacterial pathogens are the greatest threat, but fungal infection with Candida or Aspergillus species, or viral infection with herpes or cytomegalovirus (CMV) can also arise. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/29/10714?source=see_link\">",
"     \"Prophylaxis of infections in solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Broad-spectrum antibacterial antibiotics are routinely administered perioperatively. The regimen should include coverage for any potential pathogens that have been isolated from the donor or recipient. If no cultures are available, an empirical regimen should be prescribed and revised when culture results have been obtained. Our empirical antibiotic regimen is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/61/26583?source=see_link\">",
"     cefuroxime",
"    </a>",
"    1.5g three times daily until donor and recipient cultures are available.",
"   </p>",
"   <p>",
"    If Candida or Aspergillus species are isolated in the early specimens without evidence of invasion or dissemination, the addition of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    (100 to 200 mg IV or PO once daily) for Candida, or either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?20/15/20730?source=see_link\">",
"     itraconazole",
"    </a>",
"    (200 mg PO twice daily) or nebulized",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    (10 to 15 mg twice daily) for Aspergillus, should be considered as a precaution.",
"   </p>",
"   <p>",
"    Chronic immunosuppression in the weeks to months after lung transplant places recipients at an ongoing increased risk for opportunistic infection. Prophylaxis for these infections is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/29/10714?source=see_link\">",
"     \"Prophylaxis of infections in solid organ transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MONITORING AND FOLLOW-UP AFTER TRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine monitoring after lung transplantation is intended to prevent complications or to detect them as soon as possible. Although monitoring is most intensive during the first year after transplantation, it must continue for the lifetime of the recipient. The techniques include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Regular contact with a trained nurse coordinator",
"     </li>",
"     <li>",
"      Check-ups by a clinician",
"     </li>",
"     <li>",
"      Chest radiographs",
"     </li>",
"     <li>",
"      Spirometry",
"     </li>",
"     <li>",
"      Bronchoscopy",
"     </li>",
"     <li>",
"      Selected blood tests to regulate the immunosuppressive medications",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Each center has its own protocol, and regular communication among the recipient, the local clinician, and the staff at the transplant center is essential.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Lung function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung function gradually improves and usually reaches a plateau during the first three to six months after surgery. The exact values for spirometric parameters are slightly different depending on the indication for transplantation (ie, the underlying lung disease) and the type of transplant procedure. A single center retrospective series found that after bilateral transplantation, forced vital capacity (FVC) was stable at about 67 percent predicted at 1 and 5 years, while forced expiratory volume in 1 second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ) declined slightly from 65 to 59 percent predicted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/52\">",
"     52",
"    </a>",
"    ]. After single lung transplant, the FVC declined from 62 to 51 percent predicted and FEV",
"    <sub>",
"     1",
"    </sub>",
"    declined from 51 to 40 percent predicted at those same time points.",
"   </p>",
"   <p>",
"    A sustained decline of 10 to 15 percent or more in FVC or FEV",
"    <sub>",
"     1",
"    </sub>",
"    signals a potentially significant problem [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/53-57\">",
"     53-57",
"    </a>",
"    ]. One retrospective study of 15 heart-lung patients undergoing twice daily spirometry measurements found that rejection as determined via biopsy had been associated with a mean decline in FEV",
"    <sub>",
"     1",
"    </sub>",
"    and FVC of 10.4 and 9.3 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/54\">",
"     54",
"    </a>",
"    ]. Most programs equip their recipients with a hand-held, personal spirometer, teach them to monitor their own FVC and FEV",
"    <sub>",
"     1",
"    </sub>",
"    , and caution them to report any downward trend in these measurements. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/25/18841?source=see_link\">",
"     \"Chronic lung transplant rejection: Bronchiolitis obliterans\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Transbronchial lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transbronchial lung biopsy is safe and effective for the diagnosis of clinically suspected acute rejection and infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/53,58-69\">",
"     53,58-69",
"    </a>",
"    ]. When performed for a clinical indication, the sensitivity for detecting acute rejection and CMV infection is relatively high (72 to 94 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/58,60,63,68\">",
"     58,60,63,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the sensitivity of transbronchial biopsy for the diagnosis of bronchiolitis obliterans, the histologic counterpart of chronic allograft rejection, has been inconsistent, and a negative transbronchial biopsy does not exclude obliterative bronchiolitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/68,70-75\">",
"     68,70-75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/25/18841?source=see_link\">",
"     \"Chronic lung transplant rejection: Bronchiolitis obliterans\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Periodic transbronchial biopsy for surveillance in asymptomatic, clinically and physiologically stable recipients is controversial, and the practice varies among centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/76\">",
"     76",
"    </a>",
"    ]. Our practice is to perform surveillance transbronchial biopsy once a month for the first three months after transplantation, then at six months and one year. Thereafter, surveillance is determined by the rejection history during the first year. Surveillance is discontinued in recipients who have been relatively free of rejection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     RETRANSPLANTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Retransplantation is infrequent. In the ISHLT Registry, it was the indication for only 4 percent of lung and heart-lung procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/77\">",
"     77",
"    </a>",
"    ]. The most common reasons for retransplantation are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Early graft failure",
"     </li>",
"     <li>",
"      Intractable airway complications",
"     </li>",
"     <li>",
"      Chronic rejection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When retransplantation is being considered, a number of factors need to be taken into account. These include the timing and indication for retransplant, the presence of other comorbidities, immunosuppressive management, infection prophylaxis, and the likelihood of success.",
"   </p>",
"   <p>",
"    The most common retransplantation procedure in patients with a previous double transplant is a double transplant and in patients with an initial single transplant a single contralateral is most common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/80\">",
"     80",
"    </a>",
"    ]. The choice of retransplant procedure did not appear to affect outcome. Renal failure associated with prolonged immunosuppression appeared to contribute to the poorer outcomes noted after retransplantation compared with initial transplantation. Alternatively, the presence of renal failure may be a surrogate marker for either the duration and intensity of immunosuppression or the degree of disease of the microcirculation in other organs (eg, the heart).",
"   </p>",
"   <p>",
"    Conflicting data have been reported regarding outcomes after retransplantation compared with primary transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/77,79-85\">",
"     77,79-85",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective study of 205 patients who were retransplanted between 2001 and 2006 found that survival at one, two, and three years was 65, 52, and 48 percent, respectively (",
"      <a class=\"graphic graphic_figure graphicRef61310 \" href=\"mobipreview.htm?30/63/31742\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/80\">",
"       80",
"      </a>",
"      ]. This compared with initial transplant survivals of 85, 76, and 70 percent, respectively. Mechanical ventilation at the time of retransplantation and retransplantation at less than 30 days after the initial transplant were associated with an increased risk of death.",
"     </li>",
"     <li>",
"      In a retrospective study, the outcomes of 354 retransplants were compared with 10,846 primary transplants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/84\">",
"       84",
"      </a>",
"      ]. Analyzing retransplant patients matched for confounding variables with primary transplant recipients, no difference in survival time was noted, although there was a significant increase in the risk of death in the overall retransplant group. Lower serum creatinine and better functional status were predictors of better survival in the retransplant group.",
"     </li>",
"     <li>",
"      In the largest single-center experience, retransplantation represented 8.5 percent of 614 lung transplant procedures [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/83\">",
"       83",
"      </a>",
"      ]. Among the retransplant patients, those with bronchiolitis obliterans due to chronic graft rejection had an equivalent outcome to primary lung transplant (63 percent 5 year survival). In contrast, retransplant for airway dehiscence or acute primary graft failure resulted in greater than 50 percent mortality at one year after operation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/83,86\">",
"       83,86",
"      </a>",
"      ]. Patients' ambulatory status was a strong predictor of survival.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some data suggest that obliterative bronchiolitis does not recur at an accelerated rate, but has at least the same frequency (38 percent by two years) after retransplantation, as after first transplants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/82,83,87,88\">",
"     82,83,87,88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the donor shortage, retransplantation has raised many ethical issues and retransplantation for chronic rejection has been especially controversial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/50/38697/abstract/79,86,87,89-92\">",
"     79,86,87,89-92",
"    </a>",
"    ]. Retransplantation should be considered only for carefully selected patients who are ambulatory and who would meet most, if not all, other general guidelines for a first transplant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/9/19603?source=see_link\">",
"       \"Patient information: Lung transplant (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Single lung transplantation is performed through a posterolateral incision or through an anterolateral incision. Bypass is rarely needed in recipients with obstructive lung disease, but it has been required in 17 to 41 percent of patients with restrictive lung disease. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Single lung transplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bilateral lung transplantation is performed through a transverse thoracosternotomy or bilateral anterolateral incisions, and the lungs are implanted separately and sequentially. Cardiopulmonary bypass is needed for pediatric recipients, adult recipients with pulmonary vascular disease, and in about one-fourth to one-third of other patients. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Bilateral lung transplantation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lobar transplantation from living donors is an option for recipients who seem unlikely to survive until cadaveric lungs become available. One, three, and five year survivals parallel those for cadaveric lung transplant. Patients undergoing retransplant and intubated patients are at high risk for a poor outcome. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Lobar transplantation from living donors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Standard ventilation and weaning techniques have been satisfactory after single or bilateral lung transplantation except that positive end expiratory pressure (PEEP) greater than 5 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O is avoided after single lung transplantation for COPD. Weaning may be prolonged in patients transplanted for pulmonary hypertension. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Ventilatory support and weaning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ischemia-reperfusion injury is the main cause of primary graft dysfunction. Inhaled nitric oxide (iNO) and extracorporeal membrane oxygenation (ECMO) may be useful in the management of severe cases of ischemia-reperfusion injury. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Ischemia-reperfusion injury'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/13/36057?source=see_link&amp;anchor=H23#H23\">",
"       \"Primary lung graft dysfunction\", section on 'Treatment'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Before perfusion of the transplanted lung, immunosuppression is begun with loading doses of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      . Postoperatively, the three-drug maintenance regimen is begun, using cyclosporine or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      , azathioprine or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/29/4569?source=see_link\">",
"       mycophenolate",
"      </a>",
"      mofetil, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Immunosuppression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Broad-spectrum antibacterial antibiotics are routinely administered perioperatively, covering any potential pathogens that have been isolated from the donor or recipient. In the absence of specific culture results, our empiric antibiotic regimen is",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?25/61/26583?source=see_link\">",
"       cefuroxime",
"      </a>",
"      . If Candida or Aspergillus species are isolated in the early specimens, empiric antifungal coverage is added. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lung function improves over the first three to six months after transplant and is then stable. Frequent monitoring of FVC and FEV",
"      <sub>",
"       1",
"      </sub>",
"      at home is helpful to identify rejection. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Lung function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Transbronchial lung biopsy is a safe and effective method for identifying acute rejection and infection. Routine surveillance transbronchial biopsy is controversial, but our practice is to perform surveillance transbronchial biopsy once a month for the first three months after transplantation, then at six months and one year. After one year, surveillance is determined by the rejection history during the first year. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Transbronchial lung biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Retransplantation should be considered only for carefully selected patients who are ambulatory and who would meet most, if not all, other general guidelines for a first transplant. Retransplantation for chronic graft rejection appears to have a better outcome than retransplantation for airway dehiscence or acute primary graft failure. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Retransplantation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/1\">",
"      Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/2\">",
"      Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999; 340:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/3\">",
"      Hirt SW, Haverich A, Wahlers T, et al. Predictive criteria for the need of extracorporeal circulation in single-lung transplantation. Ann Thorac Surg 1992; 54:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/4\">",
"      de Hoyos A, Demajo W, Snell G, et al. Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg 1993; 106:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/5\">",
"      Triantafillou AN, Pasque MK, Huddleston CB, et al. Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults. Ann Thorac Surg 1994; 57:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/6\">",
"      Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987; 93:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/7\">",
"      Shennib H, Massard G. Airway complications in lung transplantation. Ann Thorac Surg 1994; 57:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/8\">",
"      Griffith BP, Magee MJ, Gonzalez IF, et al. Anastomotic pitfalls in lung transplantation. J Thorac Cardiovasc Surg 1994; 107:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/9\">",
"      Calhoon JH, Grover FL, Gibbons WJ, et al. Single lung transplantation. Alternative indications and technique. J Thorac Cardiovasc Surg 1991; 101:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/10\">",
"      Miller JD, DeHoyos A. An evaluation of the role of omentopexy and of early perioperative corticosteroid administration in clinical lung transplantation. The University of Toronto and Washington University Lung Transplant Programs. J Thorac Cardiovasc Surg 1993; 105:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/11\">",
"      Khaghani A, Tadjkarimi S, al-Kattan K, et al. Wrapping the anastomosis with omentum or an internal mammary artery pedicle does not improve bronchial healing after single lung transplantation: results of a randomized clinical trial. J Heart Lung Transplant 1994; 13:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/12\">",
"      Colquhoun IW, Gascoigne AD, Au J, et al. Airway complications after pulmonary transplantation. Ann Thorac Surg 1994; 57:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/13\">",
"      Daly RC, Tadjkarimi S, Khaghani A, et al. Successful double-lung transplantation with direct bronchial artery revascularization. Ann Thorac Surg 1993; 56:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/14\">",
"      Daly RC, McGregor CG. Routine immediate direct bronchial artery revascularization for single-lung transplantation. Ann Thorac Surg 1994; 57:1446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/15\">",
"      Svendsen, UG, Anderson, CB, Arendrup, H, et al. Double-lung transplantation with direct bronchial artery revascularization (abstract). J Heart Lung Transplant 1996; 15:S89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/16\">",
"      Pettersson GB, Yun JJ, N&oslash;rgaard MA. Bronchial artery revascularization in lung transplantation: techniques, experience, and outcomes. Curr Opin Organ Transplant 2010; 15:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/17\">",
"      Patterson GA. Airway revascularization: is it necessary? Ann Thorac Surg 1993; 56:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/18\">",
"      Inci I, Weder W. Airway complications after lung transplantation can be avoided without bronchial artery revascularization. Curr Opin Organ Transplant 2010; 15:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/19\">",
"      Schmid RA, Boehler A, Speich R, et al. Bronchial anastomotic complications following lung transplantation: still a major cause of morbidity? Eur Respir J 1997; 10:2872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/20\">",
"      Patterson GA, Cooper JD, Goldman B, et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg 1988; 45:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/21\">",
"      Cooper JD, Patterson GA, Grossman R, Maurer J. Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis 1989; 139:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/22\">",
"      Pasque MK, Cooper JD, Kaiser LR, et al. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 1990; 49:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/23\">",
"      Egan, TM, Detterbeck, FC. Technique and results of double lung transplantation. Chest Surg Clin North Am 1993; 3:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/24\">",
"      Fischer S, Str&uuml;ber M, Simon AR, et al. Video-assisted minimally invasive approach in clinical bilateral lung transplantation. J Thorac Cardiovasc Surg 2001; 122:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/25\">",
"      Szeto WY, Kreisel D, Karakousis GC, et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome. J Thorac Cardiovasc Surg 2002; 124:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/26\">",
"      Shaw LR, Miller JD, Slutsky AS, et al. Ethics of lung transplantation with live donors. Lancet 1991; 338:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/27\">",
"      Jones, J, Payne, WD, Matas, AJ. The living donor - risks, benefits, and related concerns. Transplant Rev 1993; 7:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/28\">",
"      Spital A. Living organ donation. Shifting responsibility. Arch Intern Med 1991; 151:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/29\">",
"      Cohen RG, Barr ML, Schenkel FA, et al. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg 1994; 57:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/30\">",
"      Starnes VA, Barr ML, Cohen RG. Lobar transplantation. Indications, technique, and outcome. J Thorac Cardiovasc Surg 1994; 108:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/31\">",
"      Starnes VA, Barr ML, Cohen RG, et al. Living-donor lobar lung transplantation experience: intermediate results. J Thorac Cardiovasc Surg 1996; 112:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/32\">",
"      Starnes VA, Woo MS, MacLaughlin EF, et al. Comparison of outcomes between living donor and cadaveric lung transplantation in children. Ann Thorac Surg 1999; 68:2279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/33\">",
"      Starnes VA, Bowdish ME, Woo MS, et al. A decade of living lobar lung transplantation: recipient outcomes. J Thorac Cardiovasc Surg 2004; 127:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/34\">",
"      Yonan NA, el-Gamel A, Egan J, et al. Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant 1998; 17:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/35\">",
"      Chatila WM, Furukawa S, Gaughan JP, Criner GJ. Respiratory failure after lung transplantation. Chest 2003; 123:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/36\">",
"      Meyers BF, de la Morena M, Sweet SC, et al. Primary graft dysfunction and other selected complications of lung transplantation: A single-center experience of 983 patients. J Thorac Cardiovasc Surg 2005; 129:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/37\">",
"      Kaplan JD, Trulock EP, Cooper JD, Schuster DP. Pulmonary vascular permeability after lung transplantation. A positron emission tomographic study. Am Rev Respir Dis 1992; 145:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/38\">",
"      Kundu S, Herman SJ, Winton TL. Reperfusion edema after lung transplantation: radiographic manifestations. Radiology 1998; 206:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/39\">",
"      Pilcher DV, Scheinkestel CD, Snell GI, et al. High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation. J Thorac Cardiovasc Surg 2005; 129:912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/40\">",
"      Lasocki S, Castier Y, Geffroy A, et al. Early cardiac tamponade due to tension pneumopericardium after bilateral lung transplantation. J Heart Lung Transplant 2007; 26:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/41\">",
"      de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/42\">",
"      Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24:1454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/43\">",
"      Whitson BA, Nath DS, Johnson AC, et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006; 131:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/44\">",
"      Ardehali A, Laks H, Levine M, et al. A prospective trial of inhaled nitric oxide in clinical lung transplantation. Transplantation 2001; 72:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/45\">",
"      Date H, Triantafillou AN, Trulock EP, et al. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996; 111:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/46\">",
"      Garat C, Jayr C, Eddahibi S, et al. Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med 1997; 155:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/47\">",
"      Fiser SM, Cope JT, Kron IL, et al. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 2001; 121:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/48\">",
"      Khan TA, Schnickel G, Ross D, et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg 2009; 138:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/49\">",
"      Meade MO, Granton JT, Matte-Martyn A, et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med 2003; 167:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/50\">",
"      Cornfield DN, Milla CE, Haddad IY, et al. Safety of inhaled nitric oxide after lung transplantation. J Heart Lung Transplant 2003; 22:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/51\">",
"      Brock MV, Borja MC, Ferber L, et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant 2001; 20:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/52\">",
"      Mason DP, Rajeswaran J, Murthy SC, et al. Spirometry after transplantation: how much better are two lungs than one? Ann Thorac Surg 2008; 85:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/53\">",
"      Starnes VA, Theodore J, Oyer PE, et al. Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg 1989; 98:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/54\">",
"      Otulana BA, Higenbottam T, Ferrari L, et al. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest 1990; 97:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/55\">",
"      Otulana BA, Higenbottam T, Scott J, et al. Lung function associated with histologically diagnosed acute lung rejection and pulmonary infection in heart-lung transplant patients. Am Rev Respir Dis 1990; 142:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/56\">",
"      Becker FS, Martinez FJ, Brunsting LA, et al. Limitations of spirometry in detecting rejection after single-lung transplantation. Am J Respir Crit Care Med 1994; 150:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/57\">",
"      Martinez JA, Paradis IL, Dauber JH, et al. Spirometry values in stable lung transplant recipients. Am J Respir Crit Care Med 1997; 155:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/58\">",
"      Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/59\">",
"      Starnes VA, Theodore J, Oyer PE, et al. Pulmonary infiltrates after heart-lung transplantation: evaluation by serial transbronchial biopsies. J Thorac Cardiovasc Surg 1989; 98:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/60\">",
"      Scott JP, Fradet G, Smyth RL, et al. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant 1991; 10:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/61\">",
"      Marshall SE, Lewiston NJ, Kramer MR, et al. Prospective analysis of serial pulmonary function studies and transbronchial biopsies in single-lung transplant recipients. Transplant Proc 1991; 23:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/62\">",
"      Marchevsky A, Hartman G, Walts A, et al. Lung transplantation: the pathologic diagnosis of pulmonary complications. Mod Pathol 1991; 4:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/63\">",
"      Trulock EP, Ettinger NA, Brunt EM, et al. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest 1992; 102:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/64\">",
"      Sibley RK, Berry GJ, Tazelaar HD, et al. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant 1993; 12:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/65\">",
"      Clelland C, Higenbottam T, Stewart S, et al. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis 1993; 147:1386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/66\">",
"      De Hoyos A, Chamberlain D, Schvartzman R, et al. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest 1993; 103:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/67\">",
"      Kurland G, Noyes BE, Jaffe R, et al. Bronchoalveolar lavage and transbronchial biopsy in children following heart-lung and lung transplantation. Chest 1993; 104:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/68\">",
"      Pomerance A, Madden B, Burke MM, Yacoub MH. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J Heart Lung Transplant 1995; 14:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/69\">",
"      Chan CC, Abi-Saleh WJ, Arroliga AC, et al. Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients. J Heart Lung Transplant 1996; 15:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/70\">",
"      Yousem SA, Paradis IL, Dauber JH, Griffith BP. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1989; 47:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/71\">",
"      Kramer MR, Stoehr C, Whang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/72\">",
"      Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1994; 13:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/73\">",
"      Yousem SA, Paradis I, Griffith BP. Can transbronchial biopsy aid in the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation 1994; 57:151.",
"     </a>",
"    </li>",
"    <li>",
"     Yousem SA, Ohori NP. Pathological classification of acute and chronic rejection of the lung. In: Immunology of the Lung Allograft, Shennib H (Ed), RG Landes, Austin 1995. p.29.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/75\">",
"      Bando K, Paradis IL, Similo S, et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 1995; 110:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/76\">",
"      McWilliams TJ, Williams TJ, Whitford HM, Snell GI. Surveillance bronchoscopy in lung transplant recipients: risk versus benefit. J Heart Lung Transplant 2008; 27:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/77\">",
"      Hosenpud JD, Novick RJ, Breen TJ, et al. The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995. J Heart Lung Transplant 1995; 14:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/78\">",
"      Novick RJ, Kaye MP, Patterson GA, et al. Redo lung transplantation: a North American-European experience. J Heart Lung Transplant 1993; 12:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/79\">",
"      Novick RJ, Sch&auml;fers HJ, Stitt L, et al. Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients. J Thorac Cardiovasc Surg 1995; 110:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/80\">",
"      Kawut SM, Lederer DJ, Keshavjee S, et al. Outcomes after lung retransplantation in the modern era. Am J Respir Crit Care Med 2008; 177:114.",
"     </a>",
"    </li>",
"    <li>",
"     Division of Transplantation, Bureau of Health Resources Development. 1995 Annual Report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network - Transplant Data: 1988-1994. Health Resources and Services Administration, US Department of Health and Human Services, Rockville, MD, 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/82\">",
"      Novick RJ, Stitt LW, Al-Kattan K, et al. Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry. Ann Thorac Surg 1998; 65:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/83\">",
"      Strueber M, Fischer S, Gottlieb J, et al. Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg 2006; 132:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/84\">",
"      Shuhaiber JH, Kim JB, Hur K, Gibbons RD. Survival of primary and repeat lung transplantation in the United States. Ann Thorac Surg 2009; 87:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/85\">",
"      McCurry KR, Shearon TH, Edwards LB, et al. Lung transplantation in the United States, 1998-2007. Am J Transplant 2009; 9:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/86\">",
"      Keshavjee S. Retransplantation of the lung comes of age. J Thorac Cardiovasc Surg 2006; 132:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/87\">",
"      Novick RJ, Sch&auml;fers HJ, Stitt L, et al. Seventy-two pulmonary retransplantations for obliterative bronchiolitis: predictors of survival. Ann Thorac Surg 1995; 60:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/88\">",
"      Brugi&egrave;re O, Thabut G, Castier Y, et al. Lung retransplantation for bronchiolitis obliterans syndrome: long-term follow-up in a series of 15 recipients. Chest 2003; 123:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/89\">",
"      Ubel PA, Arnold RM, Caplan AL. Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. JAMA 1993; 270:2469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/90\">",
"      Evans RW, Manninen DL, Dong FB, McLynne DA. Is retransplantation cost effective? Transplant Proc 1993; 25:1694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/91\">",
"      Mentzer SJ, Reilly JJ Jr, Caplan AL, Sugarbaker DJ. Ethical considerations in lung retransplantation. J Heart Lung Transplant 1994; 13:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/50/38697/abstract/92\">",
"      Novick RJ, Andr&eacute;assian B, Sch&auml;fers HJ, et al. Pulmonary retransplantation for obliterative bronchiolitis. Intermediate-term results of a North American-European series. J Thorac Cardiovasc Surg 1994; 107:755.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4651 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-D8D1174216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38697=[""].join("\n");
var outline_f37_50_38697=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SINGLE LUNG TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cardiopulmonary bypass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Bronchial anastomosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      BILATERAL LUNG TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cardiopulmonary bypass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LOBAR TRANSPLANTATION FROM LIVING DONORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      POSTOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Ventilatory support and weaning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hemodynamics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Ischemia-reperfusion injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Inhaled nitric oxide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H764950\">",
"      - Extracorporeal membrane oxygenation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MONITORING AND FOLLOW-UP AFTER TRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Lung function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Transbronchial lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      RETRANSPLANTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4651\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4651|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/63/31742\" title=\"figure 1\">",
"      Retransplantation survival",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/32/26121?source=related_link\">",
"      Airway complications after lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/25/18841?source=related_link\">",
"      Chronic lung transplant rejection: Bronchiolitis obliterans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/6/99?source=related_link\">",
"      Heart-lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/38/3688?source=related_link\">",
"      Induction immunosuppression following lung transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/47/29433?source=related_link\">",
"      Infection in the solid organ transplant recipient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12425?source=related_link\">",
"      Lung transplantation: Deceased donor evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/29/31192?source=related_link\">",
"      Lung transplantation: Disease-based choice of procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/32/5640?source=related_link\">",
"      Lung transplantation: Donor lung preservation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/20/26953?source=related_link\">",
"      Lung transplantation: General guidelines for recipient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/1/13336?source=related_link\">",
"      Overview of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/9/19603?source=related_link\">",
"      Patient information: Lung transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/13/36057?source=related_link\">",
"      Primary lung graft dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/29/10714?source=related_link\">",
"      Prophylaxis of infections in solid organ transplantation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_50_38698="Condyloma acuminatum1";
var content_f37_50_38698=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60946%7EOBGYN%2F72781%7EOBGYN%2F51759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60946%7EOBGYN%2F72781%7EOBGYN%2F51759&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Perianal condyloma acuminatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 513px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar condyloma acuminatum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Condyloma acuminatum involving vulva, vagina, and perianal region",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 491px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38698=[""].join("\n");
var outline_f37_50_38698=null;
var title_f37_50_38699="Surgery native valve IE";
var content_f37_50_38699=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76266&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA Guideline Summary: Surgery for native valve endocarditis (NVE)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class I - There is evidence and/or general agreement that surgery is indicated in patients with NVE with one of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Valve stenosis or regurgitation leading to heart failure.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Aortic or mitral regurgitation with hemodynamic evidence of elevated left ventricular end-diastolic or atrial pressures such as premature closure of the mitral valve with aortic regurgitation, rapid decelerating mitral regurgitation signal by continuous wave Doppler (v-wave cutoff sign), or moderate to severe pulmonary hypertension.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; IE due to fungal or other highly resistant organisms.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Complications such as heart block, annular or aortic abscess, or destructive penetrating lesions such as fistula from the sinus of Valsalva to the right or left atrium or right ventricle, mitral leaflet perforation with IE of the aortic valve, or infection in annulus fibrosis.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class IIa - The weight of evidence or opinion is in favor of the usefulness of surgery in patients with NVE who develop the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Recurrent emboli and persistent vegetations despite appropriate antibiotic therapy.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Class IIb - The weight of evidence or opinion is less well established for the usefulness of surgery in patients with NVE who develop the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       &bull; Mobile vegetations larger than 10 mm with or without emboli.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients withvalvular heart disease. A report of the American College ofCardiology/American Heart Association Task Force on Practice Guidelines(Writing committee to revise the 1998 guidelines for the management ofpatients with valvular heart disease). J Am Coll Cardiol 2006; 48:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38699=[""].join("\n");
var outline_f37_50_38699=null;
var title_f37_50_38700="Genetics and clinical features NPD";
var content_f37_50_38700=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Genetics and clinical features of Niemann-Pick disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        OMIM",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene (chromosome); all are autosomal recessive",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Niemann-Pick disease type A",
"       </td>",
"       <td rowspan=\"3\">",
"        257200",
"       </td>",
"       <td rowspan=\"3\">",
"        SMPD1 (11p15.4-p15.1)",
"       </td>",
"       <td>",
"        Onset in first months of life; hepatosplenomegaly, interstitial lung disease, feeding difficulty, loss of early motor skills, rapidly progressive loss of neurologic function, peripheral neuropathy, macular cherry red spot.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Death, typically from respiratory failure, occurs by age two or three years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnosis confirmed when residual acid sphingomyelinase activity is &lt;10 percent of control.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Niemann-Pick disease type B",
"       </td>",
"       <td rowspan=\"3\">",
"        607616",
"       </td>",
"       <td rowspan=\"3\">",
"        SMPD1 (11p15.4-p15.1)",
"       </td>",
"       <td>",
"        Onset in infancy or childhood; hepatosplenomegaly, thrombocytopenia, short stature with delayed skeletal maturation, interstitial lung disease, hyperlipidemia, ocular abnormalities. Neurologic abnormalities (cerebellar signs, nystagmus, extrapyramidal involvement, mental retardation, psychiatric disorders, and peripheral neuropathy) occur in about 30 percent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Generally less severe than NPD-A, with most affected patients surviving into adulthood.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnosis confirmed when residual acid sphingomyelinase activity is &lt;10 percent of control.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        Niemann-Pick disease type C",
"       </td>",
"       <td rowspan=\"6\">",
"        <p>",
"         257220",
"        </p>",
"        607625",
"       </td>",
"       <td rowspan=\"6\">",
"        <p>",
"         NPC1 (18q11-q12)",
"        </p>",
"        NPC2 (14q24.3)",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Wide phenotypic spectrum. Onset ranges from in utero to infancy, childhood, or adulthood.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Antenatal cases present with fetal ascites.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Neonatal onset occurs with severe hepatic disease and/or respiratory failure; other neonates have hypotonia and developmental delay with little or no hepatic and pulmonary involvement.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Most cases have onset in middle to late childhood after normal early development. Neurologic manifestations are cerebellar involvement (clumsiness, gait problems, eventual frank ataxia), vertical supranuclear ophthalmoplegia, and slowly progressive cognitive deterioration. Dystonia, dysarthria, dysphagia and seizures are common. Death typically occurs from aspiration pneumonia in the second or third decade of life.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &bull; Adult onset is usually similar to juvenile/childhood cases but with slower progression. Adult cases may also present with cognitive dysfunction or psychiatric disturbances.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diagnosis confirmed by impaired LDL cholesterol esterification and positive filipin staining in cultured skin fibroblasts.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38700=[""].join("\n");
var outline_f37_50_38700=null;
var title_f37_50_38701="LVEF predicts one-year mortality after STEMI";
var content_f37_50_38701=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68071&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    LVEF predicts one-year mortality after STEMI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 266px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among 3197 patients with an acute ST elevation myocardial infarction (STEMI) who were treated with thrombolytic therapy in the TIMI II trial, the one-year mortality correlated with the resting left ventricular ejection fraction (LVEF) measured by radionuclide ventriculography obtained within 14 days of the event. The mortality was highest in patients with an LVEF &lt;30 percent (9.9 percent). Patients not undergoing study for any reason had an intermediate mortality of 6.6 percent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Zaret BL, Wackers FJ, Terrin ML, et al. J Am Coll Cardiol 1995; 26:73.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38701=[""].join("\n");
var outline_f37_50_38701=null;
var title_f37_50_38702="Oxygen consumption during exercise in pregnancy";
var content_f37_50_38702=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    VO",
"    <sub>",
"     2",
"    </sub>",
"    exercise pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 523px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Oxygen consumption (VO",
"    <sub>",
"     2",
"    </sub>",
"    ) determinations obtained at rest and then at the peak of mild, moderate, and maximal oxygen consumption exercise.",
"    <div class=\"footnotes\">",
"     * P &lt;0.01.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Artal, R, Wiswell, R, Romen, Y, Dorey, F. Pulmonary responses to exercise in pregnancy. Am J Obstet Gynecol 1986; 154:378. Copyright &copy;1986 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38702=[""].join("\n");
var outline_f37_50_38702=null;
var title_f37_50_38703="Cardiac output in pregnancy";
var content_f37_50_38703=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 491px\">",
"   <div class=\"ttl\">",
"    Systemic hemodynamics during normal pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 471px; height: 518px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Bonica, JJ, McDonald, JS. Principles and Practice of Obstetric Analgesia and Anesthesia, 2nd ed, Williams &amp; Wilkins, Baltimore, 1994. p. 60.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_50_38703=[""].join("\n");
var outline_f37_50_38703=null;
